<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/sitemap?view=xsl&amp;format=xsl&amp;layout=standard&amp;id=1&amp;title=Sitemap+del+sito+Osservatorio+Terapie+Avanzate"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-sola-terapia-genica-per-fermare-l-atrofia-muscolare-spinale-e-diversi-tipi-di-distrofie]]></loc><lastmod>2020-02-04T14:50:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/crispr-cas9-le-forbici-molecolari-diventano-bisturi-di-precisione]]></loc><lastmod>2020-02-04T14:50:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/linfociti-t-potenziati-con-la-terapia-car-t-contro-la-leucemia-linfoblastica-acuta]]></loc><lastmod>2020-02-04T14:51:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-allarga-il-suo-campo-d-azione-all-adrenoleucodistrofia]]></loc><lastmod>2020-02-04T14:51:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-distrofia-di-duchenne-grazie-a-parent-project-usa-un-finanziamento-da-2-5-milioni-di-dollari]]></loc><lastmod>2020-02-04T14:51:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-cas9-alla-ricerca-della-causa-della-sla]]></loc><lastmod>2020-02-04T14:52:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-fda-autorizza-la-prosecuzione-dei-trial-clinici-dedicati-all-anemia-falciforme]]></loc><lastmod>2020-01-17T20:07:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-dopo-le-gemelline-dal-dna-alterato-nate-in-cina-si-parla-di-spermatozoi-modificati-negli-usa]]></loc><lastmod>2020-02-04T14:54:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-prosegue-la-strada-di-edit-101-contro-l-amaurosi-congenita-di-leber-di-tipo-10]]></loc><lastmod>2020-07-17T09:58:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/medicina-rigenerativa-al-prof-michele-de-luca-il-premio-innovators-in-science]]></loc><lastmod>2020-12-04T14:46:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/e-l-uomo-creo-l-uomo-ll-libro-di-medolesi-dedicato-a-crispr-e-all-editing-genomico]]></loc><lastmod>2021-03-26T14:30:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/curarsi-nel-futuro-il-libro-di-fossati-e-simone-dedicato-a-staminali-e-terapia-genica]]></loc><lastmod>2021-03-26T12:40:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genetico-in-utero-grazie-a-crispr-in-futuro-si-potranno-curare-malattie-genetiche-rare-direttamente-nel-grembo-materno]]></loc><lastmod>2020-02-04T14:53:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-scoperto-come-prolungare-l-effetto-di-crispr-nella-distrofia-di-duchenne]]></loc><lastmod>2020-02-04T14:52:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-in-vivo-per-la-cura-della-sindrome-di-hunter-sangamo-therapeutics-punta-sulle-zfn]]></loc><lastmod>2019-02-25T08:43:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-in-vivo-trattato-un-primo-paziente-con-emofilia-b]]></loc><lastmod>2019-02-25T08:43:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-2018-un-anno-di-importanti-traguardi-e-riconoscimenti]]></loc><lastmod>2019-04-11T09:47:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/riprogrammazione-cellulare-create-in-laboratorio-cellule-staminali-ad-uno-stadio-immaturo]]></loc><lastmod>2019-02-03T18:03:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-che-mirano-all-rna-combattere-la-distrofia-di-duchenne-la-sma-e-altre-patologie-con-gli-oligonucleotidi]]></loc><lastmod>2019-01-21T14:48:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/luigi-naldini-vince-il-premio-louis-jeantet-2019-per-la-ricerca-traslazionale]]></loc><lastmod>2019-02-25T14:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/scimmie-clonate-in-cina-con-crispr-un-modello-per-studiare-malattie-neurodegenerative-e-tumori]]></loc><lastmod>2019-02-26T08:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/franco-locatelli-e-il-nuovo-presidente-del-consiglio-superiore-di-sanita]]></loc><lastmod>2019-02-25T09:58:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-create-le-prime-cellule-staminali-antirigetto-invisibili-al-sistema-immunitario]]></loc><lastmod>2019-03-08T08:37:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-per-crispr-e-tempo-di-casx]]></loc><lastmod>2019-03-08T08:35:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-distrofia-muscolare-di-duchenne-a-che-punto-siamo]]></loc><lastmod>2019-02-27T15:13:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-la-rivoluzione-dell-immunoterapia-la-storia-e-le-sperimentazioni-in-corso]]></loc><lastmod>2019-03-07T09:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-quali-tumori-rispondo-meglio]]></loc><lastmod>2019-03-05T13:20:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-ottimi-risultati-per-la-beta-talassemia]]></loc><lastmod>2019-03-05T13:16:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-pluripotenti-indotte-un-nuovo-protocollo-sperimentale-per-il-trattamento-del-diabete]]></loc><lastmod>2019-03-05T13:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-da-la-caccia-alle-infezioni]]></loc><lastmod>2019-03-06T11:16:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/combinare-terapia-cellulare-e-bioingegneria-per-combattere-la-degenerazione-maculare]]></loc><lastmod>2019-03-11T09:14:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-l-approvazione-in-giappone-delle-staminali-mesenchimali-per-le-lesioni-spinali-fa-discutere]]></loc><lastmod>2019-03-11T09:34:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/unistem-day-15-marzo-2019]]></loc><lastmod>2019-09-30T14:13:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-con-crispr-si-lavora-ad-una-terapia-per-la-progeria]]></loc><lastmod>2021-01-25T17:20:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-per-prevenire-la-malattia-di-alzheimer]]></loc><lastmod>2019-03-12T14:02:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/bimbe-editate-in-cina-cosa-sappiamo-tre-mesi-dopo]]></loc><lastmod>2019-04-08T06:36:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/fermiamo-la-sperimentazione-clinica-dell-editing-genetico-su-gameti-ed-embrioni-umani-l-appello-degli-scienziati-su-nature]]></loc><lastmod>2019-03-18T15:10:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/stop-a-dna-modificato-sugli-embrioni-perche-si-e-resa-necessaria-la-moratoria-internazionale]]></loc><lastmod>2019-03-18T15:10:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/patologie-cardiovascolari-con-le-staminali-gli-scienziati-ricreano-apparato-circolatorio]]></loc><lastmod>2019-06-20T10:31:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/sclerosi-multipla-la-terapia-cellulare-e-la-migliore-opzione]]></loc><lastmod>2019-03-18T12:19:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-artificiali-nuove-strategie-per-il-trattamento-di-diverse-malattie-genetiche]]></loc><lastmod>2019-03-18T13:04:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/terapie-avanzate-per-le-malattie-rare-fondamentale-la-ricerca-ma-anche-la-comunicazione]]></loc><lastmod>2019-03-18T12:59:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-l-appello-per-una-moratoria-fa-discutere]]></loc><lastmod>2021-06-18T11:53:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-crispr-e-una-tecnologia-sicura]]></loc><lastmod>2020-06-30T17:58:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-approvata-negli-usa-per-il-cancro-al-seno]]></loc><lastmod>2019-09-25T15:16:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-per-hiv-un-secondo-paziente-con-remissione-a-lungo-termine]]></loc><lastmod>2019-03-25T09:03:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-arriva-l-ok-di-aifa-a-un-trial-clinico-contro-leucemia-mieloide-acuta-e-mieloma-multiplo]]></loc><lastmod>2019-04-11T07:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-futuro-di-crispr-e-dell-editing-genomico-passa-per-i-laboratorio-del-cibio-di-trento]]></loc><lastmod>2020-04-14T16:22:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-del-genoma-umano-un-registro-internazionale-per-la-ricerca-clinica]]></loc><lastmod>2019-04-01T08:34:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-il-primo-mini-cervello-umano-creato-in-laboratorio]]></loc><lastmod>2019-06-20T10:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-e-stampanti-3d-per-il-trattamento-delle-malformazioni-degli-orecchi]]></loc><lastmod>2019-04-01T06:00:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/liberta-di-scienza-e-liberta-di-scelta-all-epoca-di-crispr-una-riflessione-con-gilberto-corbellini]]></loc><lastmod>2019-04-01T08:25:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-nuovi-risultati-per-la-duchenne]]></loc><lastmod>2019-04-03T08:13:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-il-lups-eritematoso-sistemico-intervista-al-prof-lorenzo-dagna-san-raffaele-milano]]></loc><lastmod>2020-07-16T13:36:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-tredicimila-il-record-dei-refusi-corretti-con-un-colpo-di-crispr]]></loc><lastmod>2019-04-08T06:35:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/realizzato-crispr-chip-un-biosensore-per-rilevare-mutazioni-genetiche]]></loc><lastmod>2019-05-16T07:47:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/dagli-oligonucleotidi-antisenso-una-speranza-per-l-huntigton]]></loc><lastmod>2020-07-14T11:00:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/le-terapie-car-t-spiegate-al-grande-pubblico-tra-possibilita-e-sfide-da-affrontare]]></loc><lastmod>2019-04-11T07:47:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-beta-talassemia-una-possibilita-sempre-piu-concreta]]></loc><lastmod>2019-04-10T07:01:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/si-puo-potenziare-l-immunoterapia]]></loc><lastmod>2019-04-15T07:41:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-versioni-sempre-piu-evolute-contro-l-anemia-falciforme-e-la-beta-talassemia]]></loc><lastmod>2019-04-15T12:49:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/le-nuove-frontiere-dell-editing-alla-scoperta-dell-rna-e-di-adar]]></loc><lastmod>2019-04-17T08:26:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-biffi-fondamentale-informazione-corretta-necessaria-la-partnership-tra-accademia-e-industria]]></loc><lastmod>2019-05-16T07:28:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/terapie-del-futuro-conoscenze-mediche-dati-e-innovazioni-stanno-rivoluzionando-il-mondo-della-ricerca]]></loc><lastmod>2019-04-19T09:03:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/dalla-terapia-genica-una-speranza-per-l-immunodeficienza-scid-x1]]></loc><lastmod>2019-05-16T07:35:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-efficace-contro-la-sindrome-di-wiskott-aldrich]]></loc><lastmod>2019-04-26T10:20:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/car-t-per-i-tumori-solidi-a-che-punto-e-la-ricerca]]></loc><lastmod>2019-04-26T09:28:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-fara-esplodere-la-bolla]]></loc><lastmod>2019-05-16T07:44:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-i-primi-passi-sulla-strada-di-un-vaccino-contro-i-tumori]]></loc><lastmod>2019-05-02T15:07:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/anche-l-epidermolisi-bollosa-nel-mirino-di-crispr]]></loc><lastmod>2020-08-05T12:08:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/le-malattie-genetiche-polmonari-si-scontrano-con-crispr]]></loc><lastmod>2019-05-16T07:42:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-strategia-promettente-per-alcune-forme-di-cecita]]></loc><lastmod>2019-05-16T07:34:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/malattie-genetiche-muscolari-la-terapia-genica-non-si-ferma]]></loc><lastmod>2019-05-16T07:41:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/mini-organi-da-israele-arriva-il-primo-cuore-stampato-in-3d-da-cellule-umane]]></loc><lastmod>2019-06-20T10:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/car-t-tra-efficacia-e-rischi-di-una-terapia-che-va-all-attacco-dei-tumori-solidi]]></loc><lastmod>2019-05-15T14:31:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/veicolare-crispr-nelle-cellule-strategie-a-confronto]]></loc><lastmod>2019-05-22T09:12:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/un-algoritmo-contro-la-retinopatia-diabetica]]></loc><lastmod>2020-06-25T10:23:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-si-lavora-a-una-versione-che-riduca-i-rischi-tossicologici]]></loc><lastmod>2019-05-17T09:55:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/human-on-a-chip-un-mini-organismo-per-studiare-patologie-e-sperimentare-farmaci]]></loc><lastmod>2020-06-25T10:22:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/vasi-sanguigni-bioingegnerizzati-pronti-all-uso]]></loc><lastmod>2019-06-20T10:28:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/sma-arriva-l-approvazione-della-fda-per-la-prima-terapia-genica]]></loc><lastmod>2019-05-28T10:46:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-vettori-virali-piu-capienti-per-correggere-le-cecita-ereditarie]]></loc><lastmod>2019-05-24T10:34:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/l-editing-genomico-potrebbe-essere-piu-preciso-grazie-all-intelligenza-artificiale]]></loc><lastmod>2020-06-09T11:12:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/sma-come-le-rna-targeted-therapies-hanno-cambiato-la-storia-della-malattia]]></loc><lastmod>2020-01-21T10:52:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/atrofia-muscolare-spinale-la-rivoluzione-in-atto-arriva-anche-la-terapia-genica]]></loc><lastmod>2019-05-28T08:58:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/sma-quale-il-senso-dei-titoli-sulla-pillola-piu-costosa-al-mondo]]></loc><lastmod>2019-05-28T14:33:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/terapie-avanzate-siamo-certi-che-sia-un-problema-di-costi-assoluti]]></loc><lastmod>2019-06-03T14:50:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/terapie-avanzate-l-importanza-di-investire-nella-comunicazione]]></loc><lastmod>2019-06-07T10:41:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-le-cellule-natural-killer-contro-i-tumori-nascono-le-car-nk]]></loc><lastmod>2019-06-03T14:41:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/i-microrna-che-fanno-battere-il-cuore]]></loc><lastmod>2021-03-30T10:36:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/editing-genomico-su-embrioni-umani-a-che-punto-siamo-con-la-regolamentazione]]></loc><lastmod>2019-10-16T20:01:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-proteina-aumenta-l-efficacia-della-terapia-genica-per-l-emofilia]]></loc><lastmod>2019-06-05T09:40:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/il-machine-learning-promette-di-rivoluzionare-la-medicina]]></loc><lastmod>2020-06-25T10:20:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-trapianto-di-cromosoma-una-nuova-opportunita-per-le-malattie-genetiche]]></loc><lastmod>2019-06-12T14:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/una-nuova-tecnica-di-stampa-3d-spiana-la-strada-verso-nuovi-organi]]></loc><lastmod>2019-06-20T10:45:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/ecco-le-donne-che-hanno-cambiato-la-storia-delle-terapie-avanzate-dal-dna-a-crispr]]></loc><lastmod>2020-10-06T08:35:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/italia-culla-delle-terapie-avanzate]]></loc><lastmod>2019-06-18T08:43:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/ieri-in-scena-l-inizio-di-una-nuova-era-per-la-biomedicina-con-l-evento-di-osservatorio-terapie-avanzate]]></loc><lastmod>2019-06-24T07:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-la-nuova-dimensione-dei-modelli-cellulari]]></loc><lastmod>2019-06-20T11:19:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-usato-sul-cancro-la-prima-prospettiva-di-trial-clinico-dagli-usa]]></loc><lastmod>2019-06-20T13:09:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-cell-italia-i-10-milioni-stanziati-non-serviranno-a-fare-una-produzione-di-stato]]></loc><lastmod>2019-10-21T16:43:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-ema-individua-5-punti-chiave-per-migliorare-le-pratiche-regolatorie]]></loc><lastmod>2019-09-23T14:00:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-babies-dalla-russia-un-nuovo-potenziale-caso-pronto-a-far-discutere]]></loc><lastmod>2019-09-04T08:54:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/editing-genomico-sulle-cellule-staminali-direttamente-nell-organismo-la-ricerca-dice-si]]></loc><lastmod>2019-07-09T14:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-a-trieste-nasce-una-biobanca-dove-saranno-impiegati-per-lo-studio-dei-tumori]]></loc><lastmod>2019-07-09T14:34:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/una-combo-di-farmaci-ed-editing-genomico-potrebbe-sconfiggere-l-hiv]]></loc><lastmod>2020-04-29T08:27:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-il-bersaglio-ideale-e-l-emofilia-a]]></loc><lastmod>2021-08-04T10:34:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-52-quelle-note-per-69-diversi-processi-di-immissione-in-commercio-in-corso]]></loc><lastmod>2019-09-23T14:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/vivere-la-terapia-genica-la-storia-di-salvatore-lo-re]]></loc><lastmod>2020-05-05T13:21:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/displasia-ectodermica-la-terapia-genica-va-direttamente-in-utero]]></loc><lastmod>2019-08-06T16:39:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-analisi-e-dubbi-sul-rapporto-costo-beneficio]]></loc><lastmod>2019-12-03T16:47:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-avrebbe-potuto-salvare-l-udito-di-beethoven]]></loc><lastmod>2019-12-03T16:46:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/vescicole-extracellulari-i-nuovi-vettori-per-le-terapie-del-futuro]]></loc><lastmod>2020-07-29T15:48:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/alleanza-per-la-medicina-rigenerativa-pubblicate-le-raccomandazioni-europee-per-un-rapido-accesso-alle-terapie-avanzate]]></loc><lastmod>2019-12-03T16:46:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/il-microgel-che-aumenta-la-sopravvivenza-delle-cellule-staminali]]></loc><lastmod>2019-12-03T16:46:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/car-t-dal-progetto-genoma-alle-nuove-tecniche-di-produzione]]></loc><lastmod>2022-12-07T13:22:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-avviato-uno-studio-clinico-per-il-trattamento-dell-amaurosi-congenita-di-leber-di-tipo-10]]></loc><lastmod>2019-12-03T16:45:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-tisagenlecleucel-e-la-prima-in-commercio-in-italia]]></loc><lastmod>2019-11-20T01:16:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/car-t-farmaco-di-novartis-innovativo-anche-nel-modello-di-pagamento]]></loc><lastmod>2019-09-25T10:26:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-l-uso-della-variante-ascas12a-ha-permesso-di-correggere-due-mutazioni-legate-alla-fibrosi-cistica]]></loc><lastmod>2019-08-11T08:45:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/la-storia-della-medicina-rigenerativa-raccontata-da-uno-dei-suoi-protagonisti]]></loc><lastmod>2021-03-26T12:15:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-un-morso-per-combattere-il-tumore-al-cervello]]></loc><lastmod>2019-12-03T16:44:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/chimere-uomo-animale-come-fonte-d-organi-fantascienza-o-realta]]></loc><lastmod>2019-12-03T16:44:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/human-nature-crispr-in-scena-sullo-schermo]]></loc><lastmod>2020-01-09T15:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/mini-organi-l-occhio-stampato-in-3d-ammicca-ai-suoi-creatori]]></loc><lastmod>2019-12-03T16:43:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-una-nuova-speranza-per-la-malattia-di-niemann-pick-di-tipo-a]]></loc><lastmod>2019-12-03T16:34:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/editing-del-genoma-umano-a-che-punto-siamo-con-la-regolamentazione]]></loc><lastmod>2019-12-03T16:33:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/le-ali-di-camilla-per-sostenere-lo-sviluppo-di-una-terapia-genica-su-epidermolisi-bollosa-e-non-solo]]></loc><lastmod>2021-04-29T14:57:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/i-gel-a-dna-diventano-smart-basta-un-colpo-di-crispr]]></loc><lastmod>2019-12-03T16:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/michael-schumacher-e-stato-sottoposto-a-una-cura-a-base-di-cellule-staminali]]></loc><lastmod>2019-12-03T16:29:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/biohacking-i-rischi-della-terapia-genica-da-garage]]></loc><lastmod>2019-12-03T16:29:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/sospettosi-di-silvia-bencivelli-un-libro-che-aiuta-a-fare-chiarezza-tra-mille-interrogativi]]></loc><lastmod>2021-03-26T12:11:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-al-servizio-dei-trial-clinici]]></loc><lastmod>2020-06-25T10:19:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-passato-presente-e-futuro-raccontato-in-un-docufilm]]></loc><lastmod>2019-12-03T16:27:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-una-nuova-pista-per-sconfiggere-l-hiv]]></loc><lastmod>2019-12-03T16:27:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-cecita-ereditaria-il-fattore-tempo-risulta-essere-fondamentale]]></loc><lastmod>2019-12-03T16:26:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-identificata-la-staminale-del-fegato]]></loc><lastmod>2019-12-03T16:26:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/a-milano-l-evento-sifo-dedicato-alla-governance-nelle-terapie-avanzate]]></loc><lastmod>2019-09-25T18:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-contrastare-la-fibrosi-cardiaca]]></loc><lastmod>2019-12-03T16:25:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-in-giappone-fiorisce-un-pericoloso-business]]></loc><lastmod>2019-12-03T16:24:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-made-in-italy-per-combattere-i-tumori]]></loc><lastmod>2019-12-03T16:24:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-una-nanocapsula-per-trasportare-crispr-cas9]]></loc><lastmod>2019-10-29T15:57:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/osservatorio-terapie-avanzate-tra-i-supporter-dell-iniziativa-europea-restore]]></loc><lastmod>2019-10-29T15:56:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapia-genica-accesso-e-sostenibilita]]></loc><lastmod>2019-10-29T15:55:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-dalla-modifica-di-cellule-staminali-una-speranza-per-le-emoglobinopatie]]></loc><lastmod>2019-10-29T15:55:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-malattia-di-fabry-gli-studi-clinici-in-corso]]></loc><lastmod>2019-10-29T15:54:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-nature-medicine-fa-il-punto-sui-tumori-solidi]]></loc><lastmod>2020-07-22T11:13:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/editing-genomico-in-europa-la-sfida-e-approdare-presto-ai-sistemi-sanitari-nazionali]]></loc><lastmod>2019-10-29T15:54:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-in-italia-trattato-il-primo-paziente-con-linfoma-follicolare]]></loc><lastmod>2020-02-07T17:48:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/car-t-arrivano-i-nomi-dei-primi-centri-accreditati-in-italia]]></loc><lastmod>2019-10-29T15:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-i-sistemi-sanitari-d-europa-riusciranno-a-sostenerne-l-impatto]]></loc><lastmod>2019-10-29T15:52:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/immunoterapia-ritirata-l-autorizzazione-condizionata-al-commercio-di-zalmoxis]]></loc><lastmod>2019-10-29T15:52:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-i-superbatteri-resistenti-nel-mirino-di-crispr]]></loc><lastmod>2019-10-29T15:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-uno-studio-pilota-per-la-sindrome-iqsec2]]></loc><lastmod>2019-10-29T15:50:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-arriva-il-primo-sistema-di-mini-organi-connessi-e-funzionanti]]></loc><lastmod>2019-10-29T15:50:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-si-aprono-diverse-prospettive-per-la-sla]]></loc><lastmod>2019-10-21T00:12:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/medicina-personalizzata-un-farmaco-su-misura-per-la-malattia-di-batten]]></loc><lastmod>2020-06-03T20:58:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-un-opportunita-concreta-per-l-italia]]></loc><lastmod>2019-10-25T10:48:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-dalle-origini-al-prime-editing]]></loc><lastmod>2020-04-21T10:39:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-nih-e-gates-foundation-siglano-un-accordo-per-portarla-nei-paesi-piu-poveri]]></loc><lastmod>2019-10-27T00:58:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-promettenti-i-risultati-di-zolgensma-per-la-sma-di-tipo-2]]></loc><lastmod>2019-10-31T17:20:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-piccolissimi-biomagneti-alla-ricerca-di-nuovi-farmaci]]></loc><lastmod>2019-11-02T09:41:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/modificare-i-geni-per-curare-malattie-rare-e-tumori-la-terapia-genica-raccontata-al-grande-pubblico]]></loc><lastmod>2019-11-05T11:22:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-i-pazienti-confermano-il-miglioramento-nella-qualita-di-vita]]></loc><lastmod>2019-11-05T16:36:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/medicina-rigenerativa-la-stampa-in-3d-sara-il-futuro-degli-innesti-cutanei]]></loc><lastmod>2019-11-08T15:33:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live/geni-e-cellule-le-terapie-del-futuro]]></loc><lastmod>2019-12-03T23:51:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/terapie-genica-le-malattie-genetiche-rare-come-banco-di-prova]]></loc><lastmod>2019-11-08T16:58:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-e-iniziata-la-corsa-verso-i-trattamenti-per-il-diabete]]></loc><lastmod>2019-11-13T10:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/sviluppare-le-terapie-avanzate-tra-ostacoli-e-successi]]></loc><lastmod>2019-11-26T11:52:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/regolare-le-terapie-avanzate-un-delicato-equilibrio-tra-innovazione-e-sostenibilita]]></loc><lastmod>2020-05-05T13:25:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/car-t-anche-axicabtagene-ciloleucel-e-rimborsabile-in-italia]]></loc><lastmod>2019-11-13T08:18:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-assobiotec-lancia-il-primo-position-paper]]></loc><lastmod>2019-11-14T15:32:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/terapie-avanzate-il-punto-di-vista-del-clinico]]></loc><lastmod>2020-05-05T13:28:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-crispr-come-arma-antivirale]]></loc><lastmod>2019-12-03T23:50:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapie-avanzate-quante-come-quali-sono-approvate]]></loc><lastmod>2019-12-03T23:50:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live/focus-live-2019-le-terapie-avanzate-conquistano-il-grande-pubblico]]></loc><lastmod>2019-12-11T16:12:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-da-1-milione-di-dollari-come-renderle-sostenibili]]></loc><lastmod>2019-12-03T23:51:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-primi-dati-incoraggianti-per-anemia-falciforme-e-beta-talassemia]]></loc><lastmod>2019-12-03T23:49:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live/il-futuro-della-medicina-passa-per-la-rigenerazione-dei-tessuti]]></loc><lastmod>2019-12-03T23:49:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-avanzate-l-importanza-di-una-corretta-comunicazione]]></loc><lastmod>2020-08-28T16:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-fda-approva-givosiran-per-la-porfiria-epatica-acuta]]></loc><lastmod>2019-12-04T14:20:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live/la-sfida-delle-terapie-avanzate-tra-innovazione-investimenti-e-accesso-ai-pazienti]]></loc><lastmod>2019-12-06T10:37:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-un-arma-in-piu-nella-lotta-contro-il-cancro]]></loc><lastmod>2020-08-05T12:49:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live/stanno-nascendo-oggi-le-terapie-avanzate-che-ci-cureranno-domani]]></loc><lastmod>2019-12-06T15:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-nuove-rivelazioni-sul-caso-delle-bimbe-crispr]]></loc><lastmod>2019-12-11T13:39:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/le-terapie-avanzate-lanciano-la-sfida-al-mercato-dei-farmaci]]></loc><lastmod>2019-12-14T23:09:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/dna-revolution-le-terapie-avanzate-arrivano-in-prima-serata]]></loc><lastmod>2020-08-28T16:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-algoritmo-made-in-italy-per-la-beta-talassemia]]></loc><lastmod>2019-12-12T16:30:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-per-arrestare-la-progressione-di-un-raro-disturbo-neurologico]]></loc><lastmod>2019-12-13T11:16:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live/terapie-avanzate-dai-virus-modificati-alla-cura-delle-malattie-genetiche]]></loc><lastmod>2019-12-16T09:09:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/la-terapia-genica-che-restituisce-la-vista]]></loc><lastmod>2019-12-19T13:20:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/terapie-avanzate-le-eccellenza-italiane-premiate-oltreoceano]]></loc><lastmod>2019-12-17T17:55:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-genenta-science-e-la-startup-dell-anno]]></loc><lastmod>2019-12-23T09:12:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-potenzialita-e-limiti-dei-mini-cervelli-per-lo-studio-di-patologie-cerebrali]]></loc><lastmod>2019-12-20T10:38:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/la-storia-di-crispr-raccontata-da-jennifer-doudna]]></loc><lastmod>2021-03-26T12:06:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-l-adrenoleucodistrofia]]></loc><lastmod>2019-12-23T10:55:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-avviato-uno-studio-clinico-per-testarle-contro-la-miastenia-grave]]></loc><lastmod>2019-12-23T11:01:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/hela-le-cellule-piu-famose-del-mondo-raccontate-in-un-libro]]></loc><lastmod>2021-03-26T12:00:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live/superfarmaci-contro-forme-incurabili-di-leucemie-e-linfomi]]></loc><lastmod>2020-10-30T16:25:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-per-riparare-il-cuore-usano-il-sistema-immunitario]]></loc><lastmod>2020-01-03T11:47:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-babies-he-jiankui-condannato-a-tre-anni-di-reclusione]]></loc><lastmod>2020-01-13T09:37:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-trattato-in-italia-il-primo-paziente-con-emofilia-a]]></loc><lastmod>2020-01-13T09:42:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianti-siamo-pronti-per-i-trapianti-di-organi-provenienti-da-animali]]></loc><lastmod>2021-11-09T19:44:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/dieci-audaci-previsioni-per-il-2020-di-crispr]]></loc><lastmod>2020-01-13T09:33:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-sono-promettenti-le-prospettive-contro-il-linfoma-follicolare]]></loc><lastmod>2020-01-19T17:22:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/cancro-al-seno-l-intelligenza-artificiale-batte-l-essere-umano-nella-diagnosi]]></loc><lastmod>2020-06-25T10:17:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-dall-india-nuovi-trattamenti-dai-costi-contenuti]]></loc><lastmod>2020-01-17T14:06:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/trial-clinici-in-europa-il-fattore-limitante-e-la-burocrazia]]></loc><lastmod>2020-01-17T13:58:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-una-nuova-strategia-per-bloccare-la-sla]]></loc><lastmod>2020-01-24T09:51:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-l-impegno-delle-aziende-farmaceutiche]]></loc><lastmod>2020-01-22T08:38:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-a-modena-nasce-l-eb-hub-per-l-epidermolisi-bollosa]]></loc><lastmod>2021-04-29T14:56:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-trattare-la-dipendenza-da-cocaina]]></loc><lastmod>2020-01-24T11:55:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-identificato-l-interruttore-che-spegne-il-sistema-di-editing-genomico]]></loc><lastmod>2020-01-24T11:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-identificato-un-nuovo-recettore-esclusivo-per-i-tumori]]></loc><lastmod>2020-01-28T17:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-a-torino-trattati-con-staminali-tre-neonati-in-attesa-di-trapianto-di-fegato]]></loc><lastmod>2020-01-28T16:36:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-pubblicate-da-arm-le-indicazioni-per-un-accesso-transnazionale]]></loc><lastmod>2020-01-31T11:28:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/mappa-in-3d-del-corpo-umano-a-risoluzione-cellulare]]></loc><lastmod>2020-01-31T10:49:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-talassemia-germania-primo-paese-a-dare-il-via-libera]]></loc><lastmod>2020-02-04T17:26:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-personalizzate-industrializzarle-per-renderle-accessibili-ai-pazienti]]></loc><lastmod>2020-02-04T14:43:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-avviato-al-san-raffaele-il-trial-clinico-su-leucemia-mieloide-acuta-e-mieloma-multiplo]]></loc><lastmod>2022-10-11T13:47:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-diagnosi-nel-mirino-le-infezioni-virali]]></loc><lastmod>2020-04-01T21:30:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-per-lo-studio-della-cancerogenesi-e-del-trattamento-dei-tumori-pediatrici]]></loc><lastmod>2020-02-07T11:26:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-contro-il-cancro-la-strategia-appare-fattibile-e-sicura]]></loc><lastmod>2020-02-12T10:10:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-trial-clinico-con-ipsc-per-la-degenerazione-maculare]]></loc><lastmod>2020-02-11T15:39:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-sviluppata-una-terapia-a-base-di-cellule-t-per-combattere-gravi-patologie-virali]]></loc><lastmod>2020-02-12T12:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-sfida-la-duchenne-nuovi-incoraggianti-risultati-da-due-studi-su-modelli-animali]]></loc><lastmod>2020-02-15T18:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-al-via-uno-studio-di-confronto-per-la-sclerosi-multipla-recidivante]]></loc><lastmod>2020-02-14T11:40:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-primo-trapianto-di-staminali-cardiache-su-paziente-affetto-da-cardiopatia-ischemica]]></loc><lastmod>2020-02-18T16:26:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/modelli-di-embrioni-umani-creati-da-cellule-staminali-come-regolamentarli]]></loc><lastmod>2020-02-18T16:31:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-una-realta-ormai-presente-nei-centri-specializzati-italiani]]></loc><lastmod>2020-02-20T15:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/imperfezione-una-storia-naturale]]></loc><lastmod>2021-03-26T11:55:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-diventano-tessuto-osseo-in-laboratorio-ma-come]]></loc><lastmod>2020-02-21T17:28:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/coronavirus-dagli-antivirali-alle-staminali-oltre-80-i-trial-clinici-per-testare-possibili-trattamenti]]></loc><lastmod>2020-04-09T05:34:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-personalizzare-la-terapia-per-le-malattie-rare-e-non-solo]]></loc><lastmod>2020-02-25T11:24:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-un-correttore-ad-alta-efficienza-testato-in-organoidi-di-pazienti-con-fibrosi-cistica]]></loc><lastmod>2020-03-02T15:24:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-sfruttare-le-nanoparticelle-per-produrre-una-versione-meno-tossica]]></loc><lastmod>2022-08-03T07:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-una-nuova-ingegnosa-tecnologia-per-controllarne-il-dosaggio]]></loc><lastmod>2020-03-03T16:12:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-e-ictus-emorragico-la-strada-verso-una-possibile-terapia]]></loc><lastmod>2020-03-03T16:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-la-prima-volta-in-vivo-nell-uomo-per-restituire-la-vista]]></loc><lastmod>2020-07-17T10:08:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/una-nuova-ipotesi-per-spiegare-la-resistenza-alle-terapie-car-t]]></loc><lastmod>2020-03-06T18:35:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/editing-genomico-la-dichiarazione-di-ginevra-per-le-linee-germinali]]></loc><lastmod>2020-03-10T15:44:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-buoni-risultati-da-un-piccolo-studio-clinico-sulla-x-cgd]]></loc><lastmod>2020-03-10T15:41:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-per-hiv-il-successo-del-paziente-di-londra]]></loc><lastmod>2020-03-14T18:54:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-per-studiare-l-alzheimer]]></loc><lastmod>2020-08-05T12:13:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-dal-veleno-dello-scorpione-una-speranza-per-il-glioblastoma]]></loc><lastmod>2020-03-18T10:41:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/trapianto-di-cromosoma-il-percorso-di-sperimentazione-continua]]></loc><lastmod>2020-08-05T12:13:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/domande-e-dubbi-sul-coronavirus-oltre-25-esperti-a-disposizione-su-omar]]></loc><lastmod>2020-04-09T05:34:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/combinare-terapia-genica-ed-editing-genomico-per-malattie-del-metabolismo]]></loc><lastmod>2021-09-09T09:02:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/terapie-avanzate-in-aumento-come-gestire-la-produzione]]></loc><lastmod>2022-12-07T13:38:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/approvata-in-giappone-la-terapia-genica-per-la-sma]]></loc><lastmod>2020-08-05T12:12:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-approvato-in-italia-il-primo-farmaco-contro-l-amiloidosi-hattr]]></loc><lastmod>2020-03-25T09:59:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapia-genica-per-la-sma-parere-positivo-dal-chmp-europeo]]></loc><lastmod>2020-03-29T16:23:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/epidermolisi-bollosa-paziente-trattato-con-terapia-genica]]></loc><lastmod>2020-08-05T12:07:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/un-atlante-delle-cellule-staminali-muscolari]]></loc><lastmod>2021-10-06T07:22:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/dalle-cellule-t-una-tecnologia-innovativa-contro-i-virus]]></loc><lastmod>2020-04-09T08:45:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/combinare-crispr-a-studi-di-farmacologia-per-potenziare-la-terapia-car-t]]></loc><lastmod>2020-04-09T18:24:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/coronavirus-anche-crispr-si-mette-alla-prova]]></loc><lastmod>2020-04-09T05:33:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-in-utero-una-speranza-per-la-sindrome-di-sly]]></loc><lastmod>2020-04-05T22:02:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-malattia-di-huntington]]></loc><lastmod>2020-07-14T11:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/un-sillabario-sulla-genetica-curiosita-e-fake-news-svelate]]></loc><lastmod>2021-03-26T11:55:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-car-t-e-terapie-cellulari-reggono-bene-l-impatto-da-covid-19]]></loc><lastmod>2020-08-05T12:10:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organ-on-chip-un-ottimo-modello-per-lo-studio-di-patologie-infiammatorie]]></loc><lastmod>2020-04-15T09:18:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/una-capsula-di-idrogel-fa-sperare-nel-gruppo-sanguigno-universale]]></loc><lastmod>2020-06-08T11:03:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/covid-19-italia-in-prima-linea-nello-sviluppo-di-un-vaccino-genetico]]></loc><lastmod>2020-05-06T20:18:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/dopo-le-car-t-arrivano-le-car-m-per-combattere-i-tumori-solidi]]></loc><lastmod>2020-04-17T15:40:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-cellule-giovani-per-combattere-al-meglio-il-cancro]]></loc><lastmod>2020-04-21T15:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/chymera-un-nuovo-strumento-per-l-editing-genomico-multiplo]]></loc><lastmod>2020-04-21T15:39:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/spillover-un-salto-pericoloso]]></loc><lastmod>2021-03-26T11:45:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-cellule-della-retina-universali-per-la-degenerazione-maculare-senile]]></loc><lastmod>2020-04-24T15:29:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-diagnostico-puo-rilevare-infezioni-e-rigetto-post-trapianto]]></loc><lastmod>2020-04-28T16:27:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/covid-19-e-immunita-cio-che-sappiamo-e-cio-che-ancora-dobbiamo-scoprire]]></loc><lastmod>2020-04-28T16:26:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapie-cellulari-non-approvate-l-allarme-dell-ema]]></loc><lastmod>2020-05-05T11:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-contro-il-linfoma-mantellare]]></loc><lastmod>2020-12-14T10:55:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/donne-a-caccia-di-coronavirus]]></loc><lastmod>2020-05-03T19:39:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/le-terapie-avanzate-che-fanno-battere-il-cuore]]></loc><lastmod>2020-05-06T08:58:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/le-terapie-avanzate-stanno-rivoluzionando-la-cura-della-talassemia]]></loc><lastmod>2020-05-07T16:14:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/coronavirus-grazie-agli-organoidi-e-confermato-che-attecchisce-nell-intestino]]></loc><lastmod>2020-05-08T15:09:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/brevetti-e-proprieta-intellettuale-al-tempo-del-coronavirus]]></loc><lastmod>2020-05-08T14:50:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/covid-19-spunti-di-bioetica-tra-cellule-staminali-e-privacy]]></loc><lastmod>2020-05-13T08:38:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/via-libera-per-stopcovid-il-test-rapido-basato-su-crispr]]></loc><lastmod>2020-05-12T14:55:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/mucopolisaccaridosi-a-che-punto-siamo-con-la-terapia-genica]]></loc><lastmod>2020-05-22T18:09:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-verso-l-uso-in-oncologia]]></loc><lastmod>2020-05-18T09:11:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-alleanza-contro-il-cancro-tende-la-mano-all-industria-farmaceutica]]></loc><lastmod>2020-05-15T11:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-modello-3d-per-studiare-la-relazione-tra-alzheimer-e-herpes]]></loc><lastmod>2020-05-26T20:33:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-la-sma-zolgensma-approda-anche-in-europa]]></loc><lastmod>2020-05-22T16:11:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/cellule-t-modificate-con-crispr-contro-il-tumore-polmonare]]></loc><lastmod>2020-05-25T09:35:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-il-gene-che-mantiene-la-pluripotenza]]></loc><lastmod>2020-05-25T09:32:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-una-nuova-via-per-la-malattia-granulomatosa-cronica]]></loc><lastmod>2020-06-16T10:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/zanzare-all-male-la-nuova-strategia-genetica-contro-la-malaria]]></loc><lastmod>2020-05-26T20:31:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-un-approccio-per-le-malattie-neurodegenerative]]></loc><lastmod>2020-05-29T18:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-puntare-alle-staminali-per-la-sclerosi-multipla-progressiva]]></loc><lastmod>2020-05-29T20:04:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-tutte-le-ultime-novita-sulla-duchenne]]></loc><lastmod>2020-05-31T18:41:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-uno-studio-clinico-per-la-duchenne]]></loc><lastmod>2020-05-31T18:42:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/le-innovazioni-tecnologiche-sbarcano-su-ota]]></loc><lastmod>2020-05-29T21:18:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/app-immuni-per-il-tracciamento-covid-19-utilita-limiti-e-tempistiche]]></loc><lastmod>2021-02-06T18:54:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-premio-else-kroener-fresenius-ad-alessandro-aiuti]]></loc><lastmod>2020-06-07T21:58:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/dalle-terapie-su-rna-arrivano-i-farmaci-su-misura]]></loc><lastmod>2020-06-07T21:57:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-la-digital-health-e-tra-noi-ma-che-cos-e]]></loc><lastmod>2021-02-06T18:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-quando-la-tecnologia-e-al-servizio-della-medicina-personalizzata]]></loc><lastmod>2020-06-30T11:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-terapie-avanzate-un-nuovo-arsenale-per-l-hiv]]></loc><lastmod>2020-06-16T17:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/cellule-staminali-funzioneranno-anche-contro-il-parkinson]]></loc><lastmod>2020-06-16T17:45:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/una-combo-crispr-staminali-contro-il-diabete]]></loc><lastmod>2020-06-17T10:34:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/procedono-bene-le-terapie-avanzate-per-la-beta-talassemia-e-l-anemia-falciforme]]></loc><lastmod>2022-03-03T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-lanciata-la-sfida-al-mieloma-multiplo]]></loc><lastmod>2020-07-05T14:11:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-fda-approva-un-videogioco-per-l-adhd]]></loc><lastmod>2020-06-22T10:53:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/sla-la-strada-per-la-cura-passa-sempre-piu-per-le-terapie-avanzate]]></loc><lastmod>2020-07-05T14:10:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-buoni-risultati-per-il-linfoma-non-hodgkin]]></loc><lastmod>2020-06-24T10:25:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/unire-tecnologia-e-staminali-per-trattare-le-lesioni-cerebrale]]></loc><lastmod>2020-06-24T10:24:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-una-strategia-per-renderla-piu-sicura]]></loc><lastmod>2020-06-28T16:45:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/covid-19-continua-la-strada-verso-un-vaccino]]></loc><lastmod>2020-08-12T12:42:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/la-sinapsi-artificiale-che-parla-con-le-cellule-viventi]]></loc><lastmod>2020-06-30T14:55:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-nuova-arma-per-potenziare-la-terapia-genica]]></loc><lastmod>2020-06-30T14:56:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/una-nuova-strategia-per-migliorare-l-editing-genetico]]></loc><lastmod>2020-07-07T10:39:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/l-inchiostro-biologico-che-ripara-i-tessuti]]></loc><lastmod>2020-07-07T10:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-supercomputer-al-servizio-della-chirurgia]]></loc><lastmod>2020-07-08T08:02:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-utili-per-identificare-le-cause-della-malattia-da-coronavirus]]></loc><lastmod>2020-07-08T08:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/terapia-genica-e-immunoterapia-insieme-contro-le-metastasi]]></loc><lastmod>2020-07-19T09:22:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-ca-o-s-i-rischi-della-tecnica-di-editing]]></loc><lastmod>2020-07-13T07:19:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/realta-aumentata-per-studiare-il-cuore-si-passa-dai-libri-allo-smartphone]]></loc><lastmod>2020-07-13T14:57:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-avviato-nuovo-studio-clinico-per-l-huntington]]></loc><lastmod>2020-07-14T15:38:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/le-terapie-avanzate-sbarcano-alla-radio]]></loc><lastmod>2020-07-19T09:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/non-solo-tumori-ecco-la-car-t-senolitica-contro-l-invecchiamento]]></loc><lastmod>2020-07-27T08:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/obiettivo-retina-come-procede-la-ricerca-sulle-terapie-avanzate]]></loc><lastmod>2020-07-19T16:26:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-editing-salva-arterie-per-abbassare-colesterolo-e-trigliceridi]]></loc><lastmod>2020-07-21T18:32:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/terapie-avanzate-un-corso-di-formazione-all-avanguardia-per-gli-scienziati]]></loc><lastmod>2020-07-21T18:33:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-eventi-avversi-gravi-sollevano-il-dibattito-su-dosaggio-e-sicurezza]]></loc><lastmod>2020-07-24T13:41:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-scende-in-campo-contro-le-malattie-autoimmuni]]></loc><lastmod>2020-07-27T10:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-dalle-app-un-supporto-per-la-salute-mentale-in-tempi-di-covid-19]]></loc><lastmod>2020-07-28T14:39:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-ricreare-la-pelle-umana-in-laboratorio]]></loc><lastmod>2020-07-28T14:36:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-la-fda-approva-tecartus-contro-il-linfoma-mantellare]]></loc><lastmod>2020-07-29T14:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-scoperto-il-modo-per-modificare-il-dna-mitocondriale]]></loc><lastmod>2020-08-04T19:16:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/bersaglio-mobile-il-ruolo-del-sistema-immunitario-nella-lotta-al-cancro]]></loc><lastmod>2021-09-02T12:50:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-ottiene-la-fast-track-designation]]></loc><lastmod>2020-08-02T15:15:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-si-affinano-i-modelli-di-studio-del-cuore]]></loc><lastmod>2020-08-04T13:26:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/coronavirus-avviato-lo-studio-clinico-del-vaccino-made-in-italy]]></loc><lastmod>2020-08-28T13:25:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-per-la-sma-risdiplam-approvato-negli-stati-uniti]]></loc><lastmod>2020-08-28T13:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-un-algoritmo-al-servizio-dell-oncologia]]></loc><lastmod>2020-09-01T15:24:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/bioingegneria-dai-lego-l-idea-per-riparare-il-corpo-umano]]></loc><lastmod>2020-09-01T15:25:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-la-rivoluzione-dei-virus-a-superquark]]></loc><lastmod>2020-09-03T10:35:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-avanzate-per-la-fibrosi-cistica-a-che-punto-e-la-ricerca]]></loc><lastmod>2020-09-04T13:26:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-lenti-a-contatto-smart-per-il-diabete-2]]></loc><lastmod>2020-09-07T10:16:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-anche-il-linfoma-di-hodgkin-nel-mirino-della-ricerca-clinica]]></loc><lastmod>2020-09-08T18:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/puntare-all-editing-genomico-per-i-disturbi-dello-sviluppo-neurologico]]></loc><lastmod>2020-09-08T15:11:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-promettenti-i-risultati-per-l-adrenoleucodistrofia-cerebrale]]></loc><lastmod>2020-09-14T10:27:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-prima-approvazione-europea-per-l-asma]]></loc><lastmod>2020-09-11T08:39:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/innovazioni-dalle-nanotecnologie-nuovi-sistema-di-delivery-dei-farmaci-2]]></loc><lastmod>2020-09-20T14:16:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-non-piu-vettori-virali-ma-trasposoni]]></loc><lastmod>2020-09-22T14:49:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-come-si-sta-preparando-l-italia]]></loc><lastmod>2020-09-18T11:03:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/combattere-l-alzheimer-tra-terapie-classiche-avanzate-e-una-pandemia-in-corso]]></loc><lastmod>2020-09-22T14:56:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-un-altro-premio-all-eccellenza-italiana]]></loc><lastmod>2020-09-22T16:49:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/european-biotech-week-2020-raccontare-le-biotecnologie-al-grande-pubblico]]></loc><lastmod>2020-09-22T16:49:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-la-tecnologia-wearable-al-servizio-del-cuore]]></loc><lastmod>2020-09-25T11:16:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/il-futuro-della-salute-quando-la-medicina-incontra-il-digitale]]></loc><lastmod>2021-03-26T11:43:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-per-eliminare-il-virus-dell-herpes-simplex]]></loc><lastmod>2020-10-08T13:39:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-idrogel-per-la-crescita-in-coltura-delle-cellule-t]]></loc><lastmod>2020-10-02T11:39:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/l-editing-delle-emoglobinopatie-si-sdoppia-rompere-o-aggiustare]]></loc><lastmod>2020-10-05T10:14:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-adrenoleucodistrofia-ema-valuta-eli-cel]]></loc><lastmod>2020-10-06T08:51:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/algoritmi-per-la-diagnosi-precoce-della-sclerosi-multipla]]></loc><lastmod>2020-10-06T15:55:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-nuovi-dati-positivi-per-la-distrofia-muscolare-di-duchenne-e-dei-cingoli]]></loc><lastmod>2020-10-08T13:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-un-innovazione-da-nobel-tutta-al-femminile]]></loc><lastmod>2020-10-08T13:38:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/covid-19-cellule-t-l-altra-faccia-dell-immunita]]></loc><lastmod>2020-10-09T12:51:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-un-videogame-per-scoprirle]]></loc><lastmod>2020-10-09T12:51:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-avanzate-per-la-vista-promesse-presenti-e-future]]></loc><lastmod>2020-10-14T10:31:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/potenziare-la-terapia-genica-con-crispr]]></loc><lastmod>2020-10-22T10:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-prima-trapianto-con-holoclar-dopo-il-lockdown]]></loc><lastmod>2020-10-16T10:50:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/da-liquido-a-pellicola-di-rivestimento-la-bioingegneria-nell-intestino]]></loc><lastmod>2020-10-16T10:23:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-linfoma-mantellare-parere-positivo-del-chmp]]></loc><lastmod>2020-12-14T10:53:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-cellule-natural-killer-senza-freni-contro-il-cancro]]></loc><lastmod>2020-10-21T08:02:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/riprogrammare-le-cellule-staminali-per-riparare-le-lesioni-spinali]]></loc><lastmod>2020-10-23T13:54:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/app-immuni-ridurrebbe-infezioni-e-decessi-da-covid-19]]></loc><lastmod>2021-02-06T18:54:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/lo-sguardo-di-jennifer-doudna-sul-futuro-dell-editing-genomico]]></loc><lastmod>2020-10-28T09:11:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/puntare-agli-esosomi-per-colpire-la-duchenne]]></loc><lastmod>2020-10-28T09:25:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/cell-therapy-open-source/le-terapie-car-t-dal-laboratorio-al-paziente]]></loc><lastmod>2020-11-02T15:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/cell-therapy-open-source/car-t-promesse-e-sfide-illustrate-in-un-ebook]]></loc><lastmod>2022-04-01T18:49:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/terapia-genica-premiata-un-eccellenza-italiana]]></loc><lastmod>2020-11-05T11:22:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/covid-19-il-valore-degli-studi-di-infezione-umana-controllata]]></loc><lastmod>2020-11-05T08:59:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-prime-autorizzazioni-per-fitbit-in-usa-e-in-europa]]></loc><lastmod>2020-11-06T12:10:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/nanomateriali-per-la-riparazione-delle-lesioni-nervose]]></loc><lastmod>2020-11-06T12:21:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-progressi-e-limiti-per-la-fibrosi-cistica]]></loc><lastmod>2020-11-10T15:29:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-le-prime-due-app-sanitarie-disponibili-in-germania]]></loc><lastmod>2021-02-06T18:53:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-scoperta-la-struttura-dei-base-editor]]></loc><lastmod>2020-11-13T11:38:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/le-staminali-come-prezioso-strumento-per-studiare-una-rara-patologia-neurodegenerativa]]></loc><lastmod>2020-11-15T17:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/l-evoluzione-delle-car-t-porta-nella-direzione-delle-carcik]]></loc><lastmod>2023-07-04T11:55:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-nasce-una-rete-di-cell-factories-accademiche-nella-regione-lombardia]]></loc><lastmod>2020-11-18T15:29:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-contro-la-resistenza-agli-antimicrobici]]></loc><lastmod>2020-11-22T21:02:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-corregge-gli-errori-dei-trial-clinici]]></loc><lastmod>2020-11-20T11:25:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-aifa-approva-il-programma-di-accesso-anticipato]]></loc><lastmod>2021-01-28T10:43:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/covid-19-e-vaccini-una-corsa-a-tre-piu-due-parte-seconda]]></loc><lastmod>2020-11-25T10:35:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/covid-19-e-vaccini-una-corsa-a-tre-piu-due-parte-prima]]></loc><lastmod>2020-11-25T10:50:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-terapie-avanzate-in-sviluppo-contro-l-hiv]]></loc><lastmod>2020-11-27T08:18:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/editing-genomico-il-valore-del-consenso-informato-negli-studi-clinici]]></loc><lastmod>2020-11-27T07:39:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/base-editing-una-speranza-per-l-emofilia-a-e-non-solo]]></loc><lastmod>2020-12-02T08:40:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/la-rivoluzione-delle-terapie-avanzate-il-corso-ecm-per-professioni-sanitarie]]></loc><lastmod>2020-12-01T15:53:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/combinare-nanoparticelle-e-sirna-per-combattere-l-alzheimer]]></loc><lastmod>2020-12-04T12:55:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/finalmente-riconosciuto-il-valore-delle-cellule-hela]]></loc><lastmod>2020-12-04T12:23:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-beta-talassemia-trattato-il-primo-paziente-italiano]]></loc><lastmod>2020-12-09T14:40:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-emoglobinopatie-un-aggiornamento-sui-risultati]]></loc><lastmod>2020-12-09T15:17:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-promettenti-i-dati-sul-mieloma-multiplo]]></loc><lastmod>2020-12-10T15:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-le-lezione-del-nobel-continuiamo-a-imparare-dai-microbi]]></loc><lastmod>2020-12-17T12:20:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/la-scienza-da-leggere-i-consigli-natalizi-di-ota]]></loc><lastmod>2021-03-26T11:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/aggiornamenti-sulla-terapia-car-t-contro-il-linfoma-mantellare]]></loc><lastmod>2020-12-17T09:45:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/covid-19-e-vaccini-da-dove-provengono-i-dubbi]]></loc><lastmod>2020-12-15T16:59:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-gli-studi-sull-emofilia]]></loc><lastmod>2020-12-15T16:48:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-dati-incoraggianti-contro-il-linfoma-non-hodgkin-indolente]]></loc><lastmod>2020-12-17T09:40:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-europa-la-terapia-car-t-per-il-linfoma-mantellare]]></loc><lastmod>2020-12-22T08:54:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-embrione-di-topo-puo-svilupparsi-in-vitro]]></loc><lastmod>2020-12-18T12:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/il-gene-il-viaggio-dell-uomo-al-centro-della-vita]]></loc><lastmod>2021-03-26T11:55:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-semaforo-verde-in-eu-per-la-leucodistrofia-metacromatica]]></loc><lastmod>2021-01-12T11:56:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-parte-il-trial-in-italia]]></loc><lastmod>2021-01-12T11:53:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-trattati-i-primi-bambini-in-italia]]></loc><lastmod>2021-01-12T11:54:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/a-raffaella-di-micco-un-finanziamento-erc-per-perfezionare-le-terapie-geniche]]></loc><lastmod>2021-01-12T11:51:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/dal-laboratorio-al-paziente-raccontare-il-viaggio-delle-terapie-avanzate-media-tutorial-online-20-gennaio-ore-10-13]]></loc><lastmod>2021-09-07T15:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/covid-19-l-attesa-del-vaccino-di-astrazeneca]]></loc><lastmod>2021-01-08T11:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-una-partnership-innovativa-per-l-app-kaia-copd]]></loc><lastmod>2021-02-06T18:53:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/alla-scoperta-delle-car-t]]></loc><lastmod>2021-01-08T10:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-un-opportunita-per-l-italia]]></loc><lastmod>2021-01-14T11:28:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-per-studiare-l-insorgenza-di-specifici-tumori]]></loc><lastmod>2021-01-18T11:32:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapie-avanzate-approvate-salgono-a-12-in-europa]]></loc><lastmod>2021-01-20T10:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-un-vaccino-contro-la-leishmaniosi-cutanea]]></loc><lastmod>2021-01-20T08:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/arriva-il-primo-atlante-per-catalogare-i-mini-organi]]></loc><lastmod>2021-10-06T07:22:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/aifa-concede-la-rimborsabilita-a-luxturna]]></loc><lastmod>2021-01-21T11:20:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-cos-e-cambiato-con-covid-19]]></loc><lastmod>2021-02-06T18:53:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/tutti-i-progressi-della-terapia-genica]]></loc><lastmod>2021-01-22T12:18:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-un-altro-passo-per-la-progeria]]></loc><lastmod>2021-03-30T14:31:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-molte-aspettative-poca-pratica]]></loc><lastmod>2021-02-02T15:07:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-la-disinformazione-corre-veloce]]></loc><lastmod>2021-03-30T14:27:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/la-sfida-di-crispr-all-immunodeficienza-con-iper-igm]]></loc><lastmod>2021-03-30T14:22:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/la-sindrome-di-usher-nel-mirino-delle-terapie-avanzate]]></loc><lastmod>2021-03-30T14:18:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/potenziare-le-terapie-car-t-contro-i-tumori-solidi]]></loc><lastmod>2021-03-30T14:14:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/disponibile-online-la-fad-per-giornalisti-sulle-terapie-avanzate]]></loc><lastmod>2021-02-03T11:32:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/innovazioni-tecnologiche-usare-lo-smartphone-per-la-diagnosi-di-virus]]></loc><lastmod>2021-03-30T14:10:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/covid-19-usare-crispr-e-uno-smartphone-per-rilevare-sars-cov-2]]></loc><lastmod>2021-03-30T14:07:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-sempre-piu-vicino-il-trattamento-del-mieloma-multiplo]]></loc><lastmod>2021-03-30T14:05:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-i-benefici-della-teleriabilitazione]]></loc><lastmod>2021-03-30T14:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/donne-nella-scienza-il-progetto-she-is-a-scientist]]></loc><lastmod>2021-03-30T14:01:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-negli-stati-uniti-via-libera-a-liso-cel-contro-il-linfoma-a-grandi-cellule-b]]></loc><lastmod>2021-03-30T13:59:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-contro-la-retinite-pigmentosa]]></loc><lastmod>2021-03-30T13:57:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/cosa-resta-del-progetto-genoma-20-anni-dopo-il-sequenziamento]]></loc><lastmod>2021-03-30T13:54:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-malattia-di-pompe-la-prima-somministrazione-negli-usa]]></loc><lastmod>2021-03-30T13:29:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-le-sue-sorelle-perche-piu-strumenti-sono-meglio-di-uno]]></loc><lastmod>2021-03-30T12:17:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/editing-del-genoma-errori-che-fanno-riflettere]]></loc><lastmod>2021-03-30T12:12:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/bluebird-bio-sospende-i-trial-di-terapia-genica-per-l-anemia-falciforme]]></loc><lastmod>2021-07-19T09:30:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/quando-l-innovazione-tecnologica-aiuta-a-combattere-i-tumori]]></loc><lastmod>2021-03-30T11:59:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/sclerosi-multipla-il-trapianto-di-cellule-staminali-ematopoietiche-e-efficace-a-lungo-termine]]></loc><lastmod>2021-03-30T12:04:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/orizzonte-farmaci-2021-facciamo-il-punto-sulle-terapie-avanzate]]></loc><lastmod>2021-03-30T11:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/cancer-on-a-chip-per-lo-screening-di-immunoterapie]]></loc><lastmod>2021-03-30T11:51:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/si-fa-piu-vicina-l-approvazione-europea-di-risdiplam-per-il-trattamento-della-sma]]></loc><lastmod>2021-03-30T11:14:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/non-solo-covid-19-le-tante-potenzialita-del-rna-messaggero]]></loc><lastmod>2021-03-30T10:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-prevenire-la-tossicita-a-livello-neurologico]]></loc><lastmod>2021-03-30T10:32:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-novartis-e-la-fondazione-gates-insieme-contro-l-anemia-falciforme]]></loc><lastmod>2021-03-30T10:28:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-apple-watch-per-monitorare-il-parkinson]]></loc><lastmod>2021-03-30T10:29:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-adotta-la-filosofia-ikea-con-moduli-componibili]]></loc><lastmod>2021-03-30T10:20:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/aifa-approva-la-terapia-genica-per-la-sma]]></loc><lastmod>2021-04-21T17:54:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/boom-delle-terapie-car-t-in-europa-nel-2019]]></loc><lastmod>2021-03-30T09:54:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-obiettivo-mucopolisaccaridosi]]></loc><lastmod>2021-03-30T10:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-personalizzate-fda-pubblica-una-guida]]></loc><lastmod>2021-03-30T09:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/innovazioni-tecnologiche-stimolare-i-percorsi-neuronali-interrotti-dalla-lesione-spinale]]></loc><lastmod>2021-03-30T09:28:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-approvate-a-che-punto-siamo-e-quali-sono]]></loc><lastmod>2021-03-17T14:47:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-verso-una-soluzione-genetica-per-spegnere-il-dolore-cronico]]></loc><lastmod>2021-03-30T09:05:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/funsel-una-piattaforma-alla-ricerca-di-terapie-innovative]]></loc><lastmod>2021-03-30T09:00:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/sviluppare-le-terapie-digitali-in-italia-uno-studio-sull-obesita]]></loc><lastmod>2021-03-30T08:54:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-per-ischemia-cardiaca-un-impresa-tutta-italiana]]></loc><lastmod>2021-03-29T11:40:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-nuove-conferme-dai-risultati-a-lungo-termine]]></loc><lastmod>2021-03-26T16:24:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/da-una-nuova-cellula-ossea-indicazioni-per-combattere-le-malattie-scheletriche]]></loc><lastmod>2021-03-26T16:16:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/covid-19-comprendere-i-test-necessari-per-una-corretta-diagnosi]]></loc><lastmod>2021-03-30T14:55:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/fda-approva-la-terapia-car-t-per-il-mieloma-multiplo]]></loc><lastmod>2021-03-31T08:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-la-commissione-europea-autorizza-risdiplam-per-la-sma]]></loc><lastmod>2021-04-01T10:05:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/ricerca-sugli-embrioni-siamo-pronti-a-superare-i-limiti]]></loc><lastmod>2021-04-29T11:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-l-adrenoleucodistrofia-cerebrale-i-dati-a-lungo-termine]]></loc><lastmod>2021-04-06T18:03:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/i-retroscena-della-saga-crispr]]></loc><lastmod>2021-04-08T15:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-on-off-per-gestire-la-tossicita]]></loc><lastmod>2021-04-08T15:21:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-una-app-per-predire-la-sindrome-post-covid-19]]></loc><lastmod>2021-04-08T17:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-l-importanza-della-comunicazione]]></loc><lastmod>2021-04-13T19:27:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-nuove-strategie-per-vettori-virali-piu-sicuri-ed-efficaci]]></loc><lastmod>2021-04-13T18:58:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/un-aerosol-a-base-di-crispr-contro-l-influenza-e-i-coronavirus]]></loc><lastmod>2021-04-13T19:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-nuove-speranze-per-due-gravi-patologie-dell-occhio]]></loc><lastmod>2021-04-17T21:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/telemedicina-e-covid-19-troppe-le-disparita-negli-stati-uniti]]></loc><lastmod>2021-04-17T21:05:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-una-possibile-arma-in-piu-contro-la-malattia-di-huntington]]></loc><lastmod>2021-04-20T13:35:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-contro-le-varianti-del-covid-19]]></loc><lastmod>2021-04-20T14:17:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-l-nih-prepara-il-super-kit-del-futuro]]></loc><lastmod>2021-04-25T19:35:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-modello-di-polmoni-artificiali-per-studiare-le-infezioni-virali]]></loc><lastmod>2021-04-25T18:59:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-il-deficit-di-aadc-l-importanza-dello-screening-neonatale]]></loc><lastmod>2021-04-29T10:37:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/la-doppia-elica-sara-l-hard-disk-del-futuro]]></loc><lastmod>2021-05-02T13:55:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-quasi-2-5-milioni-di-euro-per-l-epidermolisi-bollosa]]></loc><lastmod>2021-04-30T07:44:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/chimere-umano-scimmia-una-scienza-eticamente-complessa]]></loc><lastmod>2021-04-29T14:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/endeavorrx-il-videogioco-per-l-adhd-ora-contro-covid-19]]></loc><lastmod>2021-04-30T17:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-fabry-pubblicati-i-primi-risultati]]></loc><lastmod>2021-04-30T19:01:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/la-proteogenomica-un-approccio-globale-contro-il-cancro]]></loc><lastmod>2021-04-30T18:18:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/terapie-avanzate-per-emoglobinopatie-a-che-punto-siamo]]></loc><lastmod>2021-05-10T12:43:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-puntare-agli-esosomi-per-la-somministrazione]]></loc><lastmod>2021-05-09T21:26:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-un-nuovo-interruttore-epigenetico]]></loc><lastmod>2021-05-12T10:05:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-pacemaker-impiantabile-per-il-parkinson]]></loc><lastmod>2021-05-11T20:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-combattere-l-obesita-e-il-diabete]]></loc><lastmod>2021-05-15T21:31:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/cosa-e-un-organoide-e-cosa-non-lo-e-ecco-la-consensus-degli-esperti]]></loc><lastmod>2021-05-15T21:30:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-ecco-la-versione-che-sfrutta-l-ipossia-contro-i-tumori-solidi]]></loc><lastmod>2021-05-18T19:15:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-ada-scid-ema-rinnova-l-autorizzazione-per-5-anni]]></loc><lastmod>2021-05-18T19:15:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/il-neurosviluppo-studiato-grazie-alle-cellule-staminali-neurali]]></loc><lastmod>2021-05-23T12:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-adrenoleucodistrofia-cerebrale-positivo-il-parere-del-chmp]]></loc><lastmod>2021-05-24T15:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-usare-le-nucleasi-a-dito-di-zinco-per-combattere-l-alzheimer]]></loc><lastmod>2021-10-05T15:37:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/xenobot-macchine-viventi-che-sfidano-il-concetto-di-organismo]]></loc><lastmod>2021-05-25T18:22:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/disinformazione-sanitaria-online-chi-sono-le-persone-piu-vulnerabili]]></loc><lastmod>2021-05-28T18:50:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-per-la-demenza-unire-l-esercizio-al-divertimento]]></loc><lastmod>2021-06-04T10:03:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/staminali-epiteliali-identificato-il-ruolo-della-proteina-foxm1]]></loc><lastmod>2021-05-28T19:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-modello-per-il-tumore-al-collo-dell-utero]]></loc><lastmod>2021-05-28T19:38:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/dal-covid-19-una-lezione-per-le-terapia-avanzate]]></loc><lastmod>2021-06-04T10:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/la-nuova-interfaccia-cervello-computer-per-scrivere-con-il-pensiero]]></loc><lastmod>2021-06-08T21:50:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/nominati-i-nuovi-membri-italiani-del-comitato-per-le-terapie-avanzate-dell-ema]]></loc><lastmod>2021-06-10T18:14:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/progetto-car-t-italia-trattati-con-successo-i-primi-3-bambini]]></loc><lastmod>2021-06-09T18:51:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/completato-forse-il-sequenziamento-del-genoma-umano]]></loc><lastmod>2021-06-09T18:50:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/optogenetica-sperimentata-con-successo-contro-la-retinite-pigmentosa]]></loc><lastmod>2021-06-13T22:17:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/editing-humanity-la-rivoluzione-di-crispr-e-la-nuova-era-dell-editing-genomico]]></loc><lastmod>2021-06-13T22:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-nuovi-scenari-di-studio-della-sindrome-dell-x-fragile]]></loc><lastmod>2021-06-15T21:52:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-e-non-solo-l-isscr-aggiorna-le-sue-linee-guida]]></loc><lastmod>2021-06-15T21:52:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-emoglobinopatie-nuovi-dati-per-ctx001]]></loc><lastmod>2021-06-15T22:24:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-otcd-dal-fallimento-al-successo]]></loc><lastmod>2021-06-19T21:14:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-la-leucemia-linfoblastica-acuta-nuovi-dati-dalla-conferenza-eha]]></loc><lastmod>2021-06-19T19:56:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/commercio-di-terapie-cellulari-non-approvate-lanciato-un-appello-internazionale]]></loc><lastmod>2021-06-23T06:54:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/il-valore-delle-terapie-avanzate]]></loc><lastmod>2021-06-24T10:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-nuovi-dati-e-primo-programma-di-supporto-al-paziente]]></loc><lastmod>2021-06-23T22:10:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-rende-le-car-t-piu-efficaci-e-adattabili]]></loc><lastmod>2021-06-26T17:25:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-ancora-poco-chiara-la-regolamentazione]]></loc><lastmod>2021-06-26T18:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-un-passo-avanti-per-la-malattia-di-huntington]]></loc><lastmod>2021-06-26T18:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-interfaccia-cervello-computer-per-i-pazienti-con-paralisi-completa]]></loc><lastmod>2021-06-26T19:03:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-piu-vicino-l-arrivo-di-una-terapia-contro-il-mieloma-multiplo]]></loc><lastmod>2021-07-19T09:01:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-e-fattori-proteici-due-strade-per-riparare-il-cuore]]></loc><lastmod>2021-07-05T10:07:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/innovazioni-ora-l-idrogel-si-ripara-da-solo]]></loc><lastmod>2021-06-30T15:47:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-dall-intelligenza-artificiale-nuovi-prototipi-contro-i-tumori-solidi]]></loc><lastmod>2021-07-06T14:05:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-avanzate-per-la-malattia-di-parkinson-avviati-due-nuovi-studi-clinici]]></loc><lastmod>2021-07-06T14:04:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-un-videogioco-per-la-paralisi-cerebrale]]></loc><lastmod>2021-07-09T12:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-per-eliminare-la-bilirubina-in-eccesso]]></loc><lastmod>2021-11-12T20:34:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/combinare-terapia-genica-e-cellulare-per-combattere-l-hiv]]></loc><lastmod>2021-07-13T19:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-la-prima-volta-in-vivo-sull-uomo]]></loc><lastmod>2022-01-12T16:52:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-prima-somministrazione-a-paziente-adulta-con-amaurosi-congenita-di-leber]]></loc><lastmod>2021-07-21T15:36:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/la-roadmap-flessibile-dell-oms-sull-editing-del-genoma-umano]]></loc><lastmod>2021-07-19T16:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/riprende-la-commercializzazione-della-terapia-genica-per-la-beta-talassemia]]></loc><lastmod>2021-07-21T15:19:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-nel-mirino-anche-la-malattia-di-charcot-marie-tooth]]></loc><lastmod>2021-08-04T12:10:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-pubblicati-nuovi-dati-per-il-deficit-di-aadc]]></loc><lastmod>2021-07-26T13:44:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-ieri-oggi-e-domani]]></loc><lastmod>2021-07-27T14:05:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-per-la-diagnosi-di-autismo]]></loc><lastmod>2021-07-27T14:30:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/autorizzata-in-europa-la-terapia-genica-per-l-adrenoleucodistrofia-cerebrale]]></loc><lastmod>2021-07-29T12:13:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/intelligenza-artificiale-per-riconoscere-le-malattie-della-pelle]]></loc><lastmod>2021-07-29T18:35:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-blocca-la-replicazione-di-sars-cov-2-in-laboratorio]]></loc><lastmod>2021-07-29T18:45:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/crispr-un-racconto-in-continua-evoluzione]]></loc><lastmod>2021-08-04T11:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-si-potra-agire-direttamente-in-utero]]></loc><lastmod>2021-09-02T17:45:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/autorizzata-in-europa-la-prima-car-t-per-il-mieloma-multiplo]]></loc><lastmod>2021-09-07T13:18:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-una-possibilita-per-il-diabete]]></loc><lastmod>2021-09-02T18:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/il-primo-pacemaker-temporaneo-biodegradabile]]></loc><lastmod>2021-09-09T10:44:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/cellule-cik-contro-i-linfomi-non-hodgkin]]></loc><lastmod>2021-09-07T12:01:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/una-nuova-cura-il-racconto-della-storia-dell-immunologia]]></loc><lastmod>2021-09-10T14:56:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/dalla-casmini-ai-sistemi-omega-tutte-le-novita-dal-mondo-di-crispr]]></loc><lastmod>2021-09-14T16:27:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-non-codificanti-contro-la-fenilchetonuria]]></loc><lastmod>2021-09-15T09:16:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-nuovo-sistema-di-trasporto-per-l-mrna]]></loc><lastmod>2021-09-18T12:51:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-nuovo-modello-3d-di-glioblastoma-per-testare-i-farmaci]]></loc><lastmod>2021-09-18T12:33:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-alcuni-ostacoli-all-applicazione]]></loc><lastmod>2021-09-21T20:17:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/un-avatar-per-predire-la-risposta-all-immunoterapia]]></loc><lastmod>2021-09-21T20:24:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/un-gel-antieta-per-rinvigorire-le-staminali-scheletriche]]></loc><lastmod>2021-09-23T21:26:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-usare-le-nanocapsule-per-alcune-forme-di-asma]]></loc><lastmod>2021-09-23T21:06:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-al-servizio-del-counseling-genetico]]></loc><lastmod>2021-09-23T21:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-contro-hiv-autorizzato-il-primo-studio-clinico]]></loc><lastmod>2021-09-28T22:34:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/medicina-rigenerativa-opportunita-e-preoccupazioni]]></loc><lastmod>2021-10-03T14:18:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/una-cellula-sintetica-che-elimina-i-batteri-e-trasporta-i-farmaci]]></loc><lastmod>2021-10-03T14:49:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/il-nuovo-atlante-molecolare-dello-sviluppo-prenatale]]></loc><lastmod>2021-10-13T15:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-trasposoni-e-retrovirus-le-nuove-scommesse-di-feng-zhang]]></loc><lastmod>2021-10-05T11:38:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-la-sicurezza-rimane-la-priorita]]></loc><lastmod>2021-10-10T19:46:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-nobel-per-l-arte-di-costruire-molecole]]></loc><lastmod>2021-10-10T18:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-la-medicina-del-terzo-millennio]]></loc><lastmod>2021-10-26T22:07:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-puntare-agli-rna-transfer]]></loc><lastmod>2021-10-19T22:34:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/la-macchina-del-gene-un-libro-sulle-tracce-del-ribosoma]]></loc><lastmod>2021-10-19T21:39:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/dieci-bambini-riacquistano-la-vista-con-la-terapia-genica]]></loc><lastmod>2021-10-23T18:46:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/due-terapie-geniche-in-meno-sul-mercato-europeo]]></loc><lastmod>2021-10-24T17:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-quali-strumenti-e-per-quali-patologie]]></loc><lastmod>2021-12-30T17:02:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-la-terapia-genica-un-viaggio-lungo-50-anni]]></loc><lastmod>2022-01-25T11:39:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-1-la-sfida-delle-cure-su-misura-per-pazienti-ultrarari]]></loc><lastmod>2021-11-01T00:13:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/prix-galien-italia-2021-protagoniste-la-terapia-genica-e-le-dtx]]></loc><lastmod>2021-11-03T18:40:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/un-viaggio-nell-ematopoiesi-artificiale]]></loc><lastmod>2021-11-03T17:25:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-modello-di-studio-per-la-malattia-di-fabry]]></loc><lastmod>2021-11-07T14:05:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/vaccini-a-rna-una-storia-iniziata-30-anni-fa]]></loc><lastmod>2023-04-17T13:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianti-per-la-prima-volta-un-rene-di-maiale-in-essere-umano]]></loc><lastmod>2021-11-09T19:45:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-la-terapia-car-t-per-combattere-i-tumori]]></loc><lastmod>2021-11-30T13:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/puntare-alle-cellule-staminali-per-il-diabete-mellito-di-tipo-1]]></loc><lastmod>2021-11-12T13:28:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-la-realta-virtuale-per-l-occhio-pigro]]></loc><lastmod>2021-11-12T12:27:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/dalla-terapia-genica-una-cura-per-la-sindrome-di-crigler-najjar]]></loc><lastmod>2021-11-16T16:18:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/stefania-alessia-gaia-la-nuova-vita-grazie-alla-terapia-genica-che-spenge-la-luce-blu]]></loc><lastmod>2021-11-25T16:41:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-al-via-il-primo-trial-con-un-correttore-di-basi]]></loc><lastmod>2021-11-21T19:47:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-trattati-in-italia-8-bambini-con-la-sindrome-di-hurler]]></loc><lastmod>2021-11-25T16:32:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-e-sclerosi-multipla-imparare-dai-dati-negativi]]></loc><lastmod>2021-11-23T15:30:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-progressi-nella-lotta-al-glioblastoma]]></loc><lastmod>2021-11-23T15:27:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-per-aerosol-contro-la-fibrosi-cistica]]></loc><lastmod>2021-11-28T22:31:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-cerebrali-per-studiare-le-malattie-neurodegenerative]]></loc><lastmod>2021-11-29T10:15:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/hiv-un-nuovo-caso-di-guarigione-spontanea]]></loc><lastmod>2021-11-29T23:14:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-crispr-l-editing-genomico-2-0]]></loc><lastmod>2021-11-30T14:06:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/le-bambine-crispr-crescono-come-stanno-lulu-nana-ed-amy]]></loc><lastmod>2021-12-04T22:26:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/mini-stomaci-per-studiare-l-impatto-di-covid-19-sui-bambini]]></loc><lastmod>2021-12-04T23:12:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/tumore-del-pancreas-e-mesotelioma-nel-mirino-delle-car-t]]></loc><lastmod>2021-12-11T22:10:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-i-bambini-farfalla-confermati-i-risultati]]></loc><lastmod>2021-12-12T14:01:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/un-progetto-statunitense-per-aumentare-il-numero-di-terapie-geniche]]></loc><lastmod>2021-12-14T15:47:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/veicolare-farmaci-al-cervello-con-le-nanoparticelle]]></loc><lastmod>2021-12-14T16:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-il-racconto-della-medicina-rigenerativa]]></loc><lastmod>2021-12-18T18:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-benefici-a-lungo-termine-per-il-deficit-di-aadc]]></loc><lastmod>2021-12-19T19:11:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-all-avanguardia-per-colpire-proteine-tumorali-altamente-specifiche]]></loc><lastmod>2021-12-19T22:10:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-nuove-vie-per-combattere-il-parkinson]]></loc><lastmod>2021-12-21T19:25:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/come-batteremo-il-cancro-la-sfida-dell-immunoterapia-e-delle-car-t]]></loc><lastmod>2021-12-21T18:56:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-innovativo-studio-clinico-per-la-malattia-di-wilson]]></loc><lastmod>2022-01-20T22:20:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/digital-health-il-primo-diario-digitale-per-le-malattie-autoinfiammatorie]]></loc><lastmod>2022-01-09T20:20:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-biosensore-indossabile-a-base-di-gel-per-rilevare-le-infezioni]]></loc><lastmod>2022-01-12T13:48:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-risultati-positivi-per-l-amaurosi-congenita-di-leber]]></loc><lastmod>2022-01-12T23:32:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-car-t-diventano-piccole-fabbriche-di-farmaci]]></loc><lastmod>2022-01-20T10:38:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-una-app-per-l-ipertensione]]></loc><lastmod>2022-01-14T14:24:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/la-medicina-rigenerativa-va-in-orbita]]></loc><lastmod>2022-01-18T18:42:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/varianti-dall-alfa-all-omicron-del-coronavirus]]></loc><lastmod>2022-01-18T19:29:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-una-ricerca-italiana-punta-alla-distrofia-miotonica]]></loc><lastmod>2022-01-23T16:52:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/cellule-car-t-programmate-in-vivo-per-l-insufficienza-cardiaca]]></loc><lastmod>2022-01-23T16:17:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-leucodistrofia-metacromatica-confermati-i-risultati]]></loc><lastmod>2022-01-25T15:48:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/nanocristalli-per-ridurre-gli-effetti-collaterali-della-chemioterapia]]></loc><lastmod>2022-01-25T16:56:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-la-realta-virtuale-per-il-dolore-cronico]]></loc><lastmod>2022-01-30T22:20:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-al-via-una-sperimentazione-per-il-diabete]]></loc><lastmod>2022-01-31T14:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/antonio-il-bimbo-che-sfida-la-sma-nei-panni-di-superman]]></loc><lastmod>2022-02-01T21:32:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-abbattere-lo-scudo-di-zuccheri-che-protegge-le-cellule-tumorali]]></loc><lastmod>2022-02-01T21:05:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-e-nanoparticelle-per-puntare-alle-cellule-dei-vasi-sanguigni]]></loc><lastmod>2022-02-06T00:35:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-uno-studio-clinico-per-la-sindrome-di-dravet]]></loc><lastmod>2022-02-06T01:00:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-beta-talassemia-una-svolta-per-le-trasfusioni]]></loc><lastmod>2022-02-07T16:19:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/prosegue-il-cammino-della-terapia-genica-per-l-emofilia-a]]></loc><lastmod>2022-02-09T08:02:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/sbarca-nel-regno-unito-la-terapia-genica-per-la-leucodistrofia-metacromatica]]></loc><lastmod>2023-07-08T20:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/terapia-car-t-efficace-dopo-10-anni-si-puo-forse-parlare-di-cura]]></loc><lastmod>2022-02-12T17:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/l-aifa-autorizza-il-rimborso-di-risdiplam-per-la-sma]]></loc><lastmod>2022-02-15T17:52:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/trapianto-di-insule-pancreatiche-per-il-diabete]]></loc><lastmod>2022-02-15T17:03:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/le-tecnologie-da-tenere-d-occhio-nel-2022]]></loc><lastmod>2023-03-18T07:35:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/ingegnerizzare-i-linfociti-t-contro-la-leucemia-mieloide-acuta]]></loc><lastmod>2022-03-03T12:56:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-uno-studio-italiano-sul-cancro-ovarico]]></loc><lastmod>2022-02-19T21:44:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-multi-test-anti-coronavirus-per-distinguere-le-diverse-varianti]]></loc><lastmod>2022-03-01T12:26:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/consensus/pubblicata-la-prima-consensus-italiana-sul-valore-delle-terapie-avanzate]]></loc><lastmod>2022-02-22T10:39:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/malattie-rare-e-terapie-avanzate-compagne-di-un-lungo-viaggio]]></loc><lastmod>2022-02-28T09:05:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/media-tutorial-terapie-avanzate-dalla-sperimentazione-alla-pratica-clinica]]></loc><lastmod>2022-10-27T08:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/esosomi-da-mesenchimali-un-opzione-per-le-terapie-di-precisione]]></loc><lastmod>2022-03-01T19:38:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/non-solo-doudna-e-charpentier-foto-e-fatti-sulle-donne-di-crispr]]></loc><lastmod>2022-03-06T18:38:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/dai-linfociti-t-regolatori-possibili-risposte-contro-la-sclerosi-multipla]]></loc><lastmod>2022-03-06T16:59:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-per-il-lad-1]]></loc><lastmod>2022-03-08T20:30:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/su-microchip-il-nuovo-modello-cellulare-per-la-sla]]></loc><lastmod>2022-03-08T21:15:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/immunoterapia-non-piu-personalizzata-ma-pronta-all-uso]]></loc><lastmod>2022-03-13T15:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-polmone-universale-anti-rigetto-per-tutti-i-gruppi-sanguigni]]></loc><lastmod>2022-03-13T16:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/tornare-a-camminare-dopo-una-lesione-spinale]]></loc><lastmod>2022-03-15T21:46:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-italia-la-terapia-car-t-per-il-linfoma-mantellare]]></loc><lastmod>2022-03-17T18:42:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-quando-il-bersaglio-delle-terapie-e-l-rna]]></loc><lastmod>2022-03-17T18:41:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-buoni-i-risultati-per-l-amiloidosi-da-accumulo-di-transtiretina]]></loc><lastmod>2022-03-17T18:28:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/50-grandi-idee-il-racconto-delle-biotecnologie]]></loc><lastmod>2022-03-17T18:41:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-pesce-bioibrido-formato-da-cellule-cardiache-umane]]></loc><lastmod>2022-03-22T21:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/giulio-pompilo-nominato-presidente-del-comitato-scientifico-di-ota]]></loc><lastmod>2022-03-31T10:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/venticinque-anni-di-terapia-genica-a-che-punto-siamo]]></loc><lastmod>2022-03-27T19:12:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/terapie-avanzate-presente-e-prospettive-future-di-questo-importante-settore-innovativo]]></loc><lastmod>2022-03-30T14:23:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/distrofie-retiniche-ereditarie-e-terapia-genica-e-possibile-riacquistare-la-vista]]></loc><lastmod>2022-03-30T09:22:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/comitato-etico-nazionale-per-gli-studi-clinici-con-terapie-avanzate]]></loc><lastmod>2022-03-30T14:21:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-e-il-loro-complicato-percorso-di-approvazione]]></loc><lastmod>2022-03-31T16:18:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/cell-therapy-open-source/car-t-presentato-il-secondo-volume-del-progetto-ctos]]></loc><lastmod>2022-04-03T10:59:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/dopo-piu-di-20-anni-e-finito-il-sequenziamento-del-genoma-umano]]></loc><lastmod>2022-04-04T19:16:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/horizon-scanning-2022-le-terapie-avanzate-in-arrivo]]></loc><lastmod>2022-04-05T20:39:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-alla-scoperta-delle-terapie-digitali]]></loc><lastmod>2022-05-09T20:19:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/la-terapia-genica-per-l-emofilia-b-sul-tavolo-dell-ema]]></loc><lastmod>2022-04-10T10:07:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/atrofia-muscolare-spinale-buoni-risultati-dalle-terapie-approvate]]></loc><lastmod>2022-04-10T11:11:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-creatore-delle-bimbe-crispr-e-tornato-libero-cosa-accadra-ora]]></loc><lastmod>2022-04-12T19:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/per-il-test-della-coagulazione-del-sangue-basta-uno-smartphone]]></loc><lastmod>2022-04-12T20:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-semaforo-verde-della-commissione-europea-per-liso-cel]]></loc><lastmod>2022-04-13T19:37:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/mini-fegati-per-la-porpora-trombotica-trombocitopenica-congenita]]></loc><lastmod>2022-04-13T20:21:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-del-dna-mitocondriale-un-nuovo-passo-in-avanti]]></loc><lastmod>2022-04-13T20:42:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-i-primi-risultati-per-la-sindrome-di-tay-sachs]]></loc><lastmod>2022-04-13T21:05:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/microrobot-per-il-rilascio-intelligente-dei-farmaci]]></loc><lastmod>2023-03-18T07:34:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/innovative-strategie-terapeutiche-contro-la-leucemia-mieloide-acuta]]></loc><lastmod>2022-04-27T22:03:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/terapie-car-t-pronte-in-24-ore-un-obiettivo-raggiungibile]]></loc><lastmod>2022-04-22T11:21:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-trattato-un-bambino-con-amaurosi-congenita-di-leber]]></loc><lastmod>2022-05-01T21:48:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-e-vaccini-a-mrna-insieme-contro-i-tumori-solidi]]></loc><lastmod>2023-09-07T10:32:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-elettrodo-iniettabile-salvavita-per-le-aritmie-cardiache]]></loc><lastmod>2022-05-03T21:16:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/pangenoma-progetto-che-punta-a-rappresentare-la-variabilita-genetica-umana]]></loc><lastmod>2022-05-03T20:52:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-e-non-solo-per-la-duchenne]]></loc><lastmod>2022-05-06T17:32:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/combinare-car-t-e-terapia-farmacologica-contro-i-gliomi-non-operabili]]></loc><lastmod>2022-05-06T17:13:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-made-in-italy]]></loc><lastmod>2022-05-10T13:45:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-l-importanza-della-comunicazione-scientifica]]></loc><lastmod>2022-05-09T20:18:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-estese-le-indicazioni-di-tisagenlecleucel-al-linfoma-follicolare]]></loc><lastmod>2022-05-30T10:57:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/sempre-piu-vicina-la-terapia-genica-per-l-emofilia-a]]></loc><lastmod>2022-05-16T11:36:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-virus-contro-il-cancro-che-si-attiva-con-la-luce]]></loc><lastmod>2023-03-18T07:34:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-nuovo-approccio-per-i-bambini-farfalla]]></loc><lastmod>2022-05-27T09:18:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/il-regno-unito-avvia-il-primo-studio-sul-pancreas-artificiale]]></loc><lastmod>2022-05-25T14:27:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/usare-l-mrna-per-guarire-le-fratture-ossee]]></loc><lastmod>2022-05-20T21:04:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/una-app-per-l-autoscreening-di-malattie-neurologiche]]></loc><lastmod>2022-05-20T20:45:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/tornare-a-sentire-grazie-alla-medicina-rigenerativa]]></loc><lastmod>2022-05-24T17:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-contro-malattie-autoimmuni-e-non-solo]]></loc><lastmod>2022-05-24T18:55:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-la-leucodistrofia-metacromatica-pubblicato-il-report-aifa]]></loc><lastmod>2025-02-18T14:08:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/tre-vaccini-a-rna-in-sperimentazione-per-l-hiv]]></loc><lastmod>2023-04-17T13:54:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/si-fa-piu-vicina-la-terapia-genica-per-il-deficit-di-aadc]]></loc><lastmod>2022-05-30T10:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-atlante-multi-tessuto-per-le-malattie-sistemiche-complesse]]></loc><lastmod>2022-05-31T22:13:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-la-commissione-europea-da-l-ok-a-ciltacabtagene-autoleucel]]></loc><lastmod>2022-05-31T21:47:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/un-iniezione-di-cellule-endoteliali-per-preservare-la-vista]]></loc><lastmod>2022-06-05T18:44:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/una-terapia-car-t-contro-i-tumori-dell-apparato-digerente]]></loc><lastmod>2022-06-05T19:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-in-oncologia-a-che-punto-siamo]]></loc><lastmod>2022-06-07T11:42:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/sfruttare-la-tecnologia-mrna-per-ottimizzare-la-terapia-genica-ex-vivo]]></loc><lastmod>2022-06-08T21:09:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/stessa-musica-cambia-il-volume-cosi-l-epi-editing-regola-i-geni]]></loc><lastmod>2022-06-10T10:42:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/lenti-a-contatto-smart-per-trattare-il-glaucoma]]></loc><lastmod>2022-06-10T10:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-e-malattie-rare-l-appello-di-francis-collins]]></loc><lastmod>2022-06-13T17:28:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/orecchio-stampato-in-3d-potrebbe-curare-una-malattia-rara]]></loc><lastmod>2022-06-14T15:45:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/usare-un-virus-per-combattere-i-tumori-solidi]]></loc><lastmod>2022-06-15T15:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-robot-per-crescere-tendini-artificiali-a-scopo-di-trapianto]]></loc><lastmod>2022-06-14T15:30:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-buoni-i-risultati-preliminari-per-la-mucopolisaccaridosi-di-tipo-6]]></loc><lastmod>2022-06-21T20:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/trattare-l-insonnia-con-una-app-in-uk-e-realta]]></loc><lastmod>2022-06-21T19:52:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/l-abc-delle-car-t/car-t-pubblicata-la-guida-gratuita-rivolta-ai-pazienti-ma-non-solo]]></loc><lastmod>2022-06-23T12:51:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-continui-progressi-per-tumori-e-malattie-ematologiche]]></loc><lastmod>2022-06-27T09:31:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-al-servizio-del-glaucoma]]></loc><lastmod>2022-06-26T10:51:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-per-contrastare-i-processi-infiammatori-delle-cellule-nervose]]></loc><lastmod>2022-06-28T18:21:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-nuova-indicazione-d-uso-per-axicabtagene-ciloleucel]]></loc><lastmod>2022-06-29T14:37:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-e-fibrosi-cistica-potrebbe-funzionare-una-guida-magnetica]]></loc><lastmod>2022-06-28T20:14:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/una-pelle-elettronica-piu-sensibile-di-un-polpastrello-umano]]></loc><lastmod>2023-03-18T07:33:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-trattare-l-alzheimer-familiare-un-altro-passo-verso-l-obiettivo]]></loc><lastmod>2022-07-05T11:22:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-per-i-disturbi-congeniti-della-glicosilazione]]></loc><lastmod>2022-07-05T10:59:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-sperimentale-per-la-retinite-pigmentosa]]></loc><lastmod>2022-07-11T06:59:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-le-sfide-per-le-malattie-neurodegenerative]]></loc><lastmod>2022-07-10T16:55:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-diagnosticare-la-tubercolosi]]></loc><lastmod>2022-07-12T11:45:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/primo-impianto-in-italia-di-un-pacemaker-senza-fili]]></loc><lastmod>2023-03-18T07:33:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-nuova-piattaforma-di-terapia-genica-contro-il-glioblastoma-multiforme]]></loc><lastmod>2022-07-15T17:43:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/rene-artificiale-come-eliminare-dialisi-e-trapianto]]></loc><lastmod>2022-07-15T16:39:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/primo-successo-dell-immunoterapia-contro-il-tumore-del-pancreas]]></loc><lastmod>2022-07-19T16:12:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-geniche-per-malattie-rare-la-sfida-e-la-sostenibilita]]></loc><lastmod>2022-07-21T09:57:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/quando-la-riparazione-delle-lesioni-spinali-comincia-dalle-cellule-immunitarie]]></loc><lastmod>2022-07-22T13:03:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-la-cina-accelera-nella-ricerca-e-sviluppo-e-supera-gli-stati-uniti]]></loc><lastmod>2022-07-22T12:25:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-europa-la-terapia-genica-per-il-deficit-di-aadc]]></loc><lastmod>2023-12-06T14:19:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/una-mappa-basata-su-crispr-assegna-a-ogni-gene-la-propria-funzione]]></loc><lastmod>2022-07-22T14:14:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/il-bambino-farfalla-cronaca-di-una-terapia-salvavita]]></loc><lastmod>2022-07-22T13:25:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/rendere-la-terapia-genica-piu-sicura]]></loc><lastmod>2022-07-29T16:49:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/il-millirobot-che-si-arrampica-sulle-pareti-degli-organi]]></loc><lastmod>2022-07-29T15:24:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/materiali-per-la-vita-storie-di-biomateriali]]></loc><lastmod>2022-08-02T16:31:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-alla-ricerca-di-soluzioni-terapeutiche-contro-le-metastasi]]></loc><lastmod>2022-08-13T10:50:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/corpi-estranei-cosa-significa-essere-bionico]]></loc><lastmod>2022-09-04T13:18:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-duchenne-autorizzata-la-somministrazione-a-un-paziente-negli-usa]]></loc><lastmod>2022-09-06T13:32:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-europa-la-prima-terapia-genica-per-l-emofilia-a]]></loc><lastmod>2024-01-31T20:46:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-cas12-trattato-un-paziente-con-anemia-falciforme]]></loc><lastmod>2022-09-13T09:17:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/la-terapia-genica-in-prima-serata-sulla-rai]]></loc><lastmod>2022-09-11T13:45:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-approvata-una-nuova-indicazione-per-brexucabtagene-autoleucel]]></loc><lastmod>2023-12-06T15:22:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni/reshape-la-raccolta-completa-delle-storie-illustrate]]></loc><lastmod>2022-09-14T08:03:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-nuovo-protocollo-preclinico-per-la-sla]]></loc><lastmod>2022-09-19T09:34:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/molecole-immunostimolanti-a-rilascio-mirato-contro-il-glioblastoma-multiforme]]></loc><lastmod>2022-09-18T13:49:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-spegnere-i-geni-responsabili-della-proliferazione-del-glioblastoma]]></loc><lastmod>2022-10-02T08:39:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-colesterolo-la-prima-sperimentazione-sull-uomo]]></loc><lastmod>2022-09-18T13:50:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-per-prevedere-la-risposta-all-immunoterapia]]></loc><lastmod>2022-09-22T19:06:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/una-cornea-artificiale-per-i-malati-di-cheratocono]]></loc><lastmod>2023-03-18T07:33:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-il-base-editing-entra-negli-studi-clinici]]></loc><lastmod>2022-09-27T19:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-geniche-a-rischio-il-loro-futuro-nel-campo-delle-malattie-rare]]></loc><lastmod>2022-09-27T16:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/la-prima-terapia-crispr-sta-per-tagliare-il-traguardo]]></loc><lastmod>2022-09-29T20:10:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/linfociti-nkt-una-lama-a-doppio-taglio-contro-i-tumori]]></loc><lastmod>2022-09-29T20:51:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianti-maiale-uomo-quanto-siamo-vicini]]></loc><lastmod>2022-10-19T12:29:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapia-digitale-per-insufficienza-renale-ok-alla-sperimentazione-in-italia]]></loc><lastmod>2022-10-19T12:29:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/primo-paziente-con-hiv-trattato-con-crispr]]></loc><lastmod>2022-10-19T12:28:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/una-retina-artificiale-liquida-contro-le-distrofie-retiniche]]></loc><lastmod>2023-03-18T07:33:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-intestinali-la-svolta-per-innovare-la-produzione]]></loc><lastmod>2022-10-19T12:41:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-una-rivoluzione-possibile-in-italia]]></loc><lastmod>2022-10-19T12:27:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/terapia-car-t-efficace-in-cinque-pazienti-con-lupus-eritematoso-sistemico]]></loc><lastmod>2022-10-19T09:39:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-avanzate-e-non-solo-per-la-fenilchetonuria]]></loc><lastmod>2024-01-18T12:21:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-la-storia-dei-due-fratellini-che-hanno-riacquistato-la-vista]]></loc><lastmod>2022-10-19T09:37:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/ema-concede-la-raccomandazione-alla-prima-terapia-allogenica-a-base-di-cellule-t]]></loc><lastmod>2022-10-21T09:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-si-estende-il-pannello-di-applicazioni-per-axicabtagene-ciloleucel]]></loc><lastmod>2022-10-20T08:22:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-sbarca-in-italia-un-innovativo-farmaco-per-abbassare-il-colesterolo]]></loc><lastmod>2022-10-21T10:57:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/un-vademecum-anti-truffa-per-le-terapie-a-base-di-staminali]]></loc><lastmod>2026-02-27T09:15:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/il-futuro-delle-terapie-a-rna-messaggero-tra-ostacoli-e-innovazioni]]></loc><lastmod>2023-04-17T13:56:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-primi-dati-per-l-angioedema-ereditario-e-l-amiloidosi-da-transtiretina]]></loc><lastmod>2022-10-26T18:01:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-in-vivo-le-tecniche-di-delivery]]></loc><lastmod>2022-10-30T13:56:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/evoluzione-nella-lotta-al-cancro-si-lavora-alle-car-t-attivabili-o-disattivabili]]></loc><lastmod>2022-10-30T13:54:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/ema-lancia-un-progetto-pilota-per-sostenere-lo-sviluppo-delle-terapie-avanzate]]></loc><lastmod>2022-10-31T11:05:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/torna-in-scena-at2-lo-scienze-show-sulle-terapie-avanzate]]></loc><lastmod>2022-11-08T12:06:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-far-crescere-mini-fegati-all-interno-del-corpo]]></loc><lastmod>2022-11-09T16:05:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/retreat-un-progetto-di-policy-shaping-sulle-terapie-avanzate]]></loc><lastmod>2022-11-09T16:24:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-pronte-all-uso-grazie-a-crispr]]></loc><lastmod>2022-11-14T08:34:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/maggior-rischio-di-ricaduta-in-pazienti-con-lla-e-alterazioni-del-gene-pax5]]></loc><lastmod>2022-11-11T15:15:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/placenta-on-a-chip-per-studiare-lo-scambio-di-nutrienti-tra-madre-e-feto]]></loc><lastmod>2022-11-15T12:28:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-per-la-degenerazione-maculare-senile]]></loc><lastmod>2022-11-15T15:24:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/i-linfociti-infiltranti-il-tumore-contro-il-melanoma-metastatico]]></loc><lastmod>2022-11-18T14:00:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-come-continuare-a-permettersele]]></loc><lastmod>2022-12-06T11:57:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-un-app-per-il-trattamento-dell-ipertensione-arteriosa]]></loc><lastmod>2022-11-22T17:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/come-si-fa-a-capire-se-le-car-t-stanno-funzionando]]></loc><lastmod>2022-11-22T16:24:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/comprendere-come-funzionano-le-car-t-per-potenziarne-l-effetto]]></loc><lastmod>2022-11-25T13:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/approvata-negli-stati-uniti-la-prima-terapia-genica-per-l-emofilia-b]]></loc><lastmod>2022-11-25T14:05:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-lhon-pubblicati-i-dati-dello-studio-clinico-reflect]]></loc><lastmod>2022-11-30T11:01:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/medicina-rigenerativa-del-pancreas-una-speranza-per-il-diabete]]></loc><lastmod>2022-12-05T20:04:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-monica-casucci-ottiene-uno-dei-finanziamenti-erc-starting-grants]]></loc><lastmod>2022-12-07T09:57:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/dai-fagi-ai-borg-la-genetica-del-futuro-e-un-inno-a-darwin]]></loc><lastmod>2022-12-02T15:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/medicina-rigenerativa-cecilia-laterza-vince-un-finanziamento-erc-starting-grants]]></loc><lastmod>2022-12-06T12:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/terapia-in-utero-una-speranza-per-i-difetti-enzimatici-ereditari]]></loc><lastmod>2023-03-18T07:32:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-finanziamento-europeo-per-sviluppare-organ-on-chip]]></loc><lastmod>2022-12-07T11:04:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-all-attacco-dei-tumori-cerebrali]]></loc><lastmod>2022-12-07T19:10:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-paste-la-combinazione-a-tre-per-incollare-geni-interi]]></loc><lastmod>2022-12-13T12:48:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/terapie-avanzate-per-la-gestione-delle-infezioni-post-trapianto]]></loc><lastmod>2022-12-14T14:27:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/ambiente-economia-e-societa-i-costi-della-salute]]></loc><lastmod>2022-12-14T22:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/sangue-artificiale-via-alle-prime-trasfusioni-negli-esseri-umani]]></loc><lastmod>2023-03-18T07:32:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/cinque-startup-puntano-alla-terapia-car-t-in-vivo]]></loc><lastmod>2022-12-20T19:43:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-finemente-modificate-per-combattere-una-leucemia-incurabile]]></loc><lastmod>2022-12-20T19:42:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/la-commissione-europea-concede-l-approvazione-a-tabelecleucel]]></loc><lastmod>2023-01-09T16:48:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/linee-guida-per-la-progettazione-dei-trial-sulle-terapie-digitali]]></loc><lastmod>2022-12-31T10:36:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-cas12-positivi-i-primi-dati-del-trial-sull-anemia-falciforme]]></loc><lastmod>2022-12-29T10:58:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-rigenerare-le-difese-immunitarie-nei-bambini-con-art-scid]]></loc><lastmod>2023-01-10T17:18:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/dalle-cellule-staminali-neurali-un-possibile-trattamento-per-la-sclerosi-multipla]]></loc><lastmod>2023-01-10T16:18:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/risultati-positivi-da-una-terapia-genica-per-l-emofilia-b]]></loc><lastmod>2023-01-12T16:58:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-trovato-un-bersaglio-terapeutico-per-il-rene-policistico]]></loc><lastmod>2023-01-17T15:56:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/trapianto-di-mitocondri-per-pazienti-con-malattie-rare]]></loc><lastmod>2023-03-18T07:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/nanoparticelle-lipidiche-per-portare-crispr-dentro-il-tumore]]></loc><lastmod>2023-01-20T11:04:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-una-nuova-strategia-a-ultrasuoni]]></loc><lastmod>2023-01-20T11:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/studiare-le-metastasi-per-potenziare-l-immunoterapia]]></loc><lastmod>2023-01-24T15:47:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/realta-virtuale-tecnologie-dirompenti-al-servizio-della-medicina]]></loc><lastmod>2023-01-24T16:12:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/pancreas-artificiale-una-realta-piu-vicina-anche-per-il-diabete-di-tipo-2]]></loc><lastmod>2023-01-27T10:51:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/fegati-su-chip-per-gli-studi-di-tossicita]]></loc><lastmod>2023-01-27T09:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-cellule-car-nk-all-attacco-della-leucemia-mieloide-acuta]]></loc><lastmod>2023-01-31T12:15:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/in-valutazione-ema-la-terapia-crispr-per-anemia-falciforme-e-beta-talassemia]]></loc><lastmod>2024-01-15T09:30:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/diario-di-una-cellula-dalla-fecondazione-alla-nascita]]></loc><lastmod>2023-02-02T12:30:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/in-sviluppo-la-prima-terapia-digitale-per-la-tele-riabilitazione-motoria]]></loc><lastmod>2023-02-02T14:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/sclerosi-multipla-nuovi-studi-fanno-avanzare-la-ricerca-sulle-staminali]]></loc><lastmod>2023-02-07T19:36:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/come-saranno-le-car-t-del-futuro]]></loc><lastmod>2023-02-07T20:20:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-in-gel-per-l-epidermolisi-bollosa-i-primi-risultati]]></loc><lastmod>2023-02-10T08:56:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/dna-origami-per-intrappolare-i-virus]]></loc><lastmod>2023-03-18T07:32:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/medicina-digitale-una-collaborazione-italiana-per-le-malattie-croniche]]></loc><lastmod>2023-02-14T18:19:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-il-deficit-di-aadc-nuova-vita-per-una-bimba]]></loc><lastmod>2023-02-19T20:14:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-pronte-all-uso-per-rigenerare-un-cuore-danneggiato]]></loc><lastmod>2023-02-16T16:17:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/dai-vaccini-all-editing-genomico-il-futuro-e-nelle-gocce-di-grasso]]></loc><lastmod>2023-02-21T20:36:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/una-terapia-genica-made-in-italy-per-il-glioblastoma-e-altri-tumori-solidi]]></loc><lastmod>2023-02-21T20:42:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-come-fare-uno-studio-sugli-esseri-umani]]></loc><lastmod>2023-02-24T19:56:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-europa-la-prima-terapia-genica-per-l-emofilia-b]]></loc><lastmod>2023-02-26T21:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/nanoparticelle-di-grasso-e-mrna-per-le-malattie-ereditarie-della-retina]]></loc><lastmod>2023-02-27T21:33:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-in-gel-per-ridurre-il-rischio-di-recidive-tumorali]]></loc><lastmod>2023-02-27T22:21:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-per-malattie-neurologiche-l-ipotesi-del-bioreattore]]></loc><lastmod>2023-02-28T21:39:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/via-libera-in-uk-a-quattro-app-per-trattare-l-ansia]]></loc><lastmod>2023-02-28T21:17:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/verra-da-crispr-una-nuova-strategia-per-la-malattia-di-huntington]]></loc><lastmod>2023-03-07T10:22:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/una-proteina-che-fa-ordine-nelle-car-t-per-migliorarne-l-efficienza]]></loc><lastmod>2023-03-07T23:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-possono-migliorare-la-gestione-dell-obesita]]></loc><lastmod>2023-03-10T15:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/cellule-cyborg-per-curare-il-cancro-e-possibile]]></loc><lastmod>2023-03-18T07:31:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-summit-sull-editing-di-londra-allontana-lo-spettro-di-hong-kong]]></loc><lastmod>2023-03-14T10:15:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/un-bambino-di-tre-anni-in-attesa-della-sua-terapia-genica]]></loc><lastmod>2023-03-14T13:36:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-l-emofilia-a-i-dati-a-due-anni-di-follow-up]]></loc><lastmod>2023-03-17T11:04:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/intelligenza-artificiale-un-progetto-europeo-sull-endometriosi]]></loc><lastmod>2023-03-18T07:31:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-finanziato-uno-studio-sull-atassia-di-friedreich]]></loc><lastmod>2023-10-17T08:38:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/terapie-car-t-per-le-infiammazioni-muscolari]]></loc><lastmod>2023-03-21T16:51:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-innovative-per-la-sma-nuove-conferme-sulla-durata-dei-benefici]]></loc><lastmod>2023-03-29T13:25:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-trapiantato-il-primo-paziente-affetto-da-parkinson]]></loc><lastmod>2023-03-26T07:33:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-al-via-un-trial-di-fase-ii-per-hea]]></loc><lastmod>2024-02-05T10:54:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-auto-amplificanti-i-vaccini-del-futuro-contro-le-malattie-infettive]]></loc><lastmod>2023-04-17T13:57:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-confermate-efficacia-e-sicurezza-per-la-lhon]]></loc><lastmod>2023-03-30T13:29:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/paul-berg-il-padre-del-dna-ricombinante]]></loc><lastmod>2023-03-30T12:02:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-piu-efficienti-grazie-all-acido-linoleico]]></loc><lastmod>2023-04-04T19:05:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/ricreato-in-laboratorio-il-primo-organoide-di-ovaio-interamente-umano]]></loc><lastmod>2023-04-04T16:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-per-hiv-il-caso-del-paziente-di-duesseldorf]]></loc><lastmod>2023-04-05T12:58:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-solidi-risultati-contro-il-neuroblastoma-dall-ospedale-bambino-gesu]]></loc><lastmod>2023-04-08T12:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-due-studi-clinici-sul-carcinoma-a-cellule-renali]]></loc><lastmod>2023-04-11T07:41:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/organoidi-cerebrali-fino-a-dove-puo-spingersi-la-scienza]]></loc><lastmod>2023-04-11T13:34:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-obiettivo-malattia-di-charcot-marie-tooth]]></loc><lastmod>2023-04-16T16:46:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/horizon-scanning-e-terapie-avanzate-le-poche-novita-in-arrivo]]></loc><lastmod>2023-04-16T14:51:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/cancro-del-pancreas-cosa-aspettarsi-dalle-terapie-avanzate]]></loc><lastmod>2023-04-17T16:30:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/una-terapia-basata-sull-mrna-per-l-acidemia-propionica]]></loc><lastmod>2023-04-17T19:37:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/1953-2023-i-settant-anni-della-doppia-elica]]></loc><lastmod>2023-04-25T22:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/il-junk-dna-che-spazzatura-non-e]]></loc><lastmod>2023-04-21T09:44:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/2003-2023-vent-anni-di-progetto-genoma-umano]]></loc><lastmod>2023-04-21T09:43:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/la-cura-inaspettata-l-affascinante-storia-dell-hiv]]></loc><lastmod>2023-04-28T19:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/crispr-per-ottimizzare-la-terapia-cellulare-nei-cuori-infartuati]]></loc><lastmod>2023-04-28T20:31:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/i-pazienti-diventano-co-sviluppatori-di-nuove-terapie]]></loc><lastmod>2023-04-29T12:38:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-pdta-per-le-distrofie-retiniche-ereditarie]]></loc><lastmod>2023-05-10T13:44:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/la-stampa-3d-di-organi-umani-vola-in-orbita]]></loc><lastmod>2023-05-06T21:20:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-cik-contro-i-sarcomi-si-muovono-i-primi-passi]]></loc><lastmod>2023-05-09T13:57:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/modelli-digitali-cerebrali-per-lo-studio-dell-epilessia]]></loc><lastmod>2023-05-09T14:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-un-altra-opzione-per-la-sma]]></loc><lastmod>2023-05-09T15:53:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/un-oligonucleotide-antisenso-per-combattere-l-alzheimer]]></loc><lastmod>2023-05-09T20:48:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-il-dolore-cronico-fantascienza-o-realta]]></loc><lastmod>2023-05-16T21:57:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/esiste-una-differenza-di-genere-per-le-miocarditi-associate-all-immunoterapia]]></loc><lastmod>2023-05-16T21:17:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/identificato-il-gene-che-guida-il-differenziamento-delle-staminali-pluripotenti]]></loc><lastmod>2023-05-19T14:20:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/dai-batteri-una-siringa-molecolare-per-il-rilascio-dei-farmaci]]></loc><lastmod>2023-05-24T12:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/quella-sottile-relazione-tra-antibiotici-microbiota-e-immunoterapia]]></loc><lastmod>2023-05-23T11:48:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/rosalind-franklin-e-la-scoperta-del-dna-cosa-e-cambiato]]></loc><lastmod>2023-05-23T11:48:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-in-gel-per-l-epidermolisi-bollosa-approvata-negli-usa]]></loc><lastmod>2023-07-31T11:06:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-crigler-najjar-come-neutralizzare-gli-anticorpi]]></loc><lastmod>2023-05-28T21:29:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/medicina-rigenerativa-fermato-lo-studio-su-una-forma-di-udito]]></loc><lastmod>2023-07-16T11:13:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/studiare-gli-eventi-avversi-delle-car-t-per-migliorarne-la-sicurezza]]></loc><lastmod>2023-05-30T17:21:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/vaccini-a-mrna-una-possibilita-per-il-cancro]]></loc><lastmod>2023-05-30T17:38:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/nuovi-finanziamento-per-il-crispr-made-in-italy]]></loc><lastmod>2023-06-07T21:07:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/un-nuovo-rna-base-editing-per-la-fibrosi-cistica]]></loc><lastmod>2023-06-04T14:26:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/editing-dell-rna-nel-tessuto-vascolare-regola-l-infiammazione]]></loc><lastmod>2023-06-07T11:31:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-di-precisione-per-le-malattie-genetiche-rare-un-obiettivo-possibile]]></loc><lastmod>2023-06-06T21:27:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-batten-a-che-punto-siamo]]></loc><lastmod>2024-07-16T22:39:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-avanzate-per-la-duchenne-un-addio-e-qualche-timida-speranza]]></loc><lastmod>2023-06-12T08:53:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-ad-attivazione-magnetica-contro-i-tumori-solidi]]></loc><lastmod>2023-06-10T21:11:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/nanoparticelle-lipidiche-per-trasportare-crispr-nei-polmoni]]></loc><lastmod>2023-06-14T19:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/sperimentare-sugli-embrioni-normativa-e-scienza-vanno-a-velocita-diverse]]></loc><lastmod>2023-06-13T20:40:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/retreat-2023-22-e-23-giugno-2023-roma]]></loc><lastmod>2024-02-14T21:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-correggere-le-mutazioni-che-causano-la-malattia-di-stargardt]]></loc><lastmod>2023-06-15T19:25:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/migliorare-la-ricerca-sulle-cellule-staminali]]></loc><lastmod>2023-06-15T06:28:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapie-avanzate-per-far-luce-sui-meccanismi-che-originano-la-sla]]></loc><lastmod>2023-06-26T12:07:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/dna-in-microcapsule-il-futuro-degli-hard-disk-biologici]]></loc><lastmod>2023-06-26T12:06:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-passi-avanti-per-la-malattia-di-fabry]]></loc><lastmod>2023-08-28T13:57:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapia-genica-per-il-difetto-di-aadc-la-storia-a-lieto-fine-di-simone]]></loc><lastmod>2023-06-27T12:49:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat/retreat-ota-riunisce-oltre-40-esperti-sulle-terapie-avanzate]]></loc><lastmod>2023-06-28T07:13:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/approvata-negli-stati-uniti-la-prima-terapia-genica-per-la-duchenne-2]]></loc><lastmod>2023-07-04T13:08:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/tumoroidi-stampati-in-3d-per-testare-i-farmaci-anticancro]]></loc><lastmod>2023-07-02T12:25:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-al-servizio-della-medicina]]></loc><lastmod>2023-07-02T13:17:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-fattori-che-implicano-una-buona-risposta-a-lungo-termine]]></loc><lastmod>2023-07-05T10:21:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/immune-come-funziona-il-sistema-immunitario]]></loc><lastmod>2023-07-05T08:24:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/uno-stop-provvisorio-per-la-terapia-genica-per-la-lhon]]></loc><lastmod>2023-07-06T20:23:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/autorizzata-in-usa-la-prima-terapia-cellulare-per-il-diabete]]></loc><lastmod>2023-07-09T13:27:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-si-allarga-il-ventaglio-d-uso-di-lisocabtagene-maraleucel]]></loc><lastmod>2023-07-12T08:17:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/fanzor-il-primo-sistema-di-editing-scoperto-in-organismi-complessi]]></loc><lastmod>2023-07-11T20:55:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianti-investimenti-e-riflessioni]]></loc><lastmod>2023-07-11T20:56:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/malattia-di-huntington-cosa-aspettarsi-dalle-terapie-avanzate]]></loc><lastmod>2023-07-16T15:02:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-anche-per-l-hiv-trattati-i-primi-due-pazienti]]></loc><lastmod>2023-07-16T17:40:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/abbinare-la-terapia-su-rna-alla-terapia-genica-per-la-sma]]></loc><lastmod>2023-07-17T22:36:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-per-una-diagnosi-precoce-di-parkinson]]></loc><lastmod>2023-07-17T22:36:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-creato-un-antibiotico-di-precisione]]></loc><lastmod>2023-07-19T19:56:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/la-salute-digitale-al-servizio-della-medicina-di-genere]]></loc><lastmod>2023-07-19T20:21:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-i-dati-dei-trial-testimoniano-una-buona-sopravvivenza-complessiva]]></loc><lastmod>2023-07-26T15:37:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/eroica-folle-e-visionaria-la-medicina-come-non-l-avete-mai-vista]]></loc><lastmod>2023-07-25T20:18:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/saranno-le-terapie-avanzate-ad-annientare-definitivamente-l-epatite-b]]></loc><lastmod>2023-07-25T21:19:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/mini-reni-artificiali-quando-l-intuizione-arriva-dalla-natura]]></loc><lastmod>2023-08-24T15:15:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/la-produzione-delle-terapie-avanzate-guarda-alle-startup]]></loc><lastmod>2023-08-24T08:44:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/donald-d-brown-una-vita-alla-scoperta-dei-geni]]></loc><lastmod>2023-08-24T19:59:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-va-alla-scoperta-di-nuovi-farmaci]]></loc><lastmod>2023-08-24T19:35:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-per-hiv-ora-sono-sei-le-persone-in-remissione]]></loc><lastmod>2023-08-25T21:20:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-a-rna-una-possibile-strategia-per-alcune-malattie-autoimmuni]]></loc><lastmod>2023-08-25T19:36:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/medicina-personalizzata-al-servizio-delle-malattie-ultra-rare]]></loc><lastmod>2023-08-27T21:13:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-una-realta-nella-giornata-mondiale-per-la-duchenne]]></loc><lastmod>2023-08-29T14:08:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-per-la-malattia-di-parkinson-primi-risultati-positivi]]></loc><lastmod>2023-09-11T12:56:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-si-accende-la-discussione-sui-criteri-di-accreditamento-dei-centri-clinici]]></loc><lastmod>2023-09-05T12:30:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapia-genica-per-l-ada-scid-il-passaggio-a-telethon-e-ufficiale]]></loc><lastmod>2023-09-12T10:37:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-ai-qual-e-il-potenziale]]></loc><lastmod>2023-09-07T10:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/la-ricerca-italiana-scommette-sugli-inibitori-di-microrna-contro-il-cancro]]></loc><lastmod>2023-09-07T10:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-l-alcolismo-i-primi-dati-sulle-scimmie]]></loc><lastmod>2023-09-07T11:03:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/al-via-uno-studio-clinico-su-una-car-t-allogenica-con-interruttore-di-sicurezza]]></loc><lastmod>2023-09-07T20:11:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/un-nuovo-protagonista-sulla-scena-delle-terapie-avanzate]]></loc><lastmod>2023-09-18T15:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-avanzate-per-la-sindrome-di-rett]]></loc><lastmod>2023-09-19T14:11:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/possibili-applicazioni-di-crispr-contro-la-malattia-di-alzheimer]]></loc><lastmod>2023-09-20T10:55:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/gli-antibiotici-non-funzionano-arrivano-i-fagi-armati-con-crispr]]></loc><lastmod>2023-09-07T11:04:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-disegnera-i-vaccini-a-mrna-del-futuro]]></loc><lastmod>2023-09-07T22:10:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-geniche-e-possibile-sostituire-i-vettori-virali]]></loc><lastmod>2023-09-26T19:09:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/la-pet-come-strumento-di-previsione-della-neurotossicita-delle-car-t]]></loc><lastmod>2023-09-26T17:25:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/smartphone-e-cuore-una-coppia-vincente]]></loc><lastmod>2023-09-28T09:38:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/una-terapia-a-rna-per-l-ipertensione-lo-studio-sui-pazienti]]></loc><lastmod>2023-10-01T10:01:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/il-nobel-premia-la-scienza-dietro-ai-vaccini-per-covid-19]]></loc><lastmod>2023-10-02T20:21:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/distrofie-muscolari-dei-cingoli-a-che-punto-e-la-terapia-genica]]></loc><lastmod>2024-02-21T11:39:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/epitope-editing-e-car-t-un-duo-vincente-contro-le-neoplasie-onco-ematologiche]]></loc><lastmod>2023-10-02T20:57:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-cosa-funziona-meglio-per-le-emoglobinopatie]]></loc><lastmod>2023-10-08T11:52:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/algoritmi-e-obesita-le-previsioni-nella-chirurgia-bariatrica]]></loc><lastmod>2023-10-08T11:31:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/far-riconoscere-alle-car-t-le-cellule-della-leucemia-mieloide-acuta]]></loc><lastmod>2023-10-10T15:15:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/l-occhio-bionico-del-futuro-funzionera-come-il-cervello-umano]]></loc><lastmod>2023-10-10T15:15:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/nanoparticelle-lipidiche-per-introdurre-crispr-nelle-cellule]]></loc><lastmod>2023-10-15T20:28:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/utero-artificiale-arrivera-la-sperimentazione-sull-uomo]]></loc><lastmod>2023-10-15T19:48:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapie-a-base-di-cellule-staminali-parlarne-e-ancora-una-sfida]]></loc><lastmod>2023-10-17T20:05:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/dagli-stati-uniti-una-terapia-car-t-contro-il-cancro-ovarico]]></loc><lastmod>2023-10-27T09:49:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-a-base-di-rna-dopo-i-vaccini-arrivano-i-circrna]]></loc><lastmod>2023-10-20T13:09:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/ai-e-radiografie-alleggerire-il-carico-di-lavoro-dei-medici]]></loc><lastmod>2023-10-20T12:42:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-in-sviluppo-diverse-strategie-per-le-sordita-ereditarie]]></loc><lastmod>2023-10-24T17:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianti-la-scienza-procede-ma-dove-va]]></loc><lastmod>2023-11-06T14:58:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/nuove-strategie-per-superare-i-limiti-delle-car-t]]></loc><lastmod>2023-10-29T14:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-troppi-i-fattori-che-frenano]]></loc><lastmod>2023-10-29T15:40:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-uno-studio-clinico-sulla-cistinosi]]></loc><lastmod>2023-10-31T14:21:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/staminali-non-approvate-un-problema-sempre-attuale]]></loc><lastmod>2023-11-05T19:16:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/vasi-sanguigni-artificiali-pronti-all-uso-per-le-arterie-danneggiate]]></loc><lastmod>2023-11-05T19:31:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/cell-therapy-open-source/pubblicato-il-volume-conclusivo-del-progetto-cell-therapy-open-source]]></loc><lastmod>2023-11-07T09:57:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-in-vivo-ai-blocchi-di-partenza-il-primo-trial-di-fase-iii]]></loc><lastmod>2023-11-06T22:38:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/un-fondo-per-salvare-le-terapie-avanzate-dalla-seconda-valle-delle-morte]]></loc><lastmod>2023-12-04T11:23:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-nuovi-risultati-e-una-novita]]></loc><lastmod>2023-11-12T14:36:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/rna-therapies-avviato-il-primo-corso-di-alta-formazione]]></loc><lastmod>2023-11-12T14:17:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-due-approcci-per-la-fenilchetonuria]]></loc><lastmod>2023-11-14T23:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/esosomi-dalla-terapia-genica-alla-diagnostica]]></loc><lastmod>2023-11-14T23:32:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapie-basate-su-crispr-in-uk-la-prima-approvazione-al-mondo]]></loc><lastmod>2023-11-16T19:41:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-embrionali-tanta-ricerca-ma-nessuna-terapia]]></loc><lastmod>2023-11-30T06:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/sfruttare-i-batteri-per-rendere-le-car-t-farmaci-di-precisione]]></loc><lastmod>2023-11-17T21:31:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/la-terza-generazione-di-crispr-si-appresta-al-debutto-clinico]]></loc><lastmod>2023-11-20T08:17:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-nuove-indicazioni-di-rimborsabilita-per-axi-cel-in-italia]]></loc><lastmod>2023-11-21T10:39:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-a-rischio-un-eccellenza-italiana]]></loc><lastmod>2023-11-27T13:22:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/silenziatori-epigenetici-una-promessa-di-efficacia-contro-i-tumori-solidi]]></loc><lastmod>2023-11-26T20:52:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/il-futuro-dell-rna-messaggero]]></loc><lastmod>2023-11-26T21:20:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-appello-alle-istituzioni-non-lasciate-che-holostem-venga-liquidata]]></loc><lastmod>2023-11-27T13:15:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-modificare-le-staminali-in-vivo-grazie-all-mrna]]></loc><lastmod>2023-11-29T06:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/il-decennio-del-cervello-quali-sono-i-bilanci-e-i-nuovi-orizzonti]]></loc><lastmod>2023-11-28T23:59:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/caso-holostem-arriva-l-ok-per-l-acquisizione-da-parte-di-enea-tech-e-biomedical]]></loc><lastmod>2023-11-30T09:38:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-e-rna-therapies-nasce-un-centro-nazionale]]></loc><lastmod>2023-12-04T08:06:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/neurotossicita-e-car-t-un-caso-clinico-che-fa-riflettere]]></loc><lastmod>2023-12-04T08:55:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/linfociti-antivirali-per-contrastare-gravi-infezioni-in-pazienti-immunodepressi]]></loc><lastmod>2023-12-06T12:26:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-muscolo-artificiale-3d-per-la-distrofia-muscolare-di-duchenne]]></loc><lastmod>2023-12-06T12:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-il-deficit-di-aadc-ora-rimborsata-in-italia]]></loc><lastmod>2023-12-07T13:30:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-avanzate-per-l-epidermolisi-bollosa-a-che-punto-siamo]]></loc><lastmod>2023-12-12T09:12:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-doppio-ok-dall-fda-per-l-anemia-falciforme]]></loc><lastmod>2024-01-18T11:08:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-concessa-la-rimborsabilita-a-brexu-cel-contro-la-leucemia-linfoblastica-acuta]]></loc><lastmod>2023-12-11T22:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/ai-per-un-vaccino-a-mrna-contro-la-gonorrea-il-primo-di-una-serie]]></loc><lastmod>2023-12-12T21:53:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/manifattura-la-rivoluzione-dei-sistemi-chiusi]]></loc><lastmod>2023-12-15T08:56:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/dove-prende-forma-una-terapia-avanzata]]></loc><lastmod>2024-06-23T00:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/salvaguardare-la-salute-riproduttiva-nell-era-delle-terapie-crispr]]></loc><lastmod>2023-12-15T09:44:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/l-eta-genetica-la-rivoluzione-dell-ingegneria-genetica]]></loc><lastmod>2023-12-19T11:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-geniche-e-malattie-rare-la-situazione-europea]]></loc><lastmod>2024-01-05T20:38:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/realizzato-il-primo-trapianto-di-insule-pancreatiche-a-padova]]></loc><lastmod>2024-01-15T08:52:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/sma-e-duchenne-una-storia-anche-di-terapie-geniche]]></loc><lastmod>2024-01-05T17:30:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-e-insorgenza-di-nuovi-tumori-c-e-una-correlazione]]></loc><lastmod>2024-01-05T21:00:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/terapie-avanzate-e-non-solo-il-2024-e-gia-qui]]></loc><lastmod>2024-01-13T21:20:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-a-rna-ridurre-il-colesterolo-con-una-sola-somministrazione-all-anno]]></loc><lastmod>2024-01-15T14:59:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-una-via-per-il-cuore]]></loc><lastmod>2024-01-13T20:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sordita-i-primi-dati-clinici-arrivano-dalla-cina]]></loc><lastmod>2024-01-13T20:00:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-in-ambito-pediatrico-per-malattie-autoimmuni-un-successo-italiano]]></loc><lastmod>2024-01-18T12:39:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/sviluppare-nuove-terapie-avanzate-per-le-malattie-neuromuscolari]]></loc><lastmod>2024-01-22T13:24:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/innovativita-dei-farmaci-come-funziona]]></loc><lastmod>2024-02-01T13:30:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/la-demenza-fronto-temporale-nel-mirino-della-terapia-genica]]></loc><lastmod>2024-01-23T22:05:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/mini-robot-biologici-che-rigenerano-i-tessuti]]></loc><lastmod>2024-02-01T14:11:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/luigi-naldini-vince-il-phacilitate-lifetime-achievement-award-2024]]></loc><lastmod>2024-01-24T06:41:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/tecnologia-mrna-la-corsa-verso-una-terapia-per-il-cancro]]></loc><lastmod>2024-01-27T22:54:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/mrna-in-arrivo-un-vaccino-per-il-melanoma-2]]></loc><lastmod>2024-01-28T13:41:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-cellule-b-geneticamente-ingegnerizzate-per-la-mps-i]]></loc><lastmod>2024-01-28T14:38:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-uno-studio-sulla-malattia-di-parkinson]]></loc><lastmod>2024-01-30T22:43:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/recuperare-l-udito-grazie-alla-terapia-genica-2]]></loc><lastmod>2024-02-01T07:22:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-l-emofilia-a-via-libera-dall-aifa]]></loc><lastmod>2024-02-01T20:42:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/viva-crispr-ma-il-futuro-ci-riserva-di-meglio]]></loc><lastmod>2024-02-02T21:58:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-impianto-cutaneo-per-l-insulina-contro-il-diabete-di-tipo-1]]></loc><lastmod>2024-02-03T12:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-il-parkinson-un-altro-passo-avanti]]></loc><lastmod>2024-03-12T14:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/car-t-decentralizzare-la-produzione-per-far-fronte-alle-richieste]]></loc><lastmod>2024-02-14T20:55:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-in-parlamento-si-discute-di-sostenibilita-e-accesso]]></loc><lastmod>2024-02-14T21:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/occhio-ai-geni-coinvolti-nelle-patologie-della-vista]]></loc><lastmod>2024-02-11T18:04:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/la-scienza-non-ha-genere-ma-per-ora-neanche-equita]]></loc><lastmod>2024-02-11T20:49:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/crispr-e-arrivata-in-europa]]></loc><lastmod>2024-02-13T22:02:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/aifa-concede-la-rimborsabilita-a-due-car-t]]></loc><lastmod>2024-02-13T22:24:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-ada-scid-positivi-i-risultati-a-lungo-termine]]></loc><lastmod>2024-02-14T15:33:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-colangiocarcinoma-on-chip-per-testare-farmaci-sempre-piu-mirati]]></loc><lastmod>2024-02-14T13:08:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/nuovi-fronti-di-ricerca-contro-le-malattie-autoimmuni]]></loc><lastmod>2024-02-18T20:15:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/perche-le-car-t-funzionano-contro-le-malattie-autoimmuni]]></loc><lastmod>2024-02-18T20:14:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-usa-la-prima-terapia-a-base-di-cellule-t-per-un-tumore-solido]]></loc><lastmod>2024-02-21T08:36:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-made-in-italy-per-le-cecita-ereditarie-incurabili]]></loc><lastmod>2024-02-21T09:07:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-una-speranza-per-le-malattie-rare]]></loc><lastmod>2024-02-24T20:59:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/l-mrna-e-il-futuro-dei-vaccini-antinfluenzali]]></loc><lastmod>2024-02-24T21:40:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-topica-per-epidermolisi-bollosa-migliorate-le-lesioni-oculari]]></loc><lastmod>2024-02-28T09:12:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/rendere-disponibile-la-terapia-genica-per-la-was-la-nuova-sfida-di-telethon]]></loc><lastmod>2024-02-28T09:42:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-l-emofilia-a-l-italia-ai-blocchi-di-partenza]]></loc><lastmod>2024-02-29T22:17:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-agire-sull-epigenoma-ha-i-suoi-vantaggi]]></loc><lastmod>2024-03-03T21:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/una-versione-speciale-di-car-t-per-aggredire-i-tumori-solidi]]></loc><lastmod>2024-03-03T20:58:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-sono-oltre-dieci-gli-studi-clinici-per-la-duchenne]]></loc><lastmod>2024-03-05T21:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/editing-dell-rna-uno-studio-clinico-per-la-malattia-di-stargardt]]></loc><lastmod>2024-03-06T00:28:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/la-prossima-sfida-per-crispr-e-correggere-il-genoma-dei-feti]]></loc><lastmod>2024-03-07T20:58:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-in-avvio-un-nuovo-trial-che-mira-al-cuore]]></loc><lastmod>2024-03-10T21:40:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/gli-organoidi-sono-il-futuro-della-ricerca-sulle-malattie-del-cervello]]></loc><lastmod>2024-03-10T15:04:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/anche-il-sud-del-mondo-aspetta-le-terapie-avanzate]]></loc><lastmod>2024-03-11T10:26:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/omar-diventa-media-partner-di-eupati]]></loc><lastmod>2024-03-14T11:33:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali/terapie-digitali-un-progetto-italiano-per-l-insonnia]]></loc><lastmod>2024-03-14T21:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/rotta-verso-una-terapia-genica-per-la-sindrome-di-sanfilippo-di-tipo-a]]></loc><lastmod>2024-03-15T10:56:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/nanorobot-la-nuova-frontiera-per-i-tumori-della-vescica]]></loc><lastmod>2024-03-15T10:24:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-ricorrere-all-epigenetica-per-aumentarne-l-efficacia-nel-tempo]]></loc><lastmod>2024-03-19T21:32:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-la-mld-autorizzata-anche-negli-stati-uniti]]></loc><lastmod>2024-03-19T21:09:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/le-speranze-e-le-tendenze-crispr-secondo-l-analisi-dell-igi]]></loc><lastmod>2024-03-26T13:09:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapia-genica-per-la-was-e-telethon-quali-sono-le-sfide]]></loc><lastmod>2024-03-24T15:56:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-informazioni-internet-e-intelligenza-artificiale]]></loc><lastmod>2024-03-26T18:53:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/editing-dell-rna-una-possibile-chiave-per-migliorare-l-effetto-delle-car-t]]></loc><lastmod>2024-03-26T13:48:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-l-europa-allarga-le-indicazioni-di-ide-cel-per-il-mieloma-multiplo]]></loc><lastmod>2024-03-27T14:16:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianti-un-rene-di-maiale-trapiantato-in-un-uomo]]></loc><lastmod>2024-04-12T07:16:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/join4atmp-un-progetto-europeo-dedicato-alle-terapie-avanzate]]></loc><lastmod>2024-03-28T18:38:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-eliminare-l-hiv-dalle-cellule-immunitarie]]></loc><lastmod>2024-04-03T20:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/primi-organoidi-fetali-dalle-staminali-del-liquido-amniotico]]></loc><lastmod>2024-03-28T19:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-come-coinvolgere-i-pazienti-nei-trial-per-malattie-rare]]></loc><lastmod>2024-04-09T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-di-osso-per-studiare-la-mucopolisaccaridosi-di-tipo-i]]></loc><lastmod>2024-04-09T08:30:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-dell-epigenoma-anche-l-epatite-b-nel-mirino]]></loc><lastmod>2024-04-14T11:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-una-strategia-a-lungo-termine-contro-l-ipertensione]]></loc><lastmod>2024-04-14T13:27:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-il-glioblastoma-una-sfida-in-continua-evoluzione]]></loc><lastmod>2024-04-16T20:57:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/modelli-3d-per-il-glioblastoma-una-piattaforma-italiana]]></loc><lastmod>2024-04-16T20:26:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/primo-test-di-una-terapia-genica-su-un-intero-fegato-umano]]></loc><lastmod>2024-04-19T15:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/terapie-avanzate-i-settori-emergenti-secondo-arm]]></loc><lastmod>2024-04-19T14:50:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-del-sangue-del-cordone-ombelicale-per-le-malattie-neurodegenerative]]></loc><lastmod>2024-04-23T10:58:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-si-allargano-i-criteri-di-rimborsabilita-per-la-sma-in-italia]]></loc><lastmod>2024-04-23T17:47:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-nel-mirino-anche-l-osteogenesi-imperfetta]]></loc><lastmod>2024-05-05T21:48:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/estensione-di-indicazione-per-cilta-cel-gia-dopo-una-linea-di-terapia-precedente]]></loc><lastmod>2024-05-05T22:10:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-treg-un-possibile-futuro-approccio-al-lupus-eritematoso-sistemico]]></loc><lastmod>2024-05-07T15:03:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-primi-risultati-per-l-acidemia-propionica]]></loc><lastmod>2024-05-07T15:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-deceduto-un-paziente-in-trial]]></loc><lastmod>2024-05-13T07:25:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapia-genica-la-sostenibilita-resta-un-problema-anche-oltreoceano]]></loc><lastmod>2024-05-12T20:39:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-l-emofilia-b-un-secondo-ok-negli-stati-uniti]]></loc><lastmod>2024-05-14T20:56:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/piacere-sarah-l-oms-lancia-una-nuova-promoter-di-salute-digitale]]></loc><lastmod>2024-05-12T20:05:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/studi-clinici-dallo-scorbuto-al-consenso-informato]]></loc><lastmod>2024-05-20T11:52:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/rigenerare-il-cuore-per-contrastare-le-patologie-cardiovascolari]]></loc><lastmod>2024-05-21T21:18:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/car-t-india-e-brasile-puntano-ad-abbassare-i-costi]]></loc><lastmod>2024-05-14T12:18:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-le-mutazioni-nel-gene-dell-otoferlina]]></loc><lastmod>2024-05-24T12:50:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-car-t-lavorare-sull-accesso-per-evitare-la-migrazione-dei-pazienti]]></loc><lastmod>2025-12-12T09:46:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/prime-editing-in-avvio-il-primo-studio-clinico-negli-stati-uniti]]></loc><lastmod>2024-05-28T20:43:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-la-sclerosi-multipla-una-nuova-possibilita-di-cura]]></loc><lastmod>2024-05-28T21:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/glioblastoma-verso-un-vaccino-a-mrna]]></loc><lastmod>2024-06-02T13:42:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/nonostante-tutto-la-mia-vita-nella-scienza]]></loc><lastmod>2024-06-02T13:54:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-la-vista-l-ostacolo-e-ancora-una-volta-la-sostenibilita]]></loc><lastmod>2024-06-04T22:04:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-autorizzato-in-europa-un-oligonucleotide-antisenso-per-la-sla]]></loc><lastmod>2024-06-04T21:34:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/cinque-storie-di-xenotrapianti-tra-progressi-delusioni-e-speranze]]></loc><lastmod>2024-06-09T21:52:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/horizon-scanning-aifa-pubblicato-il-report-2024]]></loc><lastmod>2024-06-10T12:59:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/telepathy-come-funziona-l-interfaccia-cervello-computer]]></loc><lastmod>2026-03-25T17:37:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/il-primo-impianto-di-neuralink-su-un-essere-umano-2]]></loc><lastmod>2024-06-13T12:38:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-risultati-negativi-da-un-trial-di-fase-iii]]></loc><lastmod>2024-07-03T09:25:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/l-evoluzione-delle-terapie-a-base-di-cellule-car-t]]></loc><lastmod>2024-06-16T13:14:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/linfociti-t-infiltranti-il-tumore-un-successo-che-ha-attraversato-molti-fallimenti]]></loc><lastmod>2024-06-17T13:00:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-la-via-indiana-ad-una-terapia-su-misura-per-i-pazienti-rari]]></loc><lastmod>2024-06-21T09:40:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-car-t-possono-davvero-provocare-il-cancro]]></loc><lastmod>2024-06-21T08:43:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-fda-amplia-le-indicazioni-d-uso]]></loc><lastmod>2024-06-25T20:31:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/prix-galien-italia-2024-dagli-anticorpi-farmaco-coniugati-alle-terapie-avanzate]]></loc><lastmod>2024-06-25T21:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-prime-editing-evolve-ancora]]></loc><lastmod>2024-06-30T16:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/sessant-anni-di-tecnologia-al-servizio-della-diabetologia]]></loc><lastmod>2024-06-30T14:26:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapie-geniche-e-sistema-immunitario-una-convivenza-possibile]]></loc><lastmod>2024-07-02T21:57:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/potenziare-i-linfociti-t-per-la-lotta-ai-tumori]]></loc><lastmod>2024-07-02T21:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/la-cellula-sintetica-muove-i-primi-passi]]></loc><lastmod>2024-07-03T09:16:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/quando-crispr-ti-cambia-la-vita]]></loc><lastmod>2024-07-09T08:01:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/un-rna-ponte-si-candida-a-rivoluzionare-l-editing]]></loc><lastmod>2024-07-10T21:01:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/i-primi-risultati-della-terapia-genica-per-l-emofilia-b]]></loc><lastmod>2024-07-10T19:44:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/riscrivere-l-mrna-un-approccio-per-la-stargardt]]></loc><lastmod>2024-07-12T22:13:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/mini-intestini-per-studiare-la-malattia-di-crohn]]></loc><lastmod>2024-07-12T13:49:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/l-editing-dell-epigenoma-prende-di-mira-le-malattie-da-prioni]]></loc><lastmod>2024-07-16T23:01:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-per-la-paraplegia-spastica]]></loc><lastmod>2024-07-16T22:35:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-trattata-in-germania-un-adolescente-con-lupus]]></loc><lastmod>2024-07-19T09:29:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-buoni-risultati-preliminari-per-la-malattia-di-huntington]]></loc><lastmod>2024-07-19T10:24:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-in-vivo-velocita-e-sostenibilita]]></loc><lastmod>2024-07-23T20:29:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/piu-in-alto-degli-dei-dove-ci-portera-l-ingegneria-genetica]]></loc><lastmod>2024-08-01T08:45:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/maxine-singer-una-donna-alla-guida-delle-biotecnologie-nascenti]]></loc><lastmod>2024-07-29T07:18:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-emofilia-b-seconda-approvazione-in-europa]]></loc><lastmod>2024-08-01T11:36:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/sul-pubblicare-in-medicina-istruzioni-per-l-uso]]></loc><lastmod>2024-07-29T22:36:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/presentazione-del-retreat-proposal-essay-17-settembre-2024-roma]]></loc><lastmod>2025-03-13T13:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-prima-terapia-a-base-di-cellule-t-contro-un-tumore-solido]]></loc><lastmod>2024-09-12T13:29:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-per-l-anemia-di-fanconi-tentativi-e-speranze]]></loc><lastmod>2024-08-28T14:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-un-nuovo-approccio-all-orizzonte]]></loc><lastmod>2024-09-03T11:20:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/obiettivo-fenib-dalla-diagnosi-alla-ricerca-di-terapie-mirate]]></loc><lastmod>2024-08-13T15:13:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-una-possibile-terapia-per-la-sindrome-della-persona-rigida]]></loc><lastmod>2024-09-06T14:00:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/combinare-terapia-cellulare-e-chemioterapia-per-colpire-il-tumore-del-pancreas]]></loc><lastmod>2024-09-06T14:13:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-tumori-al-cervello-i-risultati-sono-promettenti]]></loc><lastmod>2024-08-28T14:24:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-cubetto-di-gel-per-misurare-i-parametri-cerebrali]]></loc><lastmod>2024-08-28T14:27:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat/presentato-il-volume-retreat-proposal-essay-a-strategic-framework-document]]></loc><lastmod>2024-09-17T14:24:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/la-rivoluzione-dell-rna-in-atto-e-i-suoi-protagonisti-dimenticati]]></loc><lastmod>2024-09-17T09:57:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-usher-a-napoli-il-primo-intervento-al-mondo]]></loc><lastmod>2024-09-19T17:16:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat/terapie-avanzate-le-priorita-per-una-buona-presa-in-carico-dei-pazienti]]></loc><lastmod>2024-09-23T08:11:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat/superare-le-differenze-regionali-nei-percorsi-di-accesso-alle-terapie-avanzate]]></loc><lastmod>2024-09-23T08:12:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat/il-valore-degli-studi-di-real-world-evidence-per-le-terapie-avanzate]]></loc><lastmod>2024-09-23T08:13:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat/una-chiave-d-accesso-alle-terapie-avanzate-i-registri-di-monitoraggio-aifa]]></loc><lastmod>2024-09-23T08:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat/un-nuovo-corso-nella-produzione-delle-terapie-avanzate]]></loc><lastmod>2024-09-23T15:26:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rigenerare-il-cuore-dopo-l-infarto-del-miocardio]]></loc><lastmod>2024-09-24T10:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-i-primi-studi-sulle-somministrazioni-multiple]]></loc><lastmod>2024-09-22T16:35:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/in-avvio-in-australia-il-primo-trial-con-terapia-car-t-in-vivo]]></loc><lastmod>2024-10-02T08:46:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/e-italiana-la-piu-grande-biobanca-al-mondo-di-organoidi-di-tumore-del-colon]]></loc><lastmod>2024-10-02T09:17:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-l-ultimo-colpo-di-scena-nella-battaglia-sui-brevetti]]></loc><lastmod>2024-10-06T22:18:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-ed-emofilia-un-settore-in-piena-espansione]]></loc><lastmod>2024-10-06T21:37:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/un-premio-nobel-ai-microrna]]></loc><lastmod>2024-10-10T21:56:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/nobel-2024-e-l-annata-dell-intelligenza-artificiale]]></loc><lastmod>2024-10-09T22:09:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/crispr-italia-prima-in-eu-per-la-somministrazione-di-exa-cel]]></loc><lastmod>2024-10-09T21:35:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/realizzato-per-la-prima-volta-un-autotrapianto-di-insule-pancreatiche]]></loc><lastmod>2024-10-31T10:32:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/in-italia-un-nuovo-laboratorio-all-avanguardia-per-le-future-pandemie]]></loc><lastmod>2024-10-14T12:05:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-in-utero-uno-studio-sulla-sindrome-di-leigh]]></loc><lastmod>2024-10-15T22:23:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-microbioma-nel-mirino-dell-editing-genomico-in-vivo]]></loc><lastmod>2024-10-18T22:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/vaccino-a-mrna-per-il-cancro-al-polmone-effettuata-la-prima-somministrazione]]></loc><lastmod>2024-10-18T22:48:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-e-un-nuovo-sistema-per-la-persistenza-delle-car-t-nell-organismo]]></loc><lastmod>2024-10-22T08:03:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/accesso-alle-terapie-avanzate-le-difficolta-restano-ma-con-qualche-proposta]]></loc><lastmod>2024-10-22T06:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-trattare-l-asma-un-progetto-da-approfondire]]></loc><lastmod>2024-10-22T08:29:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/la-rivoluzione-crispr-rallenta-ecco-gli-ostacoli-da-rimuovere]]></loc><lastmod>2024-10-30T10:32:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/in-studio-car-nk-specificamente-attive-contro-il-tumore-del-colon-retto]]></loc><lastmod>2024-10-30T10:31:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/batteri-trasformati-in-vaccini-anticancro-personalizzati]]></loc><lastmod>2024-11-04T13:48:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/terapie-su-rna-per-sindrome-di-dravet-un-aggiornamento]]></loc><lastmod>2024-11-04T13:11:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-l-adrenoleucodistrofia-cerebrale-alcuni-aggiornamenti]]></loc><lastmod>2024-11-05T14:19:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/hta-per-le-terapie-geniche-un-approccio-integrato-per-un-futuro-sostenibile]]></loc><lastmod>2024-11-07T13:54:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-uno-studio-statunitense-valuta-la-somministrazione-ambulatoriale]]></loc><lastmod>2024-11-10T18:01:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/perche-e-come-donare-il-proprio-corpo-alla-scienza]]></loc><lastmod>2024-11-05T14:57:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-angioedema-ereditario-i-nuovi-dati]]></loc><lastmod>2024-11-12T14:48:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/un-insulina-smart-per-il-diabete-si-attiva-solo-quando-serve]]></loc><lastmod>2024-11-12T23:06:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/editing-dell-rna-una-nuova-frontiera]]></loc><lastmod>2024-11-17T22:17:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/l-accessibilita-ai-trattamenti-crispr-una-questione-etica-urgente]]></loc><lastmod>2024-11-20T08:49:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/in-remissione-due-gravi-patologie-autoimmuni-trattate-con-car-t-allogeniche]]></loc><lastmod>2024-11-20T11:48:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/manifattura-per-le-terapie-avanzate-un-ota-talk-per-dialogare-con-aifa]]></loc><lastmod>2025-06-25T12:52:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-alla-ricerca-di-nuovi-approcci-di-condizionamento]]></loc><lastmod>2024-11-24T14:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/i-superlinfociti-t-possono-essere-attivati-dal-sale-da-cucina]]></loc><lastmod>2024-11-24T15:05:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/efficacia-a-lungo-termine-per-la-terapia-genica-per-mps-vi]]></loc><lastmod>2024-11-25T22:42:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/cellule-staminali-spaziali-la-frontiera-della-medicina-rigenerativa]]></loc><lastmod>2024-11-25T22:29:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/rigenerazione-corneale-uno-studio-pionieristico-dal-giappone]]></loc><lastmod>2024-11-30T22:10:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/la-bioetica-dell-editing-genetico-in-dodici-domande-e-risposte]]></loc><lastmod>2024-12-01T15:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/base-editing-per-affinare-il-riconoscimento-cellulare-nelle-leucemie]]></loc><lastmod>2024-12-03T23:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/trialgpt-un-algoritmo-migliora-gli-arruolamenti-negli-studi-clinici]]></loc><lastmod>2024-12-04T00:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/una-combo-di-editing-genomico-per-identificare-mutazioni-chiave-nel-cancro]]></loc><lastmod>2024-12-08T22:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-con-vettori-lentivirali-confermata-la-sicurezza-a-lungo-termine]]></loc><lastmod>2025-02-05T21:17:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-epidermolisi-bollosa-avviato-in-italia-uno-studio-preclinico]]></loc><lastmod>2024-12-10T10:48:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-il-bilancio-di-un-2024-prolifico]]></loc><lastmod>2024-12-10T10:47:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-una-panoramica-sulle-mucopolisaccaridosi]]></loc><lastmod>2024-12-12T23:09:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/aifa-approva-la-rimborsabilita-per-la-prima-terapia-cellulare-allogenica]]></loc><lastmod>2024-12-15T23:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/staminali-per-il-parkinson-l-europa-in-prima-linea]]></loc><lastmod>2024-12-18T22:11:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapie-cellulari-per-il-parkinson-una-storia-lunga-50-anni]]></loc><lastmod>2024-12-18T22:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/io-le-patate-le-bollo-vive-cosa-sai-sulla-sperimentazione-animale]]></loc><lastmod>2024-12-18T22:29:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-la-diagnosi-di-alcune-forme-di-leucemia]]></loc><lastmod>2025-01-02T16:42:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/una-chatgpt-a-base-di-chimica-per-progettare-nuovi-farmaci]]></loc><lastmod>2025-01-02T17:49:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-nuovi-dati-a-lungo-termine-per-exa-cel]]></loc><lastmod>2025-01-10T11:12:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-malattie-autoimmuni-primo-trattamento-italiano-su-paziente-adulta]]></loc><lastmod>2025-02-17T14:37:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/la-sfida-del-2025-combinare-l-intelligenza-artificiale-con-crispr]]></loc><lastmod>2025-01-12T21:46:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-una-piattaforma-italiana-per-le-malattie-del-fegato]]></loc><lastmod>2025-01-15T09:56:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/dal-sangue-un-gel-per-riparare-le-fratture-ossee]]></loc><lastmod>2025-01-13T22:57:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-cellulare-darvadstrocel-in-fase-di-ritiro-dal-commercio]]></loc><lastmod>2025-01-16T12:48:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-terapia-genica-universale-per-l-anemia-di-diamond-blackfan]]></loc><lastmod>2025-01-19T22:16:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapie-avanzate-per-il-parkinson-gli-studi-clinici-procedono]]></loc><lastmod>2025-01-19T21:56:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/progetto-humanize-creare-un-cuore-da-trapiantare-partendo-dalle-staminali]]></loc><lastmod>2025-01-25T17:06:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/il-futuro-e-gia-qui-l-ai-spiegata-bene]]></loc><lastmod>2025-01-21T21:33:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-in-vivo-su-neonati-con-deficit-di-otc]]></loc><lastmod>2025-01-26T20:30:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-su-cellule-del-sangue-i-progressi-ex-vivo-e-le-prospettive-in-vivo]]></loc><lastmod>2025-01-26T20:29:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/la-sfida-della-nomenclatura-delle-terapie-avanzate]]></loc><lastmod>2025-01-28T22:01:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/terapie-avanzate-per-la-beta-talassemia-successi-e-sconfitte]]></loc><lastmod>2025-01-29T16:19:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/un-gps-per-guidare-le-car-t-verso-le-cellule-del-glioblastoma]]></loc><lastmod>2025-01-30T00:43:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/fastglioma-l-ai-che-identifica-il-tessuto-tumorale-in-10-secondi]]></loc><lastmod>2025-01-30T00:13:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-del-genoma-umano-tra-progresso-scientifico-e-dilemmi-etici]]></loc><lastmod>2025-02-05T10:30:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/il-2025-delle-car-t-assomiglia-all-esplosione-del-cambriano]]></loc><lastmod>2025-02-05T01:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-positivi-i-dati-a-lungo-termine-per-il-trattamento-della-lhon]]></loc><lastmod>2025-02-09T15:36:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/dal-cordone-ombelicale-una-nuova-speranza-per-la-leucemia]]></loc><lastmod>2025-02-07T13:58:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-in-vivo-la-nuova-sfida-che-vede-protagonista-anche-l-italia]]></loc><lastmod>2025-02-12T09:22:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/20-anni-di-esperienza-per-il-trapianto-di-insule-pancreatiche]]></loc><lastmod>2025-02-12T13:11:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-degenerazione-maculare-legata-all-eta]]></loc><lastmod>2025-02-13T16:39:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/l-italia-punta-alle-car-t-allogeniche-per-il-neuroblastoma-infantile]]></loc><lastmod>2025-02-17T13:30:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-diventa-ultracompatta-per-arrivare-fin-dentro-ai-muscoli]]></loc><lastmod>2025-02-18T22:09:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapie-a-base-di-cellule-t-nuove-frontiere-per-l-hiv]]></loc><lastmod>2025-02-17T23:11:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/un-cerotto-a-base-di-staminali-per-l-insufficienza-cardiaca]]></loc><lastmod>2025-02-18T08:49:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-il-record-di-piu-lunga-remissione-dal-cancro-e-di-19-anni]]></loc><lastmod>2025-02-24T08:47:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/nuove-strategie-terapeutiche-in-sperimentazione-per-il-melanoma]]></loc><lastmod>2025-02-25T14:38:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-un-settore-in-crisi]]></loc><lastmod>2025-02-25T23:31:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/malattie-rare-un-volano-per-le-terapie-avanzate]]></loc><lastmod>2025-02-25T14:33:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-a-modena-una-struttura-all-avanguardia-per-le-malattie-rare]]></loc><lastmod>2025-02-27T17:21:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-al-servizio-della-mammografia]]></loc><lastmod>2025-02-27T16:47:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-curati-a-londra-quattro-bambini-non-vedenti]]></loc><lastmod>2025-03-05T08:22:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-le-nuove-linee-guida-dell-ema]]></loc><lastmod>2025-03-04T23:26:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/la-storia-rara-di-sonia-e-eric-pionieri-per-forza-e-per-amore]]></loc><lastmod>2025-03-06T14:20:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-ai-che-scrive-il-codice-genetico-per-tutte-le-forme-di-vita-nasce-evo-2]]></loc><lastmod>2025-03-10T11:11:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/un-chip-per-valutare-l-efficacia-dell-immunoterapia-nel-melanoma]]></loc><lastmod>2025-03-12T13:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/manifattura-puntare-all-automazione-e-alle-tecnologie-digitali]]></loc><lastmod>2025-03-13T13:04:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-l-esperienza-dell-ospedale-maggiore-policlinico-di-milano]]></loc><lastmod>2025-03-17T00:13:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-dati-di-efficacia-per-il-trattamento-prenatale-per-la-sma]]></loc><lastmod>2025-03-16T18:04:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-approvata-nuova-indicazione-d-uso-per-lisocabtagene-maraleucel]]></loc><lastmod>2025-03-18T09:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-usa-una-terapia-cellulare-per-la-mactel-di-tipo-2]]></loc><lastmod>2025-03-19T18:27:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-non-regolamentate-ema-lancia-un-allarme]]></loc><lastmod>2025-03-24T12:45:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-si-punta-a-nuovi-approcci-terapeutici-per-l-ipofosfatasia]]></loc><lastmod>2025-03-25T23:43:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/ai-per-diagnosi-multiple-e-rapide-con-un-solo-prelievo-di-sangue]]></loc><lastmod>2025-03-25T23:21:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-tra-speranze-e-interrogativi-sulla-sicurezza]]></loc><lastmod>2025-04-08T10:25:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/le-sfide-per-portare-una-terapia-avanzata-sul-mercato]]></loc><lastmod>2025-04-01T08:25:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/primo-parere-positivo-dell-ema-per-uno-strumento-di-ai]]></loc><lastmod>2025-03-31T22:40:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoidi-quando-la-ricerca-e-in-tre-dimensioni]]></loc><lastmod>2025-04-02T16:56:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/il-ruolo-dell-iss-nello-sviluppo-delle-terapie-avanzate]]></loc><lastmod>2025-04-03T12:53:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/staminali-per-lesioni-spinali-i-primi-dati-su-quattro-pazienti]]></loc><lastmod>2025-04-07T08:30:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-il-deficit-di-aadc-il-racconto-di-un-traguardo-tutto-italiano]]></loc><lastmod>2025-04-08T11:03:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/si-moltiplicano-le-strade-verso-una-terapia-genica-per-la-fibrosi-cistica]]></loc><lastmod>2025-04-09T22:49:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/la-rivoluzione-biotech-cinese-forte-impulso-alle-terapie-avanzate]]></loc><lastmod>2025-04-09T13:31:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/buoni-i-risultati-delle-car-cik-per-la-leucemia-linfoblastica-acuta-di-tipo-b]]></loc><lastmod>2025-04-13T22:07:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-sfide-e-opportunita-per-l-europa]]></loc><lastmod>2025-04-13T22:22:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/l-oscar-della-scienza-va-al-correttore-dei-geni-david-liu]]></loc><lastmod>2025-04-15T13:12:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-per-malattie-ultra-rare-alla-ricerca-di-un-modello-di-sostenibilita]]></loc><lastmod>2025-04-15T14:01:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/e-arrivato-ai-co-scientist-un-supporto-anche-per-le-terapie-avanzate]]></loc><lastmod>2025-04-16T14:37:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-una-nuova-strada-all-orizzonte]]></loc><lastmod>2025-11-26T13:26:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/un-interruttore-genetico-per-rivoluzionare-le-terapie-cellulari]]></loc><lastmod>2025-04-19T12:57:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-per-rivelare-i-meccanismi-biologici-della-sindrome-di-vexas]]></loc><lastmod>2025-04-29T12:06:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-confermata-l-efficacia-per-la-leucodistrofia-metacromatica]]></loc><lastmod>2025-04-29T12:40:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-topica-per-l-epidermolisi-bollosa-approvata-in-europa]]></loc><lastmod>2025-05-01T19:33:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/l-editing-genomico-per-esplorare-la-dominanza-clonale-e-ideare-terapie]]></loc><lastmod>2025-05-03T15:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-una-possibilita-per-i-disordini-linfoproliferativi-post-trapianto]]></loc><lastmod>2025-05-03T15:46:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapie-avanzate-il-nuovo-report-horizon-scanning-di-aifa]]></loc><lastmod>2025-05-07T09:21:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-car-t-contro-le-neoplasie-onco-ematologiche-sono-il-futuro-divenuto-presente]]></loc><lastmod>2025-05-11T22:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/autorizzata-negli-stati-uniti-la-seconda-terapia-genica-per-l-epidermolisi-bollosa]]></loc><lastmod>2025-05-11T21:20:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-in-vivo-uno-studio-clinico-per-l-epatite-b]]></loc><lastmod>2025-05-13T16:14:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/guida-facile-all-intelligenza-artificiale-in-medicina]]></loc><lastmod>2025-05-13T16:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-neonato-trattato-con-la-prima-terapia-personalizzata]]></loc><lastmod>2025-05-19T09:03:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-un-nuovo-approccio-per-la-sindrome-di-rett]]></loc><lastmod>2025-05-16T18:42:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/una-staffetta-con-due-car-t-per-il-mieloma-multiplo]]></loc><lastmod>2025-05-16T12:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/sitgec-muove-i-primi-passi-un-workshop-sull-accesso-alle-terapie-avanzate]]></loc><lastmod>2025-05-20T22:55:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-l-importanza-della-rwe-e-del-coinvolgimento-dei-pazienti]]></loc><lastmod>2025-05-20T23:11:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/emma-e-i-linfociti-infiltranti-una-bella-storia-da-studiare]]></loc><lastmod>2025-05-22T21:46:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/sviluppare-nuove-terapie-basate-sullo-studio-di-bersagli-molecolari-specifici]]></loc><lastmod>2025-05-22T22:16:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-i-primi-studi-clinici-per-l-artrite-reumatoide-e-l-artrosi]]></loc><lastmod>2025-05-28T10:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/un-cerotto-smart-per-monitorare-lo-stato-delle-ferite-croniche]]></loc><lastmod>2025-05-28T10:01:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/una-car-t-contro-le-metastasi-epatiche-del-tumore-al-colon]]></loc><lastmod>2025-05-29T11:01:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/un-unica-piattaforma-di-sviluppo-per-tre-terapie-geniche]]></loc><lastmod>2025-06-03T22:31:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/l-osservatorio-globale-sull-editing-auspica-un-reset-della-bioetica]]></loc><lastmod>2025-06-03T23:27:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/tumori-travestiti-da-tessuti-di-suino-cosi-l-immunita-impara-ad-attaccarli]]></loc><lastmod>2025-06-06T13:45:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-e-malattie-rare-il-futuro-passa-da-dati-e-politiche-piu-eque]]></loc><lastmod>2025-06-06T14:07:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/le-terapie-avanzate-sono-la-rivoluzione-della-cura]]></loc><lastmod>2025-06-10T13:03:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/crispr-quattro-i-pazienti-con-emoglobinopatie-gia-trattati-in-italia]]></loc><lastmod>2025-06-11T12:13:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/nuove-nomine-per-il-comitato-etico-nazionale-per-i-trial-con-terapie-avanzate]]></loc><lastmod>2025-09-15T09:28:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-baby-kj-e-un-simbolo-di-speranza-ma-il-suo-caso-e-replicabile]]></loc><lastmod>2025-06-13T13:58:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/manifattura-il-dialogo-con-gli-enti-regolatori-per-aprire-all-innovazione]]></loc><lastmod>2025-06-13T14:18:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/alla-ricerca-di-terapie-innovative-per-una-neoplasia-spesso-avanzata]]></loc><lastmod>2025-06-17T11:19:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-lo-studio-clinico-sniper-per-il-tumore-del-pancreas]]></loc><lastmod>2025-06-20T12:42:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/la-ricerca-italiana-sulla-terapia-genica-e-farmaci-a-rna-da-i-suoi-frutti]]></loc><lastmod>2025-06-17T13:32:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/una-nuova-strategia-per-la-terapia-genica-in-vivo]]></loc><lastmod>2025-06-23T13:13:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianto-di-reni-cresce-l-attesa-per-la-prima-sperimentazione-clinica]]></loc><lastmod>2025-06-20T13:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/prime-editing-per-la-prima-volta-su-un-paziente]]></loc><lastmod>2025-06-24T12:33:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-una-partnership-per-l-epidermolisi-bollosa]]></loc><lastmod>2025-06-24T12:35:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-malattia-di-danon-evento-fatale-in-un-trial-clinico]]></loc><lastmod>2025-06-28T13:46:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/organi-umani-da-chimere-uomo-animale-la-nuova-frontiera-dei-trapianti]]></loc><lastmod>2025-06-27T13:24:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/un-nuovo-sistema-crispr-per-inserire-geni-interi-nel-dna]]></loc><lastmod>2025-07-01T15:11:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/dallapiccola-il-maestro-che-ha-ridisegnato-il-volto-della-genetica]]></loc><lastmod>2025-07-01T15:55:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-staminali-contro-il-diabete-di-tipo-1]]></loc><lastmod>2025-07-06T22:16:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/nuove-lipoparticelle-mirate-per-le-car-t-in-vivo]]></loc><lastmod>2025-07-06T21:59:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/un-sistema-innovativo-per-il-trasporto-mirato-dell-rna]]></loc><lastmod>2025-07-08T13:34:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/incubatori-di-terapie-avanzate-l-esperienza-di-evotec]]></loc><lastmod>2025-07-09T09:09:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-buoni-i-risultati-clinici-sul-glioblastoma-multiforme]]></loc><lastmod>2025-07-13T22:08:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/un-ecosistema-a-piu-voci-per-far-crescere-le-terapie-avanzate]]></loc><lastmod>2025-07-13T21:47:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapia-cellulare-gli-stati-uniti-puntano-alla-sindrome-di-pearson]]></loc><lastmod>2025-07-15T13:05:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/quando-sentire-e-questione-di-un-gene]]></loc><lastmod>2025-07-20T15:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/leukemia-on-a-chip-un-innovativo-modello-preclinico-per-valutare-le-car-t]]></loc><lastmod>2025-07-20T14:48:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/nasce-il-primo-centro-pediatrico-per-le-cure-crispr-negli-usa]]></loc><lastmod>2025-07-22T17:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/paracetamolo-dal-pet-e-coli-sara-il-farmacista-del-futuro]]></loc><lastmod>2025-07-20T15:30:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-la-settima-car-t-in-europa]]></loc><lastmod>2025-07-24T21:23:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/il-cervello-adulto-genera-nuovi-neuroni-addio-a-un-vecchio-dogma]]></loc><lastmod>2025-07-25T00:33:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/oltre-la-barriera-una-nuova-speranza-per-le-malattie-del-cervello]]></loc><lastmod>2025-07-25T00:10:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-duchenne-stop-in-usa-e-parere-negativo-in-eu]]></loc><lastmod>2025-07-29T12:45:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-emofilia-b-aifa-approva-la-rimborsabilita]]></loc><lastmod>2025-07-31T15:19:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-ridona-la-vista-a-un-paziente-con-una-rara-malattia-della-retina]]></loc><lastmod>2025-07-30T22:45:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/le-terapie-avanzate-al-cinema-un-immagine-da-ritoccare]]></loc><lastmod>2025-09-09T22:18:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/la-biologia-ai-tempi-dell-ai-esperimenti-su-cellule-virtuali]]></loc><lastmod>2025-08-14T10:45:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-angioedema-ereditario-positivi-i-dati-a-3-anni]]></loc><lastmod>2025-08-22T23:40:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-malattie-autoimmuni-come-si-manifesta-la-tossicita-al-trattamento]]></loc><lastmod>2025-08-14T12:53:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-gpt-l-intelligenza-artificiale-per-democratizzare-l-editing]]></loc><lastmod>2025-08-22T23:47:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/come-stabilire-l-impatto-delle-terapie-avanzate-sul-sistema-sanitario]]></loc><lastmod>2025-08-14T15:27:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/confermate-sicurezza-ed-efficacia-per-le-car-t-contro-il-neuroblastoma]]></loc><lastmod>2025-09-09T22:38:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/effettuato-un-trapianto-di-insule-pancreatiche-senza-immunosoppressione]]></loc><lastmod>2025-09-09T22:59:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/vaccini-a-mrna-tra-scelte-politiche-e-traguardi-scientifici]]></loc><lastmod>2025-09-09T23:27:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/quando-lo-sport-incontra-la-genetica-il-caso-dei-test-per-le-atlete]]></loc><lastmod>2025-09-13T21:32:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-al-servizio-del-reclutamento-nei-trial]]></loc><lastmod>2025-09-13T21:02:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-riattivare-i-geni-sani-nella-sindrome-di-rett]]></loc><lastmod>2025-09-16T20:55:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/nati-otto-bambini-sani-grazie-alla-donazione-mitocondriale]]></loc><lastmod>2025-09-16T19:45:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/l-ospedale-gaslini-di-genova-si-dota-di-una-cell-factory]]></loc><lastmod>2025-09-17T21:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/editing-genomico-per-la-prima-volta-aifa-approva-la-rimborsabilita]]></loc><lastmod>2025-11-16T22:54:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/oltre-baby-kj-i-prossimi-passi-per-produrre-le-terapie-crispr]]></loc><lastmod>2025-09-20T18:19:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/cellule-nk-potenziate-per-arrestare-gli-effetti-delle-malattie-autoimmuni]]></loc><lastmod>2025-09-24T07:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-somministrata-in-sardegna-per-la-prima-volta]]></loc><lastmod>2025-09-24T12:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-sempre-piu-promettenti-i-dati-per-la-malattia-di-huntington]]></loc><lastmod>2025-09-28T20:18:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-ai-sta-riscrivendo-le-regole-dell-oncologia-per-i-target-impossibili]]></loc><lastmod>2025-09-28T20:38:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/linfociti-t-infiltranti-il-glioblastoma-verso-una-nuova-terapia]]></loc><lastmod>2025-09-30T10:36:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/effettuato-in-cina-il-primo-xenotrapianto-di-polmone]]></loc><lastmod>2025-09-28T20:52:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/un-cocktail-di-fagi-armati-con-crispr-per-trattare-tumori-ematologici]]></loc><lastmod>2025-09-29T12:55:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/aso-piu-efficaci-modulando-il-traffico-intracellulare]]></loc><lastmod>2025-10-06T12:16:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/il-nobel-per-la-medicina-svelati-i-guardiani-del-sistema-immunitario]]></loc><lastmod>2025-10-07T13:50:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-intelligenza-artificiale-inventa-virus-per-sconfiggere-i-super-batteri]]></loc><lastmod>2025-10-07T19:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/il-nuovo-assetto-di-aifa-maggiore-efficienza-e-flessibilita]]></loc><lastmod>2025-10-09T13:39:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/staminali-e-parkinson-tra-entusiasmo-e-cautela-la-ricerca-procede]]></loc><lastmod>2025-10-12T21:54:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-anche-treviso-avra-un-centro-somministratore]]></loc><lastmod>2025-10-20T22:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/una-possibile-origine-autoimmune-per-la-sclerosi-laterale-amiotrofica]]></loc><lastmod>2025-10-14T21:37:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/l-ai-alla-guida-di-una-chirurgia-piu-precisa]]></loc><lastmod>2025-10-14T22:05:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura/manifattura-realizzato-a-parma-il-primo-isolatore-robotizzato-al-mondo]]></loc><lastmod>2025-10-17T09:09:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-tumore-dello-stomaco-risultati-interessanti-ma-in-bilico]]></loc><lastmod>2025-10-20T22:26:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-riflettori-accesi-sull-alfa-talassemia]]></loc><lastmod>2025-10-26T23:47:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/creato-in-laboratorio-il-modello-di-rene-umano-piu-realistico-di-sempre]]></loc><lastmod>2025-10-20T23:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/prix-galien-italia-2025-premiata-una-terapia-genica]]></loc><lastmod>2025-10-27T11:45:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/ovuli-e-spermatozoi-artificiali-quanto-e-vicino-il-traguardo]]></loc><lastmod>2025-10-27T07:39:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/holostem-la-rinascita-del-made-in-italy-nelle-terapie-avanzate]]></loc><lastmod>2025-10-29T07:35:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/inaugurato-il-nuovo-laboratorio-di-terapia-genica-di-opbg]]></loc><lastmod>2025-10-30T10:53:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/vaccini-a-mrna-dal-covid-alle-terapie-oncologiche]]></loc><lastmod>2025-11-02T22:15:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/xenotrapianti-i-primi-record]]></loc><lastmod>2025-11-02T22:42:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/i-progressi-della-terapia-genica-contro-la-sordita-genetica]]></loc><lastmod>2025-11-05T00:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health/un-cerotto-hi-tech-per-affrontare-le-dipendenze]]></loc><lastmod>2025-11-04T23:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni/riusciranno-bioingegneria-e-ai-a-sostituire-i-test-sugli-animali]]></loc><lastmod>2025-11-08T20:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/un-microchip-da-impiantare-nella-retina-per-tornare-a-vedere]]></loc><lastmod>2025-11-08T21:16:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/terapie-a-base-di-cellule-staminali-una-roadmap-dall-isscr]]></loc><lastmod>2025-11-08T21:41:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/una-mini-placenta-per-studiare-le-fasi-precoci-della-gravidanza]]></loc><lastmod>2025-11-08T22:01:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-l-emofilia-a-trattato-il-primo-paziente-nel-lazio]]></loc><lastmod>2025-11-14T12:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/il-dna-ha-una-struttura-a-doppia-elica-elementare-watson]]></loc><lastmod>2025-11-17T12:44:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/parere-positivo-del-chmp-per-la-terapia-genica-per-la-was]]></loc><lastmod>2025-11-18T09:26:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/svolta-dell-fda-per-le-terapie-su-misura-per-i-pazienti-rari]]></loc><lastmod>2025-11-18T09:10:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/nanoparticelle-super-adiuvanti-nuova-frontiera-per-i-vaccini-anticancro]]></loc><lastmod>2025-11-22T23:37:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/microrna-uno-studio-italiano-sul-tumore-al-cervello]]></loc><lastmod>2025-11-24T08:56:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-colesterolo-buoni-i-risultati-di-uno-studio-di-fase-i]]></loc><lastmod>2025-11-25T15:43:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-risultati-promettenti-per-lo-scompenso-cardiaco]]></loc><lastmod>2025-11-25T14:51:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-sma-approvata-la-somministrazione-intratecale-in-usa]]></loc><lastmod>2025-11-27T12:54:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-puo-correggere-il-dna-mitocondriale]]></loc><lastmod>2025-11-30T22:56:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-la-commissione-europea-autorizza-una-nuova-indicazione-per-liso-cel]]></loc><lastmod>2025-11-30T22:42:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-cgd-la-storia-di-remi]]></loc><lastmod>2025-12-02T15:01:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/nuove-nanoparticelle-per-vaccini-a-mrna-efficacia-con-dosi-100-volte-minori]]></loc><lastmod>2025-12-02T13:43:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-emofilia-b-trattato-il-primo-paziente-in-italia]]></loc><lastmod>2025-12-04T17:14:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/eliminare-le-cellule-treg-del-tumore-e-potenziare-la-risposta-immunitaria]]></loc><lastmod>2025-12-09T23:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/itreg-cellule-piu-durature-ed-efficaci-per-combattere-malattie-autoimmuni]]></loc><lastmod>2025-12-09T23:45:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/terapia-genica-per-la-was-via-libera-dalla-fda]]></loc><lastmod>2025-12-12T09:51:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/vertigine-la-scienza-ci-mantiene-in-equilibrio]]></loc><lastmod>2025-12-14T20:52:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/microrobot-magnetici-per-il-trasporto-mirato-di-farmaci]]></loc><lastmod>2025-12-14T22:35:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/il-presente-e-il-futuro-delle-rna-therapies]]></loc><lastmod>2025-12-17T00:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-geniche-ultra-rare-nasce-un-nuovo-modello-di-accesso-sostenibile]]></loc><lastmod>2025-12-16T23:58:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/2026-cosa-accadra-nel-mondo-della-ricerca-clinica]]></loc><lastmod>2026-01-07T14:17:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/dalle-car-t-una-futura-opportunita-per-la-sindrome-della-persona-rigida]]></loc><lastmod>2026-01-08T10:39:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-la-sfida-del-cervello-perche-i-neuroni-seguono-regole-diverse]]></loc><lastmod>2026-01-11T22:58:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/trapianto-di-cromosomi-si-apre-una-nuova-frontiera]]></loc><lastmod>2026-01-11T22:36:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/crispr-per-la-beta-talassemia-la-sardegna-ai-blocchi-di-partenza]]></loc><lastmod>2026-01-13T23:04:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-e-pku-la-sfida-della-nuova-startup-ispirata-dal-successo-di-baby-kj]]></loc><lastmod>2026-01-13T23:57:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-anche-in-europa-la-terapia-genica-per-la-was]]></loc><lastmod>2026-01-19T14:54:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni/impianto-neurale-per-ridare-la-parola-al-via-lo-studio-clinico-negli-usa]]></loc><lastmod>2026-01-13T23:27:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/leggere-i-geni-viaggio-nelle-meraviglie-del-dna]]></loc><lastmod>2026-01-20T23:21:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-all-istituto-besta-un-trial-per-la-demenza-frontotemporale]]></loc><lastmod>2026-01-26T23:09:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/vaccino-a-mrna-per-il-melanoma-i-dati-a-5-anni]]></loc><lastmod>2026-01-26T23:22:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/una-pet-per-seguire-le-terapie-avanzate-nel-corpo-umano]]></loc><lastmod>2026-01-28T16:58:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/tutte-le-strategie-per-indirizzare-crispr-verso-il-giusto-bersaglio]]></loc><lastmod>2026-02-03T08:16:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-per-mieloma-multiplo-robuste-evidenze-di-efficacia-gia-alla-prima-recidiva]]></loc><lastmod>2026-02-03T22:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/car-t-nuova-indicazione-per-liso-cel-in-italia]]></loc><lastmod>2026-02-03T22:50:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/car-t-in-remissione-completa-sette-bambini-con-malattie-autoimmuni]]></loc><lastmod>2026-02-08T23:26:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-geniche-ultra-rare-l-innovazione-resta-fuori-dal-mercato]]></loc><lastmod>2026-02-08T23:09:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica/organoro-una-piattaforma-basata-su-organoidi-cardiaci-personalizzati]]></loc><lastmod>2026-02-10T15:00:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/approcci-sempre-piu-innovativi-per-il-diabete-di-tipo-1]]></loc><lastmod>2026-02-16T10:39:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-un-nuovo-approccio-per-ringiovanire-il-sistema-immunitario]]></loc><lastmod>2026-02-16T00:10:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/un-interruttore-genetico-per-il-dolore]]></loc><lastmod>2026-02-19T15:02:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/milenari-un-progetto-per-rendere-ancora-piu-accessibili-le-car-t]]></loc><lastmod>2026-02-22T17:22:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna/rna-therapies-un-sistema-smart-di-nanoparticelle-per-l-osteoartrite]]></loc><lastmod>2026-02-22T17:43:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/pert-una-strategia-di-editing-genetico-per-le-mutazioni-non-senso]]></loc><lastmod>2026-02-26T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/quando-le-truffe-a-base-di-staminali-bussano-alla-porta-di-casa]]></loc><lastmod>2026-03-03T16:03:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-per-emoglobinopatie-nuovi-dati-nei-bambini-di-5-11-anni]]></loc><lastmod>2026-03-04T12:54:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/le-car-t-oltre-l-oncologia-primi-dati-preclinici-nell-alzheimer]]></loc><lastmod>2026-03-03T15:37:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/aifa-concede-la-rimborsabilita-a-ciltacabtagene-autoleucel]]></loc><lastmod>2026-03-06T11:33:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/il-prime-editing-testa-l-fda-due-pazienti-rari-posson-bastare]]></loc><lastmod>2026-03-06T12:17:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/un-dottorato-nazionale-in-medicina-di-precisione-e-terapie-avanzate]]></loc><lastmod>2026-03-09T11:08:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/ai-blocchi-di-partenza-in-italia-uno-studio-clinico-con-virus-oncolitici]]></loc><lastmod>2026-03-11T09:23:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-epigenetico-avviato-il-primo-studio-clinico-per-l-epatite-b]]></loc><lastmod>2026-03-15T22:39:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/pseudo-terapie-con-staminali-a-domicilio-il-caso-arriva-in-parlamento]]></loc><lastmod>2026-03-15T22:06:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-fabry-migliorata-la-funzione-renale]]></loc><lastmod>2026-03-15T22:58:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/macrofagi-per-riparare-il-tessuto-nervoso-un-innovazione-che-parla-italiano]]></loc><lastmod>2026-03-23T11:45:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-l-emofilia-a-un-altro-ritiro-dal-mercato]]></loc><lastmod>2026-03-24T23:45:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-e-malattie-rare-quando-il-modello-industriale-non-basta]]></loc><lastmod>2026-03-23T13:51:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/n-of-1-studi-clinici-personalizzati]]></loc><lastmod>2026-03-29T20:23:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/terapie-avanzate-studi-clinici-piu-solidi-per-le-cure-innovative]]></loc><lastmod>2026-03-29T20:22:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare/staminali-a-domicilio-presadiretta-torna-sul-tema-e-intervista-aifa]]></loc><lastmod>2026-03-31T21:00:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/perche-moriamo-la-nuova-scienza-dell-invecchiamento]]></loc><lastmod>2026-03-31T21:26:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/in-memoria-di-claudio-bordignon-primo-direttore-dell-istituto-sr-tiget]]></loc><lastmod>2026-04-08T14:05:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/centro-nazionale-rna-gene-therapy-i-risultati-del-pnrr]]></loc><lastmod>2026-04-09T11:39:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-la-lad-1-prima-approvazione-in-usa]]></loc><lastmod>2026-04-10T09:05:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio/biotech-act-una-rivoluzione-legislativa-per-competitivita-e-innovazione]]></loc><lastmod>2026-04-10T09:44:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/l-immunoterapia-che-verra-i-linfociti-t-gamma-delta]]></loc><lastmod>2026-04-15T10:49:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico]]></loc><lastmod>2025-11-17T11:25:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/vertex-e-crispr-therapeutics-studiano-l-applicazione-di-crispr-cas9-contro-la-beta-talassemia]]></loc><lastmod>2020-05-27T16:35:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/in-cosa-consiste-l-editing-genomico-un-video-per-saperne-di-piu]]></loc><lastmod>2019-02-26T08:59:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/crispr-spiegato-da-ellen-jorgensen]]></loc><lastmod>2019-02-25T08:44:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/editing-genomico/editing-genomico-per-beta-talassemia-e-anemia-falciforme-gli-ultimi-aggiornamenti-sullo-sviluppo-clinico-di-ctx001]]></loc><lastmod>2019-03-11T08:25:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica]]></loc><lastmod>2021-03-25T19:36:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/terapia-genica-per-il-trattamento-dei-pazienti-con-beta-talassemia-trasfusione-dipendenti-le-novita-dal-congresso-eha]]></loc><lastmod>2019-01-25T09:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/crisrp-cas9-la-superstar-dei-laboratori-di-genetica-e-biologia-molecolare]]></loc><lastmod>2019-11-26T12:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/distrofia-muscolare-dei-cingoli-sarepta-e-e-myonexus-therapeutics-uniscono-le-forze-sul-fronte-terapia-genica]]></loc><lastmod>2020-02-04T14:53:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/la-cura-per-l-atrofia-muscolare-spinale-sma-e-piu-vicina]]></loc><lastmod>2019-01-31T12:21:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-genica/talassemia-autorizzata-l-immissione-in-commercio-in-ue-della-prima-terapia-genica-per-la-patologia]]></loc><lastmod>2020-06-28T17:05:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapia-cellulare]]></loc><lastmod>2024-12-18T22:15:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia]]></loc><lastmod>2021-03-30T09:55:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/l-immunoterapia-e-una-delle-strategie-di-trattamento-piu-promettenti-per-il-neuroblastoma]]></loc><lastmod>2020-02-04T15:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/immunoterapia/l-editing-del-genoma-e-l-immunoterapia-l-incontro-di-due-realta-che-sovvertiranno-l-universo-della-medicina]]></loc><lastmod>2020-02-04T14:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-su-rna]]></loc><lastmod>2023-04-17T14:18:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/organoidi-e-ricerca-biomedica]]></loc><lastmod>2021-03-26T10:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate]]></loc><lastmod>2026-01-19T14:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-approvate/approvata-in-europa-la-terapia-cellulare-per-le-neoplasie-ematologiche]]></loc><lastmod>2026-02-10T15:47:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/terapie-avanzate/terapie-avanzate-un-video-per-spiegare-terapia-genica-terapia-cellulare-ed-editing-genomico]]></loc><lastmod>2019-01-31T11:36:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/terapie-digitali]]></loc><lastmod>2022-09-22T18:43:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/digital-health]]></loc><lastmod>2021-03-26T10:43:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/innovazioni-tecnologiche/altre-innovazioni]]></loc><lastmod>2023-03-18T07:40:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/regolatorio]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/bioetica-e-dintorni]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/focus/manifattura]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/retreat]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/podcast-e-illustrazioni]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/consensus]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/cell-therapy-open-source]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/progetti/l-abc-delle-car-t]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/at2/organizza-il-tuo-at2]]></loc><lastmod>2019-10-14T09:14:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/eventi-ota/focus-live]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/car-t-congress-eu-30-31-gen-london]]></loc><lastmod>2019-03-19T13:36:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/2-10th-annual-rna-therapeutics-conference-20-21-feb-london]]></loc><lastmod>2019-09-30T14:13:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/therapeutic-genome-editing-congress-20-21-marzo-boston]]></loc><lastmod>2020-03-24T06:34:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/9th-international-conference-and-exhibition-on-advanced-cell-and-gene-therapy-21-22-marzo-roma]]></loc><lastmod>2019-09-30T14:13:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/3rd-annual-gene-therapy-for-rare-disorders-26-28-marzo-boston]]></loc><lastmod>2019-10-27T00:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/22nd-annual-meeting-asgct-29-aprile-2-maggio-washington]]></loc><lastmod>2019-10-27T00:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/premio-citta-di-firenze-sulle-scienze-molecolari-12-febbraio-2019-firenze]]></loc><lastmod>2019-03-19T13:36:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-orphan-drug-congress-wodc-2019-10-12-aprile-washington]]></loc><lastmod>2019-10-27T00:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/incontro-del-comitato-consultivo-dell-oms-sullo-sviluppo-di-standard-globali-per-la-governance-e-la-supervisione-dei-processi-di-editing-del-genoma-umano-18-19-marzo-ginevra]]></loc><lastmod>2019-09-30T14:13:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/car-t-congress-usa-16-17-aprile-boston]]></loc><lastmod>2019-10-27T00:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-del-futuro-la-svolta-e-adesso-17-aprile-milano]]></loc><lastmod>2019-10-27T00:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-avanzate-in-pediatria-la-ricerca-la-sostenibilita-e-l-accesso-alle-cure-13-maggio-milano]]></loc><lastmod>2019-10-27T00:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-advanced-regenerative-medicine-congress-2019-15-17-maggio-londra]]></loc><lastmod>2019-10-27T00:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/festival-della-scienza-medica-2019-9-12-maggio-bologna]]></loc><lastmod>2019-12-12T16:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/pint-of-science-20-22-maggio]]></loc><lastmod>2019-12-12T16:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/editing-genetico-saremo-davvero-tutti-perfetti-24-maggio-roma]]></loc><lastmod>2019-12-12T16:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-talks-on-advanced-therapies-roma-20-giugno-2019]]></loc><lastmod>2019-12-12T16:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/20-21-giugno-2019-wageningen-paesi-bassi-crisprcon2019]]></loc><lastmod>2019-12-12T16:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/conferenza-annuale-2019-bsgct-19-21-giugno-sheffield-uk]]></loc><lastmod>2019-12-12T16:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/1st-italian-workshop-on-car-t-cell-therapy-24-giugno-2019-milano]]></loc><lastmod>2020-01-09T15:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/european-biotech-week-23-29-settembre-2019]]></loc><lastmod>2020-01-09T15:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/storie-dal-futuro-migliore-24-settembre-2019-milano]]></loc><lastmod>2020-01-09T15:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/proiezione-del-documentario-human-nature-11-ottobre-2019-roma]]></loc><lastmod>2020-02-17T21:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/italian-infrastructure-for-regenerative-medicine-30-settembre-2019-bologna]]></loc><lastmod>2020-01-09T15:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/la-medicina-rigenerativa-gene-therapy-e-terapie-car-t-i-principi-e-il-modello-organizzativo-11-ottobre-2019-firenze]]></loc><lastmod>2020-04-09T16:06:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapia-genica-una-sfida-per-il-servizio-sanitario-nazionale-2-ottobre-2019-roma]]></loc><lastmod>2020-01-09T15:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mesa-2-4-ottobre-2019-california-usa]]></loc><lastmod>2020-01-09T15:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/gene-therapy-for-rare-disorders-europe-15-17-ottobre-2019-londra-uk]]></loc><lastmod>2020-04-09T16:06:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esgct-27-annual-congress-22-25-ottobre-2019-barcellona-spagna]]></loc><lastmod>2020-05-06T15:28:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/1st-advanced-therapies-science-meeting-25-26-novembre-2019-berlino-germania]]></loc><lastmod>2020-05-20T00:04:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/47esimo-congresso-nazionale-sie-7-9-ottobre-2019-roma]]></loc><lastmod>2020-03-11T11:38:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/the-healthcare-to-come-convegno-internazionale-sulla-medicina-personalizzata-16-ottobre-2019-milano]]></loc><lastmod>2020-05-06T15:28:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/focus-live-2019-21-24-novembre-2019-milano]]></loc><lastmod>2020-05-20T00:04:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/secondo-report-italiano-sulle-atmp-come-rendere-attrattiva-l-italia-nella-ricerca-e-produzione-delle-atmp-24-ottobre-2019-roma]]></loc><lastmod>2020-05-16T12:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-cell-therapies-and-tissue-engineering-14-16-novembre-milano]]></loc><lastmod>2020-05-16T12:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/icmra-summit-28-30-ottobre-roma]]></loc><lastmod>2020-05-16T12:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/immunita-e-immunoterapia-del-cancro-un-sogno-e-una-sfida-13-novembre-2019-roma]]></loc><lastmod>2020-05-16T12:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/conoscere-e-comunicare-le-terapie-avanzate-cure-rivoluzionarie-14-dicembre-2019-roma]]></loc><lastmod>2020-08-28T16:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/scienza-al-quadrato-2-dicembre-2019-palermo]]></loc><lastmod>2020-05-20T00:04:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-therapies-state-of-the-industry-briefing-13-gennaio-2020-san-francisco-usa]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-congress-expo-2020-30-marzo-1-aprile-2020-londra]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-week-20-24-gennaio-2020-miami-usa]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/mostra-alla-scoperta-del-genome-editing-fino-al-6-gennaio-2020-bergamo]]></loc><lastmod>2020-08-28T16:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/car-t-una-sfida-sostenibile-15-gennaio-2020-milano]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/asgct-annual-meeting-12-15-maggio-2020-boston-usa]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/3rd-annual-cell-gene-therapy-innovation-leaders-summit-2020-5-6-febbraio-2020-berlino-germania]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-symposia-gene-and-cell-based-therapies-crispr-stem-cells-and-beyond-2-4-marzo-2020-san-francisco-usa]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/first-international-stemnet-meeting-6-8-maggio-2020-padova]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-avanzate-il-futuro-e-gia-qui-il-sistema-italiano-e-pronto-a-riceverle-5-marzo-2020-roma]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/acgt-2020-cancer-summit-16-aprile-2020-new-york-city-usa]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isscr-2020-the-global-stem-cell-event-24-27-giugno-2020-boston-usa]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/2020-pda-europe-advanced-therapy-medicinal-products-24-25-giugno-2020-bruxelles-belgio]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/eshg-2020-6-9-giugno-2020-conferenza-virtuale]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ecrd-2020-14-15-maggio-2020-conferenza-virtuale]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/eha-annual-congress-11-21-giugno-2020-conferenza-virtuale]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/targeted-cancer-drugs-what-s-on-the-market-what-s-in-the-pipeline-24-giugno-webinar-stat]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/exploring-gene-therapy-treatments-in-the-hemophilia-space-20-maggio-webinar-stat]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/milano-digital-week-25-30-maggio-2020-edizione-online]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-orphan-drug-congress-usa-2020-24-26-agosto-2020-congresso-virtuale]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/asgct-policy-summit-23-25-settembre-2020]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mesa-14-16-ottobre-2020-carlsbad-california-usa]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/6th-annual-genome-editing-congress-4-6-novembre-2020-conferenza-virtuale]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/annual-gene-therapy-for-rare-disorders-europe-26-28-ottobre-conferenza-virtuale]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/programmable-medicines-and-digital-biotechnology-28-settembre-webinar]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/premio-omar-23-settembre-2020-roma]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/digital-health-world-congress-2020-29-30-settembre-2020-conferenza-digitale]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crisprcon-2020-virtual-1-3-settembre-2020-conferenza-virtuale]]></loc><lastmod>2020-09-15T13:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/trieste-science-the-city-9-29-settembre-conferenza-virtuale-e-a-trieste]]></loc><lastmod>2020-09-17T16:37:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-avanzate-il-futuro-e-gia-qui-il-sistema-italiano-e-pronto-a-riceverle-15-settembre-2020-webinar]]></loc><lastmod>2020-09-17T16:37:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/frontiere-22-27-settembre-2020-evento-virtuale]]></loc><lastmod>2020-09-21T14:58:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ashg-s-annual-meeting-27-30-ottobre-2020-conferenza-virtuale]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/applying-organoids-the-3d-frontier-7-27-ottobre-2020-conferenze-digitali]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-crispr-day-20-21-ottobre-2020-conferenza-digitale]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/2-digital-therapeutics-day-22-ottobre-2020-conferenza-digitale]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/frontiers-health-2020-12-13-novembre-2020-conferenza-digitale-e-in-presenza]]></loc><lastmod>2021-05-27T12:55:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/v-annual-meeting-alleanza-contro-il-cancro-28-30-ottobre-2020-conferenza-virtuale]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/presentazione-del-ebook-le-terapie-car-t-dal-laboratorio-al-paziente-diretta-streaming-3-novembre-2020]]></loc><lastmod>2021-02-13T17:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/la-rivoluzione-delle-terapie-avanzate-come-garantire-governance-sostenibilita-e-accesso-nel-prossimo-futuro-corso-fad-24-25-novembre-2020]]></loc><lastmod>2021-05-27T12:55:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-innovative-potenziale-di-cura-e-sostenibilita-in-italia-1-dicembre-2020-diretta-streaming]]></loc><lastmod>2021-06-03T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ash-annual-meeting-exposition-5-8-dicembre-2020-conferenza-virtuale]]></loc><lastmod>2021-06-03T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/chromatin-epigenetics-and-nuclear-architecture-in-stem-cells-23-novembre-14-dicembre-2020-conferenze-online]]></loc><lastmod>2021-06-03T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-state-of-the-industry-briefing-13-gennaio-2021-conferenza-virtuale]]></loc><lastmod>2021-06-03T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/vision2030-isscr-7-8-gennaio-2021-conferenza-virtuale]]></loc><lastmod>2021-06-03T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-digitali-una-opportunita-per-l-italia-19-gennaio-2021-live-webinar]]></loc><lastmod>2021-06-03T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/car-tcr-digital-summit-europe-16-18-febbraio-2021-conferenza-digitale]]></loc><lastmod>2021-09-07T15:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapia-genica-per-la-duchenne-22-gennaio-2021-webinar]]></loc><lastmod>2021-09-07T15:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/24th-annual-meeting-asgct-11-15-maggio-2021-conferenza-virtuale]]></loc><lastmod>2022-03-31T12:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isct-2021-26-28-maggio-2021-conferenza-virtuale]]></loc><lastmod>2021-11-17T16:02:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mediterranean-6-9-aprile-2021-conferenza-virtuale]]></loc><lastmod>2021-09-27T11:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-digitali-nuove-frontiere-per-la-cura-16-febbraio-2021-webinar]]></loc><lastmod>2021-09-07T15:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xviii-conferenza-internazionale-sulla-distrofia-muscolare-di-duchenne-e-becker-17-21-febbraio-2021-conferenza-virtuale]]></loc><lastmod>2021-09-27T11:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/gamification-e-app-sono-le-medicine-del-futuro-scenari-di-applicabilita-in-italia-2-marzo-2021-webinar]]></loc><lastmod>2021-09-27T11:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esmo-targeted-anticancer-therapies-congress-2021-1-2-marzo-2021-congresso-virtuale]]></loc><lastmod>2021-09-27T11:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/47-ebmt-annual-meeting-14-17-marzo-2021-conferenza-virtuale]]></loc><lastmod>2021-09-27T11:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/alliance-for-cancer-gene-therapy-summit-2021-29-aprile-2021-conferenza-virtuale]]></loc><lastmod>2021-11-03T21:05:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/data-4-healthy-recovery-hackathon-18-20-giugno-2021-evento-virtuale]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/bio-international-convention-2021-10-11-e-14-18-giugno-2021-evento-digitale]]></loc><lastmod>2021-11-17T16:02:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/3d-bioprinting-nel-settore-della-salute-15-aprile-2021-webinar]]></loc><lastmod>2021-09-27T11:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/smaspace-23-aprile-2021-evento-online]]></loc><lastmod>2021-09-27T11:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/how-to-make-this-a-success-story-in-europe-26-maggio-2021-evento-online]]></loc><lastmod>2021-11-11T21:03:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esploriamo-la-bioproduction-delle-terapie-avanzate-19-maggio-e-2-giugno-2021-webinar]]></loc><lastmod>2021-11-17T16:02:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-2021-19-21-maggio-2021-evento-virtuale]]></loc><lastmod>2021-11-11T21:03:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isccr-annual-meeting-21-26-giugno-2021-conferenza-digitale]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/asco-annual-meeting-2021-4-8-giugno-2021-conferenza-virtuale]]></loc><lastmod>2021-11-17T16:02:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/eha2021-9-17-giugno-2021-conferenza-virtuale]]></loc><lastmod>2021-11-17T16:02:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/gene-targeted-therapies-early-diagnosis-and-equitable-delivery-3-10-17-giugno-2021-evento-online]]></loc><lastmod>2021-11-17T16:02:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/frontiers-health-italia-2021-25-giugno-evento-online]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crispr-new-techniques-and-complex-models-30-giugno-2021-evento-virtuale]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapia-genica-e-nuovi-farmaci-per-le-malattie-rare-la-risposta-della-regione-fvg-all-innovazione-tecnologica-23-giugno-2021-webinar]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/l-importanza-della-telemedicina-nell-emofilia-il-progetto-remote-10-settembre-2021-evento-digitale]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/newtom-forum-2021-the-pioneer-of-the-cone-beam-ct-11-settembre-evento-in-modalita-combinata]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-congress-expo-2021-5-6-ottobre-2021-londra]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/gp-write-5-0-21-22-ottobre-2021-conferenza-virtuale]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/nanoinnovation-2021-21-24-settembre-2021-roma]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/sperimentazioni-cliniche-il-processo-di-ricerca-scientifica-sull-uomo-13-ottobre-2021-media-tutorial]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/technology-forum-life-science-week-2021-27-settembre-1-ottobre-2021-evento-in-modalita-combinata]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mesa-2021-12-14-ottobre-2021-evento-in-modalita-combinata]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/le-terapie-avanzate-come-strumento-di-innovazione-in-medicina-11-ottobre-2021-webinar]]></loc><lastmod>2022-01-20T22:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-crispr-day-20-ottobre-2021-conferenza-digitale]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esgct-congress-2021-19-22-ottobre-2021-congresso-virtuale]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/il-nostro-futuro-crispr-29-ottobre-2021-modalita-mista]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/frontiers-health-global-conference-11-12-novembre-2021-modalita-mista]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-avanzate-in-italia-l-oggi-e-il-domani-24-novembre-2021-evento-online]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/scienza-ultima-frontiera-5-novembre-3-dicembre-2021-modalita-mista]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/rare-diseases-17-novembre-2021-webinar]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/mrna-day-2021-16-novembre-2021-evento-virtuale]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/riparare-la-vita-l-editing-genomico-tra-opportunita-e-rischi-20-novembre-2021-milano]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/viii-edizione-del-premio-omar-2-dicembre-2021-modalita-mista]]></loc><lastmod>2022-04-11T12:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/63-ash-annual-meeting-exposition-11-14-dicembre-2021-modalita-mista]]></loc><lastmod>2022-09-28T09:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esploriamo-la-bioproduction-delle-terapie-avanzate-11-gennaio-2022-webinar]]></loc><lastmod>2022-09-28T09:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crispr-and-metachromatic-leukodystrophy-26-gennaio-2022-webinar]]></loc><lastmod>2022-09-28T09:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/48th-annual-meeting-of-the-ebmt-19-23-marzo-2022-praga-e-online]]></loc><lastmod>2022-10-27T08:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advancing-gene-therapy-2022-28-30-marzo-2022-boston]]></loc><lastmod>2022-10-27T08:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/international-conference-on-lyphocyte-engineering-2022-31-marzo-2-aprile-2022-monaco]]></loc><lastmod>2022-10-27T08:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/stem-cells-from-genes-to-organs-30-31-marzo-2022-israele]]></loc><lastmod>2022-10-27T08:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/israeli-society-of-gene-and-cell-therapy-meeting-2022-10-febbraio-2022-tel-aviv]]></loc><lastmod>2022-09-28T09:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/presentazione-sulle-modalita-di-accesso-alla-terapia-risdiplam-14-febbraio-2021-webinar]]></loc><lastmod>2022-09-28T09:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/conferenza-internazionale-sulla-distrofia-muscolare-di-duchenne-e-becker-17-20-febbraio-2022-webinar]]></loc><lastmod>2022-09-28T09:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/nuove-frontiere-in-oncologia-22-febbraio-2022-evento-online]]></loc><lastmod>2022-09-28T09:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/wired-health-15-marzo-2022-milano]]></loc><lastmod>2022-10-27T08:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mediterranean-20-22-aprile-2022-evento-ibrido]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/25-meeting-annuale-asgct-16-19-maggio-2022-evento-ibrido]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/conferenza-annuale-isct-2022-4-7-maggio-2022-san-francisco]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/master-di-ii-livello-in-sanita-digitale-telemedicina-e-telefarmacia-iscrizioni-entro-il-30-aprile-2022]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advance-5-day-workshop-on-atmp-development-20-24-giugno-2022-roma]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-congress-24-25-maggio-2022-londra]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/prodotti-di-terapia-avanzata-dalla-ricerca-al-trattamento-26-28-maggio-2022-modalita-ibrida]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/eha2022-9-12-giugno-2022-modalita-ibrida]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/european-tissue-repair-society-annual-meeting-15-17-settembre-2022-lione-francia]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/embo-regeneration-26-30-settembre-2022-barcellona-spagna]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isscr-asgct-2022-madison-international-symposium-22-23-settembre-2022-evento-ibrido]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/car-t-quali-nuove-competenze-per-il-farmacista-ospedaliero-21-luglio-2022-padova]]></loc><lastmod>2022-12-29T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/x-ed-european-biotech-week-26-settembre-2-ottobre-2022]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/annual-meeting-di-alleanza-contro-il-cancro-21-23-settembre-2022-roma]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xix-congresso-associazione-luca-coscioni-13-16-ottobre-2022-modena]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/frontiers-health-global-conference-2022-20-21-ottobre-2022-modalita-ibrida]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esgct-congress-2022-11-14-ottobre-2022-modalita-ibrida]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapie-digitali-dallo-sviluppo-alla-pratica-clinica-una-rivoluzione-possibile-in-italia-14-ottobre-2022-webinar]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/la-rivoluzione-delle-terapie-avanzate-2-edizione-27-ottobre-2022]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-crispr-day-20-ottobre-2022-conferenza-digitale]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/at2-advanced-talks-on-advanced-therapies-07-novembre-2022-roma]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isscr-boston-international-symposium-17-19-novembre-2022-modalita-ibrida]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/milano-digital-week-2022-10-14-novembre-2022-milano]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/webinar-scientifici-di-gfb-per-i-pazienti-affetti-da-lgmd-15-novembre-2022-roma]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ash-annual-meeting-and-exposition-10-13-dicembre-2022-modalita-ibrida]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ix-edizione-del-premio-omar-15-dicembre-2022-roma]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xx-conferenza-internazionale-parent-project-aps-17-19-febbraio-2022-roma]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-congree-2023-14-15-marzo-2023-londra]]></loc><lastmod>2023-09-06T09:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/termis-eu-2023-28-31-marzo-2023-manchester-uk]]></loc><lastmod>2023-09-06T09:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/epithelioid-sarcoma-digital-expert-panel-2023-15-e-16-marzo-2023]]></loc><lastmod>2023-09-06T09:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/international-summit-on-human-genome-editing-6-8-marzo-2023-londra]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esmo-tat-congress-2023-6-8-marzo-2023-parigi-francia]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/panorama-of-the-dtx-policy-and-reimbursement-landscapes-14-marzo-2023-online]]></loc><lastmod>2023-03-21T17:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/1st-nota-annual-meeting-30-31-marzo-torino-e-online]]></loc><lastmod>2023-09-06T10:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mediterranean-12-14-aprile-2023-barcellona]]></loc><lastmod>2023-09-06T10:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/49th-annual-meeting-ebmt-23-26-aprile-2023-parigi-e-online]]></loc><lastmod>2023-09-06T10:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/gordon-research-conference-on-stem-cells-and-cancer-14-19-maggio-2023-lucca]]></loc><lastmod>2023-09-06T10:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/next-generation-organoids-11-aprile-2-maggio-2023-webinar]]></loc><lastmod>2023-09-06T10:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/innovazione-farmaceutica-4-aprile-2023-roma]]></loc><lastmod>2023-09-06T10:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xix-giornata-mondiale-dell-emofilia-ieri-utopia-oggi-terapia-17-aprile-2023-roma-e-online]]></loc><lastmod>2023-09-06T10:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advance-summer-school-on-cell-and-gene-therapies-5-9-giugno-2023-lubiana-slovenia]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/next-generation-atmps-nordic-meeting-24-maggio-2023-uppsala-svezia]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/asco-annual-meeting-2023-2-6-giugno-2023-chicago-usa-e-online]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/eha2023-8-11-giugno-francoforte-germania-e-online]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/eacr-2023-congress-innovative-cancer-science-12-15-giugno-2023-torino]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xxiii-congresso-nazionale-aim-8-10-giugno-2023-padova]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/pharma-life-sciences-2023-15-giugno-2023-milano-e-in-diretta-streaming]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isscr-annual-meeting-2023-14-17-giugno-2023-boston-usa-e-online]]></loc><lastmod>2023-11-13T15:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crispr-conference-2023-27-giugno-1-luglio-2023-wuerzburg-germania]]></loc><lastmod>2024-02-14T21:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/terapia-genica-al-policlinico-umberto-i-il-primo-intervento-in-italia-per-una-rarissima-malattia-27-giugno-2023-roma]]></loc><lastmod>2024-02-14T21:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/malattia-di-anderson-fabry-prospettive-future-di-una-rivoluzione-lunga-20-anni-12-luglio-2023-online]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/corso-public-engagement-in-stem-7-8-settembre-2023-trieste]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/convegno-nazionale-famiglie-sma-2-3-settembre-2023-roma-e-online]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/workshop-crispr-cas-from-biology-to-therapeutic-applications-7-10-novembre-2023-siviglia-spagna]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/49-congresso-esao-ifao-28-agosto-1-settembre-2023-bergamo]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/future-summit-2023-5-7-settembre-2023-online]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/european-biotech-week-2023-25-settembre-1-ottobre-2023-in-presenza-e-online]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/iii-simposio-italiano-sulle-terapie-avanzate-27-29-settembre-2023-rimini]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/sao-paulo-international-symposium-22-24-settembre-2023-ribeirao-preto-brasile-e-online]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-conference-on-targeting-mitochondria-2023-11-13-ottobre-2023-berlino]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mesa-2023-10-12-ottobre-2023-california-usa]]></loc><lastmod>2024-03-04T09:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esgct-congress-2023-24-27ottobre-2023-bruxelles]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ipita-ixa-ctrms-joint-congress-26-29-ottobre-2023-san-diego-usa]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-orphan-drug-congress-europe-2023-30-ottobre-2-novembre-2023-barcellona]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/teach-me-in-10-accelerating-cell-and-gene-therapy-development-29-novembre-2023-online]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/4th-annual-crispr-2-0-28-30-novembre-2023-boston-usa]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/frontiers-health-2023-8-10-novembre-2023-roma-e-online]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/italia-stati-uniti-cooperazione-internazionale-sulle-biotecnologie-emergenti-e-scienze-della-vita-14-novembre-2023-online]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/healthcare-summit-2023-16-novembre-2023-roma-e-online]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/x-edizione-del-premio-omar-5-dicembre-2023-roma]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/65th-ash-annual-meeting-and-exposition-9-12-dicembre-2023-san-diego-usa]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-state-of-the-industry-briefing-2024-8-gennaio-2024-san-francisco]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/pharmameet-2024-12-14-febbraio-2024-roma-e-online]]></loc><lastmod>2024-05-16T10:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/aaas-annual-meeting-2024-15-17-febbraio-2024-denver-stati-uniti]]></loc><lastmod>2024-09-26T14:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esmo-tat-congress-2023-26-28-febbraio-2024-parigi-francia]]></loc><lastmod>2024-09-26T14:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xxi-conferenza-internazionale-parent-project-16-18-febbraio-2024-roma]]></loc><lastmod>2024-09-26T14:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ricerca-genomica-e-malattie-rare-dal-laboratorio-al-paziente-21-febbraio-2024]]></loc><lastmod>2024-09-26T14:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-congress-2024-19-20-marzo-2023-londra]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mediterranean-9-11-aprile-2024-roma]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ii-international-meeting-on-cell-science-and-molecular-biology-11-13-marzo-2024-lisbona-portogallo]]></loc><lastmod>2024-09-26T14:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/2nd-nota-annual-meeting-14-15-marzo-2024-torino-e-online]]></loc><lastmod>2024-09-26T14:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/human-genome-meeting-2024-8-10-aprile-2024-roma]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crispr-medicine-conference-2024-23-25-aprile-2024-copenaghen]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/ii-international-cell-science-and-molecular-biology-forum-6-8-maggio-2024-praga]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-congress-on-cardiology-cardiac-diseases-27-28-maggio-2024-roma]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/european-human-genetics-conference-eshc-1-4-giugno-2024-berlino-e-online]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xxiv-national-congress-of-italian-association-of-myology-5-8-giugno-2024-roma]]></loc><lastmod>2024-11-21T17:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esgct-congress-2024-22-25-ottobre-2024-roma]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/trieste-next-2024-27-29-settembre-2024-trieste]]></loc><lastmod>2025-03-13T13:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/taranto-biotech-days-2024-11-13-ottobre-2024-taranto]]></loc><lastmod>2025-03-13T13:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mesa-2024-7-9-ottobre-2024-arizona-usa]]></loc><lastmod>2025-03-13T13:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/7th-international-conference-on-crispr-technologies-14-16-ottobre-2024-california-usa]]></loc><lastmod>2025-03-13T13:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/world-orphan-drug-congress-europe-2024-22-25-ottobre-2024-barcellona]]></loc><lastmod>2025-03-13T13:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/14-convegno-nazionale-sulle-malattie-mitocondriali-25-27-ottobre-2024-padova]]></loc><lastmod>2025-05-29T11:06:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-congress-2024-12-13-novembre-2024-philadelphia-usa]]></loc><lastmod>2025-05-29T11:06:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/5th-annual-genome-editing-therapeutics-summit-3-5-dicembre-2024-boston-usa]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/66th-ash-annual-meeting-and-exposition-7-10-dicembre-2024-san-diego-usa]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/translating-innovation-into-access-for-atmps-3rd-eu-innovation-network-multi-stakeholder-meeting-15-novembre-2024-online]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/stem-cell-revolutions-for-neurodegenerative-diseases-27-novembre-2024-milano]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/aaas-annual-meeting-2025-13-15-febbraio-2025-boston-stati-uniti]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xi-edizione-del-premio-omar-18-febbraio-2025-roma]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esmo-tat-congress-2025-3-5-marzo-2025-parigi-francia]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-technologies-in-single-cell-omics-4-5-febbraio-2025-milano]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/the-state-of-cell-and-gene-therapy-29-gennaio-2025-online]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/human-genome-meeting-2025-12-14-marzo-2025-durban-sud-africa]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xxii-conferenza-internazionale-parent-project-28-febbraio-2-marzo-2025-roma]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/assistenza-e-ricerca-sulle-malattie-rare-in-umbria-la-terapia-genica-in-clinica-28-febbraio-2025-perugia]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xxii-convention-scientifica-17-19-marzo-2025-rimini]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/iii-meeting-annuale-nota-27-28-marzo-2025-torino]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/cell-gene-meeting-on-the-mediterranean-15-17-aprile-2025-roma]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/advanced-therapies-congress-2025-18-19-marzo-2025-londra]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crispr-medicine-conference-2025-7-11-aprile-2025-copenaghen]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/malattie-rare-e-innovazione-la-sicilia-una-eccellenza-nel-campo-della-terapia-genica-8-aprile-2025-online]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/executive-masterclass-cmc-e-gmp-per-atmp-14-23-maggio-2025-online]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isct-congress-7-10-maggio-2025-new-orleans-usa]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xxv-national-congress-of-italian-association-of-myology-28-31-maggio-2025-taormina]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/28-conferenza-annuale-asgct-13-17-maggio-2025-new-orleans-stati-uniti]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/the-european-human-genetics-conference-2025-24-27-maggio-2025-milano-e-online]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/broadening-and-securing-access-to-atmps-6-giugno-2025-roma]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/looking-towards-the-future-16-17-giugno-2025-napoli]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/congresso-eha-2025-12-15-giugno-2025-milano]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isscr-2025-annual-meeting-11-14-giugno-2025-hong-kong]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/car-t-cells-in-ematologia-18-giugno-2025-treviso]]></loc><lastmod>2025-06-12T11:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esgct-congress-2025-7-10-ottobre-2025-siviglia]]></loc><lastmod>2025-09-16T21:12:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/congresso-internazionale-della-cell-transplant-and-regenerative-medicine-society-22-25-ottobre-2025-tokyo]]></loc><lastmod>2025-09-16T21:12:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crispr-cas-from-biology-to-therapeutic-applications-2-5-novembre-2025-sorrento]]></loc><lastmod>2025-09-16T21:12:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/rna-based-innovative-therapies-for-neurological-disorders-5-7-ottobre-2025-napoli]]></loc><lastmod>2025-09-16T21:12:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/esgct-academy-26-29-agosto-parigi]]></loc><lastmod>2025-07-21T13:01:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/v-convegno-italiano-sulle-terapie-avanzate-i-radiofarmaci-17-19-settembre-2025-rimini]]></loc><lastmod>2025-09-18T21:10:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xxviii-congresso-della-societa-italiana-di-genetica-umana-23-25-settembre-2025-rimini]]></loc><lastmod>2025-09-16T21:12:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/the-pharmacology-of-rna-drugs-an-unmet-pharmacological-need-tackled-by-the-national-centre-of-rna-drugs-4-5-novembre-2025-milano]]></loc><lastmod>2025-10-08T22:38:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/atmp-sweden-2025-conference-27-28-novembre-2025-gothemburg-svezia]]></loc><lastmod>2025-11-20T11:33:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/convegno-macula-today-2025-17-novembre-2025-roma]]></loc><lastmod>2025-11-06T11:02:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/premio-galileo-2025-20-21-novembre-2025-padova]]></loc><lastmod>2025-11-20T11:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/mitoconference-2026-23-25-gennaio-2026-pisa]]></loc><lastmod>2026-01-12T14:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/the-state-of-cell-and-gene-therapy-21-gennaio-2026-online]]></loc><lastmod>2026-01-12T14:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/summit-on-access-and-affordability-in-cell-and-gene-therapies-20-marzo-2026-los-angeles-california-usa]]></loc><lastmod>2026-03-02T09:25:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/crispr-medicine-conference-2026-14-16-aprile-2026-copenaghen-danimarca]]></loc><lastmod>2026-03-31T21:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/xii-edizione-del-premio-omar-18-febbraio-2026-roma]]></loc><lastmod>2026-01-22T15:37:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/isct-2026-6-9-maggio-2026-dublino-irlanda]]></loc><lastmod>2026-03-31T21:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/iv-annual-meeting-nota-26-27-marzo-2026-torino]]></loc><lastmod>2026-03-02T09:25:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/truffe-a-base-di-staminali-il-contributo-di-ota-a-presadiretta-1-marzo-2026-rai3]]></loc><lastmod>2026-03-03T16:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/sitgec-2026-annual-meeting-17-18-luglio-2026-milano]]></loc><lastmod>2026-04-09T11:10:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/icle-2026-15-17-luglio-2026-milano]]></loc><lastmod>2026-04-09T11:10:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/il-futuro-e-adesso-2-aprile-2026-roma]]></loc><lastmod>2026-03-31T21:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/agenda/woma-forum-25-26-giugno-2026-milano]]></loc><lastmod>2026-04-09T11:10:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/cerca-nel-sito]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/news/che-cos-e-la-medicina-rigenerativa-intervista-a-giulio-cossu]]></loc><lastmod>2019-02-27T10:34:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/privacy-policy]]></loc><lastmod>2022-03-21T10:24:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/cookies-policy]]></loc><lastmod>2019-03-06T09:28:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/newsletter]]></loc><lastmod>2019-10-24T07:18:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/recensione-libri/la-paura-delle-biotecnologie-un-libro-di-francesca-ceradini]]></loc><lastmod>2021-03-26T12:20:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/crispr]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/manifattura]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/coronavirus]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/car-t]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatorioterapieavanzate.it/video]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url></urlset>